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UNIVERSITY OF EDINBURGH
ABSTRACT OF THESIS 3.5.10,
This thesis has outlined the development of operations for duodenal ulcer from gastro¬
enterostomy which sought initially to merely bypass the ulcer, to an increasing
physiological approach which progressively sought to reduce gastric secretion whilst
minimising operative sequelae. The published results for gastro-enterostomy alone,
Polya gastrectomy, truncal vagotomy with gastro-enterostomy and with pyloroplasty
and finally for highly selective vagotomy have been critically reviewed. Dissatisfaction
with operative mortality and recurrent ulcer as the sole criteria of success led to the
development of methods to assess quality of life. The application of computer technology
has permitted analysis of quality of life over some 20 years after five principal operations
for duodenal ulcer at the Western General Hospital, Edinburgh. Paradoxically partial
gastrectomy was associated with a superior quality of life than the more commonly used
procedures involving truncal vagotomy. Highly selective vagotomy has been shown to
be a safe and effective operation for duodenal ulcer which modifies the diathesis so that
recurrent ulcer is more amenable to medical therapy. The incidence of duodenal ulcer
has been shown to be in continuing decline. The treatment of perforated duodenal
ulcer by simple closure and H2 receptor antagonists has been shown to have superseded
immediate definitive operation for perforated ulcer. Surgical treatment of duodenal
ulcer has been shown to be associated with an increased long term mortality
predominantly through increased respiratory and circulatory deaths in the first post¬
operative year. A long term increase in death from malignant disease particularly of
bronchus has also been demonstrated.
INTRODUCTION
THE DEVELOPMENT OF SURGICAL TREATMENT FOR DUODENAL ULCER
1.
Although there are records in Greek, Roman and Medieval manuscripts
of symptoms which can be interpreted with hindsight as descriptions of
duodenal ulcer, the first clear record of the symptoms and pathology was by
Sir Benjamin Travers in 1817 (Travers 1817). In 1830 Dr. John Abercrombie,
an Edinburgh physician described in great detail 7 cases of duodenal ulcer
(Abercrombie 1830). The cases include the first accounts of the clinical
features of duodenal ulcer, including the relationship to meals and localisation
of pain in the epigastrium. Abercrombie also described post mortem
findings after fatal haemorrhage, but noted that the "quantity of blood
brought up is often immense - and yet the disease is often not fatal". He
also recognised perforation describing a specimen in the museum of The
Royal College of Surgeons of Edinburgh in which a perforated duodenal ulcer
was clearly demonstrated. That specimen remains on display in the College
museum today and is shown in Plate 1.
Plate 1
Specimen of perforated duodenal ulcer in Museum of RCSEd.
described by Abercrombie (1830). (Photograph courtesy of the
conservator of the museum RCSEd.)
2.
Abercrombie's was the first clear description of the symptoms of
duodenal ulcer disease and is worth quoting. He wrote "The leading
peculiarity of disease of the duodenum seems to be that the food is taken
with relish and the first stage of digestion is not impaired; but the pain
begins about the time when the food is passing out of the stomach or about
two to four hours after a meal". This was the first occasion in which the
possibility of making the diagnosis in life had been suggested. Abercrombie's
contribution was followed by similar reports from Treir in Copenhagen,




In 1867 Clark at the London Hospital described the clinical features
of perforated duodenal ulcer thus introducing the condition as a possible
cause of peritonitis (Clark 1867). Mackenzie in 1888 wrote that
"duodenal ulcer, although much rarer than gastric ulcer is not so very
uncommon as the textbooks would imply" (Mackenzie 1888). The turn of
the century saw a dramatic rise in duodenal ulcer and fall in gastric ulcer.
The earliest recommendations about treatment were those of
Abercrombie (1828) who recommended milk, a view endorsed by Cruveilhier
(1842). Brinton (1856) and Fox (1875) recommended the use of regular
meals and antacids. Sippy (1915) advocated regular bland meals and
milk in an effort to ensure thorough and continuous neutralisation of acid.
The growing body of knowledge about the clinical features increasingly
allowed surgeons to diagnose duodenal ulcer with sufficient confidence to
operate. The contributions of Mayo-Robson (1900) and of Moynihan (1900)
in describing the clinical features, and operative treatment were immense.
The history and development and published results of the surgical
treatment of duodenal ulcer are described in the initial chapters of this
thesis. The results obtained at the Western General Hospital, Edinburgh,
in terms of curing the symptoms of duodenal ulcer disease, and immediate
and long term side effects and complications created by the treatment
are considered in later chapters.
FOREWORD
DUODENAL ULCER A DISEASE OF THE 20TH CENTURY ?
4.
The surgery of duodenal ulcer disease may well be seen by future medical
historians as a phenomenon of the 20th century. Although a clear
description of the clinical features had been given as early as 1830, the
condition was rarely diagnosed in life before the end of the century.
The early gastric operations - gastric resection and gastro-enterostomy -
devised for the treatment of gastric cancer, were first performed
successfully in 1881, by Billroth and his assistant Wolfler. During the
following decade these operations were applied to duodenal ulcer. Before
the turn of the century the operation was usually performed for vomiting
when a preoperative diagnosis of gastric cancer had been made. It was
natural that the inflammatory mass discovered on such occasions should be
treated by bypass in the form of gastro-enterostomy.
As the new century began gastro-enterostomy became the accepted
procedure as duodenal ulcer was diagnosed clinically with increasing
confidence. In the first decade of the 20th century the advocacy of gastro¬
enterostomy by Moynihan and Mayo helped ensure the predominance of
this procedure in the treatment of duodenal ulcer until the time of the First
World War.
The problem of stomal ulceration had been described soon after the
introduction of the procedure, yet it was not until the 1920's that this was
shown to be a common problem. In the post-war decade an increasing
number of surgeons notably Polya in Hungary, von Heberer in Germany and
Lewisohn in the United States began to recommend gastric resection for the
treatment of chronic duodenal ulcer. In the 1930's in continental Europe
and the U.S.A. and in the 1940's in Britain, gastrectomy gradually superseded
gastro-enterostomy as the preferred operation.
The incidence and prevalence of duodenal ulcer had continued to rise until
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the mid 1950's in both the U.S.A. and the U.K. By the middle of the 20th
century, it had reached virtual epidemic proportions affecting some 10% of
the population of the U.K. at some time in their lives. Research into its
aetiology and treatment came to dominate surgical departments throughout
the Western World in the 1940's and 1950's.
As understanding of the physiological control of gastric secretion
increased so operations based on decreasing vagally and antrally mediated
acid output were introduced. Dragstedt reported truncal vagotomy in man
for the first time in 1943, and, combined with antrectomy in the U.S.A. and
with a drainage procedure in the U.K., this gained in popularity throughout
the 1950's and 1960's.
Thereafter the incidence and prevalence began to decline and that
decline continues. Paradoxically the onset of this decline coincided with the
widespread introduction of more physiological surgical operations with fewer
side effects. The emergence of the long term sequelae of gastric resection
had added impetus to the search for safer procedures. Truncal vagotomy
and drainage became the favoured surgical procedure for duodenal ulcer in
the 1960's in the U.K. and most of Europe. The problems of gastric
incontinence, resulting from the drainage procedure, and of parasympathetic
denervation of the entire gastro-intestinal tract from truncal vagotomy,
pushed research in the direction of less radical more physiological techniques
to reduce gastric acid output. The development of selective vagotomy by
Griffith and Harkins in the late 1950's led in turn to the description of highly
selective vagotomy by Johnston and Amdrup in the late 1960's. This was
widely practised, particularly in European centres, throughout the 1970's and
1980's.
6.
It was ironic that as surgical treatment became safer and more
effective so the incidence of the disease began to decline from about the
middle of the 20th century. There followed a decline in ulcer operations
which was precipitated when effective medical treatment became
available for the first time at the start of the last quarter of the century.
As we enter the last decade of the century the flood of ulcer operations
of fifty years ago has slowed to a trickle. Indeed elective surgical
operations have all but disappeared throughout the developed world.
Non-operative techniques are increasingly displacing emergency operations
for bleeding and to a limited extent for perforation.
At the time of writing surgery for duodenal ulcer is almost exactly
100 years old. It seems a particularly appropriate time therefore to assess
the contribution of surgery to the management of duodenal ulcer.
This thesis aims to trace the development of the various operations
which have been used to treat this disease and to assess their strengths
and weaknesses.
The work on which the thesis is based was done in the Western General
Hospital, Edinburgh. The Gastro-Intestinal Unit was established at the
start of the National Health Service aimed to investigate and treat patients
with gastro-intestinal disease using a combined medical and surgical approach
(Card and Bruce 1958).
Duodenal ulcer was the problem which dominated gastro-intestinal
practice at that time. Card in 1952 had been the first to demonstrate the
phenomenon of maximal acid output from the parietal cell mass in response
to histamine (Card 1952), work acknowledged by Kay in his seminal paper
the following year (Kay 1953). Subsequently Card and Marks demonstrated
a linear relationship between the maximal acid output from the stomach and
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the number of parietal cells in duodenal ulcer patients. The demonstration
that patients with duodenal ulcer had a spectrum of maximal acid output
led to the hypothesis that logically operation for the ulcer should be
determined by the level of acid output - the more radical procedures
being indicated for high acid secretors, ranging through vagotomy for
medium secretors to gastro-enterostomy alone for low secretors.
Until that time the choice of operation had been largely an arbitrary
one. In order to assess the results of this treatment policy and to assess the
long term outcome after operations for duodenal ulcer, the Gastric Follow-
Up Clinic was established by W. P. Small in 1959. Details of these patients,
their operations and the outcome of those operations were meticulously
recorded over some 30 years so that by 1985 over 4500 patients had been
documented.
The aim of the thesis is to establish the part played by surgery in the
treatment of duodenal ulcer by analysing the results of the various
operations used in its treatment. The results of the principal operations
in terms of relief of symptoms, side effects, quality of life and cause of
death are critically assessed.
PART I





In many respects it is surprising that gastric resection represented
the first surgical attempt to treat duodenal ulcer, preceding the less
demanding procedures of gastroenterostomy or vagotomy.
Gastrectomy was introduced for the treatment of obstructing antral
or pyloric tumours and it was a logical step for this then to be applied
to obstructing duodenal ulcer disease.
The first published account of gastric resection was that of Christian
Michaelis, Professor of Surgery at Marburg University 1786-1814.
Aware of the problem of gastric outlet obstruction he attempted
unsuccessfully to resect the pylorus in experimental animals.
However, in 1810 his pupil Daniel Merrem was able to perform the
successful resection of the distal stomach with restorative anastomosis
to the duodenum in three animals (Merrem 1810).
Temkin's translation of the original work indicates that the resection
was a very limited one with only 0.6 cm. of tissue being excised from
either side of the pyloric sphincter (Temkin 1957). It was nonetheless
an important advance which Billroth referred to and drew inspiration
from 70 years later. The first gastric resection in man was performed
by Jules Pean, a Parisien surgeon who had carried out the first
successful splenectomy in 1867. In April 1879 Pean performed what
amounted to a pylorectomy for a carcinoma at the pylorus but the patient






Credit for the first planned gastric resection in man is given to Ludwig
Rydygier. Born in Poland in 1850 he studied medicine in Berlin where he
received his M.D. thesis in 1874 for investigations into the effects of
carbolic acid. This was an important contribution to antisepsis as it
described not only the benefits but also the side effects of carbolic acid used
10.
as a surgical antiseptic (Rudowski 1986). He was thus familiar with the
advances in antisepsis and anaesthesia which paved the way for modern
gastro-intestinal surgery. Rydygier also was well versed in experimental
method. A series of gastric resections in dogs preceded his operations in
man. On November 16th, 1880 he performed a limited gastric resection
with a two layer gastro-duodenal anastomosis on a patient with an antral
cancer. As with Pean's original effort Rydygier's operation was not




It is the name of Theodor Billroth that will for ever be eponymously
associated with gastric resection. Although not the first, his was the
first successful gastric resection, the patient surviving for four months.
It was Billroth and the school which he established which laid the
foundations upon which gastric surgery was built.
Billroth was born in 1829 at Bergen on the island of Rugen just off
the North German Coast. From his early years Billroth had shown a
love of music and was a gifted pianist. Although he wished to pursue
a career as a musician his mother had decided that he should instead
become a doctor but throughout his life he never relinquished his
enjoyment of music. He became a close friend and confidant of
Johannes Brahms and many of the young surgeons he chose as assistants
were also talented musicians (Mendelbaum 1957).
The family moved to Griefswald where Billroth began his medical
studies in 1848. After studying for three years at Gottingen, Billroth
qualified in medicine from Berlin in 1852. The influence of Langenbeck,
at that time the leading German surgeon of his day, and von Graefe
attracted him to a surgical career (Sigerist 1971). In 1860 he became
the Professor of Surgery in Zurich and here, by meticulous collection of his
results and their presentation before his contemporaries, he laid the
foundations for surgical audit. He was the first clinician to systematically
record patient temperature and to record the results of operations not
only in terms of in-patient but also 5 year outcome.
In 1867 Billroth accepted the Chair of Surgery in Vienna. This
appointment of a Prussian, coming as it did just one year after the defeat
of the Austrian armies at the hands of the Prussians at Sadowa, was not
an easy decision either for Billroth or for the faculty in Vienna where
anti-Prussian feeling was high. Gersterer, an American surgeon who
studied at Billroth's clinic, speculated that his move to Vienna was to
join Brahms who had moved there one year earlier (Gersterer 1917).
Whatever the reason behind it, with this move to Vienna began one of the
most productive and important periods, perhaps the single most important,
in the history of gastric surgery.
Plate 5
Theodor Billroth
The foundations for the many surgical innovations which Billroth's
school was to produce were laid on firm scientific principles. In 1878
his first assistant Wolfler was sent to Lister's Edinburgh clinic and when
he returned the principles of antisepsis were adopted in Vienna.
The concept of gastrectomy was first tested in the animal laboratory
by two assistants, Gussenbauer and von Winiwater in 1874. They
performed what has come to be known as a Billroth I gastrectomy and
obtained long term survival in two of seven dogs. Having demonstrated
that the technical problems could be overcome they moved on to assess
the feasibility of resecting gastric tumours in man. In an autopsy
study they found that 223 (41%) of 542 pyloric tumours had no metastases
and that 43% were mobile (Gussenbauer and von Winiwater 1876).
These preliminary studies paved the way for the first planned and
successful gastric resection. In 1877, following success with the first
gastrorrhaphy Billroth felt sufficiently confident to predict that "No
insurmountable obstacles to partial excision of the stomach exist, either
on anatomical, physiological grounds. It must succeed." That first
successful gastrectomy was performed by Billroth on January 20th, 1881
(Billroth 1881). Ziegler in a review of the operation records, described
the lengthy pre-operative gastric lavage lasting one and a half hours. The
procedure was performed under Chloroform anaesthesia and all drapes
and sutures soaked in carbolic although Lister's carbolic spray was not
used. A transverse abdominal incision was made. The duodenum was
divided 1.5 cm. distal to the tumour and anastomosed to the stomach with
carbolised silk. The patient recovered well only to die of tumour
recurrence some 4 months later (Ziegler 1949). Billroth in his Offenes
Schreiben emphasised the preparation which had led up to this first
successful gastrectomy when he wrote "Gastric resection like any other
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operation has been fully prepared anatomically, physiologically and
technically by my pupils and myself" (Billroth 1881). By 1890 some 41
gastrectomies had been performed at Billroth's clinic with 19 operative
successes.
Gastric resection had become established in surgical practice not by
serendipity but as the result of a methodical progression through animal
research, planned surgical procedures, careful follow-up, autopsy studies
and statistical analysis.
The first gastric resection for peptic ulcer was first performed by Ludwig
Rydygier. Like Billroth, whom he had visited in Vienna, his surgical
innovations were based on preliminary laboratory research. After initial
studies on experimental dogs, and the initial failure described above, he
performed a successful resection in November 1881 for a prepyloric peptic
ulcer (Rydygier 1882). His account in Zentalblatt fur Chirurgie of this
first gastrectomy for ulcer was accompanied by an editorial footnote
"Hoffenentlich auch letzte" (Hopefully also the last).
Far from being the last it was the start of a new era of surgical
treatment for the new epidemic of peptic ulcer disease.
It was Billroth himself who in 1885 performed the first major modification
of gastrectomy - duodenal stump closure and gastro-jejunal anastomosis -
the Billroth II procedure or Polya procedure.
Inevitably it was in Billroth's clinic that first refinements to the technique
of gastrectomy with gastro-jejunal anastomosis were made and these will
be described shortly.
As experience with the procedure increased so the mortality from
Billroth I gastrectomy continued to fall. By 1890 the operative mortality
in Billroth's clinic was around 5096. The next decade saw improvements in
surgical technique and postoperative care which progressively reduced this
operative mortality.
Mayo-Robson and Moynihan in 1901 reviewed the mortality rates from
several major clinics and the results are shown in Table 1.1.
Date Cases Deaths % Mortality
Kocher 1898 57 5 8.7%
Konlein 1898 24 5 20.8%
Czerny 1899 29 11 37.9%
Rutherford-Morrison 1900 16 7 43.7%
Table 1.1
Mortality following gastrectomy (from
Mayo-Robson and Moynihan 1901)
Although the procedure was widely practised in continental Europe by the
turn of the century, in Britain and America gastrectomy was slower in
gaining acceptance because of the advocacy of gastro-enterostomy as a
safer, more effective operation. A summary of the history and development
of the operation is shown in Table 1.2.
1879 Pean unplanned, unsuccessful
1880 Rydygier planned, unsuccessful
1881 Billroth planned, successful
1882 Rydygier for peptic ulcer
1902 Kocher side to end
1911 Shoemaker lesser curve resection
1922 von Haberer end to side
1947 Perman as conversion for dumping
1953 Harkins as antrectomy with vagotomy
Table 1.2
Summary of History of Billroth I
Gastrectomy
The popularity of the procedure for duodenal ulcer was in decline by the
1950's. A few enthusiasts like Bohmasson (1953) and Nissen (1953)
continued to report good results, Nissen claiming only 1 death in his
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latter 277 cases (an operative mortality of 0.4%) without any recurrent ulcer.
In the years after the Second World War the increasing understanding
of the physiology of gastric secretion and of ulcer disease enabled several
investigators to test the scientific basis of the various operations for
ulcer. Salmon (1959) measured gastric and duodenal pH in dogs after
Billroth I or Billroth II gastrectomy. Whilst gastric pH was similar after
each procedure, duodenal pH was significantly more acidic after Billroth I.
In the 1950's and 60's series were published with more complete follow-up
extended over many years and with ever improving techniques of radiological
and endoscopic diagnosis. The recurrence rates were high. Ordahl (1955)
28.6%; Goligher (1956) 17.5%; Walters (1956) 21.9%; Fisher (1958) 13.1%;
Borg (1969) 17.6% and Goligher (1970) 13.7% were typical. By this time
the long term nutritional and metabolic effects of gastrectomy were
well established and vagotomy, which promised less morbidity, was
increasing in popularity. Studies comparing Billroth I and Billroth II
had clearly shown a much higher recurrence rate for the former (Table 1.3).




































Recurrent ulcer after Billroth I and Billroth II gastrectomy
for duodenal ulcer in published series
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These studies might well be regarded as the epitaph of the Billroth I
procedure in the treatment of duodenal ulcer.
The reasons for the failure of the procedure in duodenal ulcer are
probably two-fold. Firstly only a limited amount of stomach can be
resected whilst ensuring that the gastro-duodenal anastomosis is under no
tension. It seems likely therefore that in many instances the operation
failed because antral resection was inadequate. Secondly, the gastro-
duodenal anastomosis allows ingested food to pass through the duodenum
stimulating gastrin release, a phenomenon which does not occur after
the Billroth II procedure.
The Billroth I procedure was the first surgical treatment of duodenal
ulcer and its ability to cure the ulcer diathesis was similar to that of some
of the more physiological procedures which were to follow. The mortality
and long term morbidity, however, combined with such a high rate of
recurrence rendered this, the first operation for peptic ulcer, obsolete.
Gastro-enterostomy, whose origins and development are considered in
detail later, had first been described in Billroth's clinic (Wolfler 1881).
Two influential surgeons, Moynihan (1908) and Mayo (1904) published results
which claimed gastro-enterostomy as an effective treatment of ulcer with a
lower mortality than gastrectomy. As a result it remained the procedure
of choice in the U.S.A. until the 1930's, and Britain till the 1940's.
Reports of a high incidence of stomal ulceration following gastro¬
enterostomy (Lewisohn 1925) and the influence of Ileanage Ogilvie converted
British and American surgeons to gastrectomy over the next two decades.
In continental Europe, however, gastric resection, initially largely
Billroth I, became the most popular treatment for the increasing tide of
duodenal ulcer disease. Shoemaker (1911), von Haberer (1915) and
Friedman (1922) were prominent advocates.
By the decade 1920-1930 gastrectomy, (by this time largely Billroth II
gastrectomy) had become the accepted procedure for duodenal ulcer on
the continent of Europe, in America 10 years later, and in Britain after the
Second World War.
Several authors continued to advocate Billroth I gastrectomy for
duodenal ulcer, most notably von Haberer, who published the results of his
initial experience in 1919 (von Haberer 1919). In a series of papers
published over the next three decades he continued to promote this
operation claiming it to be more physiological. By 1947 he was able to
report a vast personal series of 3602 gastrectomies for duodenal ulcer,
of which 2152 were Billroth I (von Haberer 1947). The quality of his
follow-up information is not and could not have been acceptable by today's
standards. He claimed that in 1644 consecutive Billroth I gastrectomies
recurrence was observed in only 12, a rate of 0.7%. The recurrence
rate following Billroth II gastrectomy was allegedly 0.5% (6/1111).
Plate 6
Hans von Haberer
von Haberer continued to publish his experience with the procedure until
1952 some 37 years after his first contribution (von Haberer 1952).
CHAPTER 2
BILLROTH H (POLYA) GASTRECTOMY
The original Billroth II gastrectomy performed by Billroth for antral
cancer in 1885 has been referred to in Chapter 1.
Billroth's original procedures involved closing the divided antrum with a
row of sutures and performing an anterior gastro-enterostomy. Many
variations have been described and the following account is limited to those
which are considered, in retrospect, to have improved the technique or to
have been widely practised.
As more extended resections for cancer were performed, Krolein (1888)
advocated the anastomosis of the jejunum to the entire length of the divided
stomach.
Hofmeister (1888) partially closed the divided antrum leaving the distal
5 cm. as a stoma to which the jejunum was then anastomosed.
Braun (1892) and Jaboulay (1892) independently modified this by describing
an entero-anastomosis between afferent and efferent loops. This
represented an attempt to overcome the problems of vomiting, a post¬
operative complication which had been recognised since the early days of
both gastrectomy and gastro-enterostomy.
von Eiselsberg, a pupil of Billroth, described in 1889 the closure of the
divided proximal stomach and linear gastrotomy to allow for a smaller
gastro-jejunal stoma (von Eiselsberg 1889). The credit for this variation has
been ascribed to Polya whose report in 1911 was given widespread exposure by
Mayo resulting in subsequent eponymous fame. During the period up to the
end of the First World War a number of modifications to the Billroth II
gastrectomy had been described - almost all of them by continental surgeons.
Hofmeister (1908), Polya (1911), von Haberer (1915) and Finsterer (1918)
making the most important contributions.
Franz von Hofmeister (1867-1926)
Plate 7
Franz von Hofmeister
Polya of Budapest described a retrocolic anastomosis, with the advantage
of the short afferent loop, and a gastro-jejunal anastomosis along the length
of the divided stomach with no valvular arrangement (Polya 1911).
Although Polya performed over 2000 of these resections for duodenal
ulcer during his working lifetime, the operation took some time to become
established in the treatment of duodenal ulcer.
22.
It is relevant to speculate on the reasons for this. Undoubtedly the
popularity of gastroenterostomy resulted from its enthusiastic advocacy






Moynihan's record of "only one death in the last thousand cases" (Moynihan
1932) must have been a powerful argument against gastrectomy whose
mortality in the best hands in that period was of the order of 20%
(Table 2.1) and for the average surgeon presumably even higher.
Secondly, although Edkins had in 1906 described a substance isolated
from the pyloric mucosa which increased acid output and which he called
gastrin (Edkins 1906), surgical thinking was slow to follow the logic that
removal of the antrum would reduce acid output. For example Cook
writing from Chicago some 40 years later referred to the "yet unproven Edkins
theory". This despite the maxim of "no acid no ulcer" which had been
described as early as 1910 by Schwarz (Schwarz 1910). By the 1930's
research into antral function was following two separate lines. Groups
like those of Grossman and Gregory looked for a substance secreted by the
antrum while others like Dragstedt concentrated more on the function of the
antrum by excluding, isolating and denervating.
The Billroth II resection was slow to find favour in the U.S.A. and
even slower in Britain. Lewisohn's favourable results from the Billroth I
procedure published in 1925 compared to his 30% recurrence rate after
gastro-enterostomy began to sway surgical opinion in the U.S.A. toward
gastrectomy (Lewisohn 1925). Strauss and his colleagues reported a series
in 1930 with a 5.4% mortality rate (Strauss 1930). Yet by 1935 at the
Mayo clinic less than 10 per cent of operations for duodenal ulcer were











With increasing disenchantment about the rate of stomal ulceration
following gastro-jejunostomy the Billroth II resection became widely adopted
throughout Europe and America as the operation of choice in the years after
World War II. In Britain as a result of wartime service more surgeons came
under the influence of Heanage Ogilvie, a committed gastrectomist for
duodenal ulcer since the mid 1930!s.
The experimental work on the gastric phase of acid secretion continued
meantime to provide a surer scientific rationale for the surgical resection
of the gastric antrum in the treatment of duodenal ulcer. Komarov (1938)
isolated gastrin from dry pyloric mucosa and showed it to be a protein.
Unvas (1945) isolated gastrin for the first time from human pyloric mucosa.
Wells records that from 1945 Billroth II resection rapidly supplanted gastro¬
enterostomy as the commonest operation for duodenal ulcer in Britain (Wells 1960).
1935 36 37 38 39 40 41 42 43 44 45 46 47 48 49
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Fig. 2.1
Gastrectomy for D.U. Mayo Clinic 1935-49
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Throughout the 1940's and 1950's Billroth II continued to be the most
popular operative treatment for duodenal ulcer. The published results of
the time suggested that the operation carried what was regarded as a low
mortality (about 2%) and the results were good in 75-90% of patients.
Series published in the 1940's are shown in Table 2.1.
Number of Good Improved Fair to Recurr. Mort.
Cases Poor
Allen (1947) 196 85 _ 15 _ 2%
Bartels (1943) 100 86 6.7 - 6.7 4%
Gaviser (1948) 364 86 10 4 1 4.5%
Gray (1949) 223 83 13 4 3.0 2.6%
Helferty (1950) 178 91.5 - 7.2 1.2 4.5%
Hosford (1949) 200 72 25 3.0 - 0.5%
McClure (1940) 74 78.6 13.8 - 4 5.3%
MiHer T.G. (1946) 113 92.6 - - -
MRler G. (1942) 230 90 10 - 0 3.0%
Mimpriss (1948) 248 73 22 5.0 0 2.0%
Rienhoff (1945) 260 78 12 8.0 - 2.0%
Sanders (1945) 101 90 - 10.0 - 2.7%
St. John (1948) 344 85 - 15.0 1.5-1.4 2.5%
Visick (1948) 505 78.7 16.4 4.9 0.9 4.9%
Walters (1940) 212 83.5 - 14 2.5 1.9%
Stephenson (1948) 72 87 - - 4.0 6.9%
Watson (1947) 132 83 11.4 3 2.3 9.0%
Table 2.1
Series of Polya gastrectomy for duodenal ulcer
published in the 1940's.
(Results in per cent of cases foliowed-up)
The debate in the immediate post war decade was less about which
operation and more about the extent of the gastric resection. By the early
1950's the American Gastroenterological Association Committee on Peptic
Ulcer had documented the mortality and recurrence rates for 2441 patients
having gastrectomy for duodenal ulcer and followed up for a mean of 2.5
years. The operative mortality averaged around 2% and recurrence rate
about the same (Jordan 1951).
Despite these impressive results, doubts grew about the operation.
Gordon-Taylor (1929) and Inglefinger (1944) had alerted the surgical
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community to the possibility of anaemia and weight loss in the long term
but both remained enthusiastic gastrectomists.
The post war years also saw the rise of the formal Follow-Up Clinic
which for the first time was able to achieve a comprehensive review of
patients for many years after the operation with little loss to follow-up.
These clearly showed that the subtotal resection as advocated for
example by Visick, could reduce recurrence to negligible levels but only at
the expense of frequent dumping, small stomach syndrome and more severe
nutritional and metabolic sequelae.
Anaemia after gastric resection was first described by Moynihan who
suggested that the cause was lack of acid (Moynihan 1911). Faber (1913)
was the first to suggest that there was in addition a macrocytic component.
Morawitz (1930) suggested that the anaemia was usually hypochromic and
that pernicious anaemia was uncommon. Lyngar (1959) showed a disturbance
of absorption of iron and poor utilisation of the iron that was absorbed. In
a review of 33 published reports dealing with some 7500 patients Deller and
Witts (1962) found anaemia in 28% of patients after gastrectomy. In 0.33%
of these the anaemia was megaloblastic. Both Mahmud (1973) and Buxton
(1977) suggested that Vitamin B12 deficiency was rather more common and
that the incidence increased with time. Fischer (1984) found that 7% of
766 patients were anaemic 22-30 years after resection but in none of these
was the anaemia megaloblastic. Even with the prolonged follow-up possible
in those studies published in the 1980's there is discrepancy in the incidence
of post gastrectomy anaemia. Dinbar (1980) found 5% whilst Tovey and
Clark (1980) described a 40% incidence.
Vitamin B12 deficiency varied from 10-50% in the published literature
(Deller 1962, Schafer 1973, Mahmud 1974). Some series, however, have
shown no Vitamin B12 deficiency on long term follow-up (McEwan 1972,
Buxton 1977, Dinbar 1980).
Metabolic bone disease following gastrectomy was documented by
Everson in 1952. Because of the need, until recently, to establish the
diagnosis by bone biopsy studies have almost certainly included senile
osteoporosis as many of the post gastrectomy patients studied had reached
the age group in which this is common. The incidence has consequently
varied in the reported literature from 0.4% to 43% (Jones 1963, Morgan
1965, Eddy 1971, Silen 1973).
Weight loss after Polya gastrectomy was documented by Muir (1949)
and by Wells and Welbourne (1951) who stressed the importance of its
relationship to pre-operative weight. Wallensteen (1954) reviewed 17
published studies and found the incidence of significant weight loss after
gastrectomy to vary between 10 and 75%. Ivy (1950) and Raunch (1952)
found that post operative weight loss was related to the extent of the gastric
resection. McLean (1954) and Johnston (1958) suggested that the main
cause of post gastrectomy weight loss was largely due to reduced intake as
a result of reduced gastric capacity.
The series published in the 1950's, 60's and 70's showed Billroth II
resection in a much less favourable light than hitherto in terms both of






















Recurrent ulcer rates in series
of Billroth II gastrectomy
These showed furthermore that the subtotal resection as advocated for
example by Visick, could reduce recurrence to negligible levels but only at
the expense of frequent dumping, small stomach syndrome and more severe
nutritional and metabolic sequelae (Stammers and Williams 1963).
As more and more reports were published showing the long term
nutritional and metabolic sequelae which could follow gastric resection so
vagotomy and drainage increasingly found favour. Stammers and
Alexander-Williams in an authoritative monograph (Stammers and Williams
1963) recorded the results in their series of 75% gastrectomy with a Billroth
II anastomosis. Despite a low operative mortality of 1.4% and a recurrent
ulcer rate of only 2%, they concluded that the operation should be abandoned
because of the long term metabolic sequelae.
In what was to be the last major controlled randomised trial comparing
subtotal gastrectomy with vagotomy + gastro-enterostomy and vagotomy +
antrectomy, the Leeds/York trial showed an advantage for gastrectomy in
terms of Visick grading, recurrent ulceration and no difference in
operative mortality or "post-gastrectomy syndromes" (Goligher 1968).
Yet despite this conclusion the authors were unable to recommend
gastrectomy because of the reported long term sequelae (Cox and Pulvertaft
1968) and because the results of gastrectomy deteriorated with time
(Pulvertaft 1964).
Thereafter subtotal gastrectomy declined in popularity as the operation
of first choice in the U.K. although, as antrectomy combined with





Gastro-enterostomy was first performed in September 1881 by Wo'lfler,




The intention had been to resect an antral tumour which proved at
laparotomy to be immobile and thus unresectable. According to Moynihan's
later account (Moynihan 1910) Wolfler was about to close the abdomen when
his assistant Nicolandoni suggested that a bypass be attempted. An ante-
colic gastro-jejunal anastomosis was fashioned with a long anterior loop.
The patient lived for 4 months. When Billroth himself later attempted the
procedure the patient died after a few days from what sounds like a stomal
obstruction. The result of this early disaster was that the procedure fell
into disrepute in Billroth's clinic and was developed elsewhere. The first
development was introduced by Courvoisier, Professor of Surgery at Basle.
As a result of a series of cadaver studies he concluded that taking the
jejunum through the transverse colon would be less likely to produce
obstruction. In 1883 Courvoisier's pride in the success of this the first
retrocolic gastro-enterostomy clouded his clinical judgement. He took
the patient by carriage to a meeting of the Swiss Medical Association on
the fifth postoperative day. Although she apparently survived this ordeal
she died 5 days later (Waugh 1953).
Successful results following posterior gastro-enterostomy were reported
by von Hacker in 1885 (von Hacker 1885). Gastro-enterostomy for peptic
ulcer was probably first performed by Doyen in 1894 (Olch 1962).
From its earliest days the procedure was complicated by the problem
which Billroth had encountered at his first attempt at the operation -
afferent loop obstruction. A variety of modifications were tried in attempts
to overcome this. In the earliest days the mistaken concept that partially
obstructing the efferent loop would produce equal resistance to gastric
outflow via the stoma resulted in several unsuccessful variations. Chaput
packed iodoform gauze around the efferent loop, while von Hacker (1885)
plicated it with a row of sutures. Rydygier (1884), hitched the afferent
loop to the stomach to widen the angle between them. This was
elaborated by Hadra (1891) who sutured both afferent and efferent loops to
the stomach to widen the angle which the two loops made to the stomach.
A physiological rather than mechanistic approach was adopted by
Rockwitz (1887) who described the first isoperistaltic anastomosis.
In a further attempt to overcome these problems of stomal obstruction,
Jaboulay (1892) described an entero-anastomosis between duodenum and
efferent loop. In the same year Braun performed an entero-anastomosis
between afferent and efferent loops (von Braun 1892). Further refinements
came from Peterson who introduced the no-loop concept in Czerny's clinic
recommending an isoperistaltic anastomosis (Peterson 1900). This operation
was adopted by Mikulicz who demonstrated it to Mayo in 1902. Mayo
(1904) confirmed the benefits of the short loop but considered that there
was no advantage in the isoperistaltic technique. The rationale for the
operation when performed for duodenal ulcer was that the gastro¬
enterostomy would divert food from the duodenum and thereby "rest" the
duodenum. The demonstration in dogs that ingested thiomin blue stained
the duodenum as much as the jejunal loops led to several attempts to close
the duodenum. Kelling (1900) used 3 sutures in the pre-pyloric region, and
Wilms (1912) a strip of fascia. These inevitably failed to exclude the
duodenum. Eiselsberg's suggestion (1910) of complete duodenal exclusion
by division and resuture of the pylorus did not find favour.
The retrocolic "no-loop" operation rapidly gained in popularity. With
increasing experience mortality rates fell as shown by the experience of the
Mikulicz clinic as exemplified by Chlumski (Mayo-Robson and Moynihan 1901).
Cases Deaths % Mortality
1881-1885 35 12 65.7%
1886-1890 114 53 47%
1891-1896 401 136 33.9%
Table 3.1
The decreasing mortality rates
from gastro-enterostomy between
1881 and 1896 at Mikulicz clinic
The operation was championed by Mayo-Robson and Moynihan who in 1901
reported 40 posterior gastroenterostomies for peptic ulcer with only 2
deaths (Mayo-Robson and Moynihan 1902). Moynihan's advocacy of this
as a safe, effective operation was responsible for its widespread adoption in
Britain as the procedure of choice in the treatment of duodenal ulcer - a
position which did not alter until the 1930's.
Plate 10
Lord Moynihan of Leeds
Instead, in 1932 Moynihan was able to write that "in my last 1000 cases
of operation for duodenal ulcer I have had 1 death" (Moynihan 1932). The
influence of W. J. Mayo, who had learned the technique at Mikulicz clinic,
ensured the predominance of gastro-enterostomy as the mainstay of
duodenal ulcer treatment in the U.S.A. until the 1930's.
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The complication, which was to bring about the demise of gastro¬
enterostomy, stomal ulceration, had been noted independently by Braun
and Hahn as early as 1899 (Braun 1899 and Hahn 1899). By 1908
Paterson was able to report 61 cases (Paterson 1908).
The problem had been reported in the English language literature by
authoritative figures like Mayo (1902) and Wilkie (1910). It was generally
accepted that the advantage of much lower mortality more than
compensated for this complication.
The lag period between gastro-enterostomy and stomal ulceration was
first recognised by Van Roojen in 1910. His results showing the delay
between operation and jejunal ulcer are reproduced in Table 3.2.
Table 3.2
Time to appearance of jejunal
ulcer after gastro-enterostomy
(Van Roojen 1910)
Wilkie (1910) reporting 6 jejunal ulcers following gastro-enterostomy,
concluded after histological studies that non-absorbable suture material
was responsible, at least in some, for ulceration and recommended that
absorbable sutures be used.
Within 10 days
10 days - 3 months
3 months - 6 months
6 months - 12 months
12 months - 18 months

















The problem of jejunal ulceration was recognised increasingly
throughout the 1920's, and largely, although not solely, prompted Pribram
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in 1923 to write that "Gastro-enterostomy is a disease and not an operation".
It was Lewisohn who in 1925 published the series which was to move
American surgeons away from gastro-enterostomy as the standard
treatment for duodenal ulcer (Lewisohn 1925). Lewisohn had worked
for 2 years as assistant to Czerney where he had learned not only surgical
techniques but the value of careful audit. His report of a stomal
ulceration rate of 25% proved a major influence on American surgeons.
By the 1930's gastro-enterostomy had been supplanted in the U.S.A. by
gastrectomy as the favoured operation. Wangensteen (1942) recorded
its "obituary as the standard operation for duodenal ulcer". The demise
of the procedure in the Mayo clinic between 1935-1949 is graphically
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Fig. 3.1
The decline in gastro-enterostomy at the Mayo
Clinic 1935-1949
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In Britain gastro-enterostomy as sole treatment for duodenal ulcer
was being performed less often. In 1929 Luff had reported the results on
2609 cases on behalf of the British Medical Association whose members had
contributed cases to the review. His conclusion that the rate of recurrent
ulcer following simple gastro-enterostomy was 2.8% was heralded by a
leading article in the British Medical Journal as the definitive study
endorsing the procedure (Luff 1929). This 'definitive' study was soon
condemned by Hurst who pointed out that no follow-up was obtained in 23%
of patients, that 2-9 years follow-up in the remainder was inadequate to
comment on recurrent ulcer incidence, and that patients who bled or had pain
during follow-up, must be assumed to have recurrent ulcer. He concluded
that the incidence of recurrent ulcer was at least 10% and probably
considerably higher (Hurst 1929).
A similar mass survey was carried out in 1935 by Wright on behalf of
the Association of Surgeons of Great Britain and Ireland. He reported a
recurrence rate of 8.6% in 2051 cases (Wright 1935). In his view follow-up
was unnecessary because most patients return to the same surgeon when
symptoms recur.
Moynihan continued to advocate gastro-enterostomy into the 1930's and
Sherren in 1925 went so far as to say that gastro-enterostomy had done "more
than any other operation for the good of the human race" (Sherren 1925).
Heanage Ogilvie took a different view and his opinion was influential.
He calculated that the true incidence of recurrent ulcer after gastro¬
enterostomy was 20% (Ogilvie 1935). On the basis of this and the low
mortality in the published results of the time, he advocated gastrectomy
which had become the favoured procedure in continental Europe. Ogilvie's
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views were enhanced by the esteem in which he was held in the U.K. and by
his position of seniority in the British Army during the Second World War,
when he rose to the rank of major-general. In 1956 he scathingly condemned
gastro-enterostomy by writing that "For the unskilled surgeon on the unfit
patient it has much to recommend it".
Other reports confirmed a high incidence of stomal ulceration. Clark
(1951) reported 18% and Illingworth (1953) 20%.
Wells (1960) records that after 1945 gastro-enterostomy was rapidly
supplanted in the U.K. by partial gastrectomy because the long term
results were unsatisfactory in 25%. The era of more complete and long term
gastric follow-up had dawned. Clark (1951), from Illingworth's unit, was
able to report a follow-up rate of 77% at 20 years. At 10 years 43% of
patients had recurrent symptoms described as severe in 23%. Tanner (1959)
reported a 50% recurrence rate on long term review. Truncal vagotomy
with antrectomy had replaced it in all but a handful of centres by the late
1950's.
Its continuing use was recorded in two units (both in Edinburgh) into the
1960's and in one of these into the 1970's. Farquharson (1956) expressed
misgivings about the widespread use of gastrectomy with its attendant
sequelae. In support of gastro-enterostomy he recorded 5170 cases
followed up for 4-10 years with a recurrent ulcer rate of 3.5% (Farquharson
1956).
In the Western General Hospital, the selective policy (described in the
foreword to this thesis) in which gastro-enterostomy was reserved for
patients with an MAO below 50 mEq. was proposed by Bruce and colleagues
in 1959 (Bruce, Card, Marks, Sircus 1959). This followed their observation
that jejunal ulcer was more frequent in high acid secretors. In one of the
last published accounts of the results of gastro-enterostomy for duodenal
ulcer, Small and Smith (1977) recorded 139 patients with pre-operative
MAO of less than 30 mEq/hr. who were followed up for 4-18 years. The
recurrent ulcer rate was 2.2%. Results like this, however, were too late
to save gastro-enterostomy as an accepted operation for duodenal ulcer.
Gastro-enterostomy alone is no longer advocated or practised in the
treatment of uncomplicated duodenal ulcer. In retrospect it was a
procedure whose use in duodenal ulcer evolved from its logical use to
bypass the stenosing duodenal ulcer. The rationale for its use in man must
be regarded as defective. It was applied to the problem of ulcer because
it was available rather than planned on an understanding of the underlying
patho-physiology. While truncal vagotomy will reduce the acid response
to circulating pentagastrin or histamine by 65-70% gastro-enterostomy
will reduce it by only 15-20% (Gillespie 1960). As understanding of the
physiology of gastric secretion increased it became apparent that this level
of acid buffering was insufficient in many patients to control the disease
and to prevent jejunal ulceration (Christiansen 1981). Furthermore
Harkins (1961) showed the cyclical increase in acid output resulting from
antral and duodenal stimulation with subsequent increase in gastrin and
somatostatin output which more than negated any buffering effect of
duodenal contents being returned to the antrum. A review of those larger
studies with long follow-up periods suggested that the operation has failed
in its objective in about 30% (Small 1964).
Furthermore, in the days before H2 receptor antagonists, the
development of jejunal ulcer demanded re-operation. Since the arrival
of H2 receptor antagonists some jejunal ulcers can be successfully treated
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with these drugs but this must nonetheless be regarded as failure of the
operation.
Gastro-enterostomy also has nutritional and metabolic sequelae in the
long term. In the series from the Western General Hospital, Edinburgh,
24% of patients lost weight.
Gastrojejunostomy alone as a treatment for duodenal ulcer was
introduced because of expediency, was not based on physiological principles
and its short lived popularity owed more to its safety rather than its efficacy





The earliest known written work on the vagus was that of Marinus, who,
in the first century A.D. described the anatomy of the vagi. None of his
original work survives today but is cited by Galen in his book "On the
usefulness of the Parts of the Body" (May 1968).
The earliest scientific observations on the role of the vagus in gastric
secretion were made by Sir Benjamin Brodie (1814). In a series of
experiments published in 1814, he demonstrated that copious volumes of
watery fluid were present in the stomachs of dogs after sacrifice by an
intravenous injection of arsenic. In dogs whose vagal nerves were sectioned
before sacrifice secretions were absent and in some instances the lining of
the stomach was seen to be completely dry.
Beaumont (1833) among his observations of the gastric fistula of Alexis
St. Martin, noted alterations in the volume of gastric secretion in times
of emotion. Heidenheim (1879) developed an isolated denervated
antral pouch in the dog which was to prove the experimental model for many
of the subsequent studies of the controls of gastric secretion. The
contributions of Pavlov and his school to our understanding of secretory
controls were immense. Jurgens (1892) in Pavlov's laboratory, was able
to demonstrate that subdiaphragmatic vagal section in dogs, could abolish
hydrochloric acid from the fasting gastric juice. Pavlov produced
experimental evidence to demonstrate a cephalic or psychic phase of
gastric secretion mediated through the vagi. Section of the vagi inhibited
this response.
Of particular interest to future developments in the surgery of duodenal
ulcer was his observation that in dogs this inhibition remained present for
several months. The side effects of vagal section were also described about
this time. Cannon (1906) showed that vagotomy in cats delayed gastric
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emptying, while Ungar (1911) found gastric dilatation and stasis in
vagotomised dogs.
Thus by the turn of the century the physiological basis for vagal section
as a means of reducing gastric acid secretion was well established. The
relationship between acid secretion and duodenal ulcer was also becoming
clearer. The interest which Pavlov's school had created in the investigation
of gastric acid secretion was such that the measurement of gastric acid
secretion had become common in clinical practice. In the absence of
investigative tools to diagnose those ulcers which did not bleed or perforate,
a syndrome called "hypersecretion" was described.
It was Moynihan (1908) who gave a clear and authoritative description
of the characteristic symptoms which enabled a much more confident
diagnosis of duodenal ulcer to be made. In an uncompromising dismissal of
prevailing concepts he wrote "Hypersecretion is not a disease in itself.
Hypersecretion is duodenal ulcer".
The early attempts at vagotomy were not designed to lower gastric
secretion. Jaboulay in 1899 was probably the first to perform vagotomy in
man according to McCrea (1926). This procedure was done in an attempt
to treat the abdominal pains of tabes dorsalis. Exner (1912) performed a
subdiaphragmatic truncal vagotomy to try to control the vomiting in tabetic
patients with "gastric crisis". Exner and Schwarzmann (1914) reported 20
cases of gastric crisis treated by vagotomy, with success in 10. Exner
also gave this first description in man of gastric stasis following the
procedure, and advocated a gastrostomy to overcome this complication.
Bircher (1920) reported the results of vagotomy on 20 patients whose
symptoms suggested a diagnosis of gastric ulcer. The symptoms were
reportedly abolished but at operation the diagnosis of ulcer was confirmed in
only one instance.
Latarjet's writings in 1922 had to wait some 40 years before being
afforded the credit they deserved.
After initial cadaver dissection Latarjet described in detail his
technique of vagotomy in which the anterior trunk was divided below its
hepatic branch and the posterior trunk below its coeliac branch. He
presented results of this procedure in 24 patients, 6 of whom had tabetic
crisis. Three of these had vagotomy alone and 3 a vagotomy with gastro¬
enterostomy. The latter was not performed as a drainage procedure to
accompany the vagotomy but was the commonly performed procedure at
that time for the abdominal pain and vomiting of the tabetic crisis to which
Latarjet added vagotomy hoping for a cummulative effect. Eight of his
patients with gastric ulcer were cured by vagotomy alone and seven by
vagotomy and gastro-enterostomy (Latarjet 1922).
Hartzell (1929) showed that vagal section in the dog resulted in a marked
reduction in free and total acid secretion.
McCrea (1926) of Manchester was the first surgeon to suggest that the
vagi-contributed to chronicity and complications of ulcer and recommended
vagotomy for these problems. Pieri (1927) endorsed this view and reported
successful results in eight patients with peptic ulcer.
In 1926 Klein in New York performed anterior truncal vagotomy as an
adjuvant to gastrectomy for duodenal ulcer with the express objective of
further lowering acid output (Klein 1929). In 1938 the same group was able to
report 26 cases all of whom became achlorhydric after the procedure
(Winkelstein and Berg 1938). Thus the rationale for vagotomy in treating
duodenal ulcer and the technical expertise to perform it safely were known
from the 1920's. Why then did it fail to become accepted into mainstream
surgical practice for another 30 years ?
Several reasons contributed to this. The first was failure of surgeons in
clinical practice to consistently perform a complete vagotomy. This
inevitably led to a high failure rate.
Review of the sketches of vagal anatomy made in the 19th and first two
decades of the 20th century shows that although dissection had apparently
been meticulous and the drawings detailed, important deficiences are
apparent (Ruckley 1970). These workers had failed to appreciate for
example the high origin of a branch to the fundus (later described by Grassi
as the "criminal nerve") (Grassi 1977), and the presence of branches to the
lesser curve, which pursue an independent pathway to the parietal cell mass.
So early attempts at vagotomy confined only to the main trunks are certain
to have been incomplete. Clinical results are poorly documented but it is
likely that incomplete vagotomy led to early failure to relieve symptoms.
Although Birchner in Germany and Pieri in Italy performed vagotomy in
patients with peptic ulcer, it was the methodical experimental and clinical
work of Dragstedt and his colleagues which firmly established the place of
truncal vagotomy in clinical practice from the early 1950's. In 1943 he
reported two patients in whom transthoracic truncal vagotomy had been
performed for chronic duodenal ulcer (Dragstedt and Owens 1943). The
gastric acid secretion was lowered postoperatively and the ulcers healed.
Further reports followed rapidly over the next few years. Dragstedt changed
to an infradiaphragmatic vagotomy and reported the same lowering of acid
secretion and ulcer healing. Yet in addition to recording the benefits
of vagotomy, Dragstedt and his colleagues also noted some problems
(Dragstedt 1950).
Firstly, whilst acid secretion was reduced it was not abolished, the
pH of gastric secretion remaining in the range 1.9 to 3.7. Following
vagotomy there was still free hydrochloric acid in the fasting gastric juice
in many patients. Furthermore intravenous histamine still produced an
acid secretory response in the face of vagal section. These observations
and the resultant failure to control the disease in some patients, were the
stimuli for those who regarded vagotomy as inadequate treatment. Their
alternative, vagotomy and antrectomy is described in Chapter 6.
Thus vagotomy alone was slow to find favour, particularly in the United
States where vagotomy with antrectomy became the most popular
procedure. This may have been because of the association in the surgical
mind of gastro-enterostomy with jejunal ulcer or perhaps because
Dragstedt's group in continuing animal research had shown the antrum (and
thus antrectomy) to be the key to the abolition of ulcer disease in the dog.
By 1951 he was able to report that when the entire canine stomach was
isolated from the intestinal tract and its vagal supply interrupted, that
ulcers never developed.
In 1948 the American Gastroenterological Association formed the
National Committee for the study of Peptic Ulcer. Their report concluded
that gastro-enterostomy alone was the treatment of choice for peptic ulcer
disease (Jordan 1952).
The second problem which Dragstedt described was that of gastric stasis
as a result of the section of the vagal motor fibres to the antrum. The need
for a drainage procedure was recognised early. The development of gastro¬
enterostomy has been outlined in Chapter 3.
Pyloroplasty was first performed by Heineke (1886). A longitudinal
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incision was made through all layers of the anterior wall of duodenum and
antrum across the pylorus and was sutured transversely to avoid narrowing
the gastric outlet. Mikulicz described an identical procedure 2 years
later (Mikulicz 1888). Thus although the two did not collaborate their
names are eponymously linked as the Heineke-Mikulicz pyloroplasty which
was to become the most widely performed drainage procedure. It was not
used initially as a drainage procedure but rather to excise anterior ulcers
and then for infantile congenital hypertrophic stenosis. In the latter
condition the results were almost always fatal until Ramstedt performed
the first pyloromyotomy in 1910 (Ramstedt 1912).
The first pyloroplasty for duodenal ulcer was performed in 1896 at the
Mayo clinic and excision of the ulcer with closure as a pyloroplasty was
reported from there in 1902. Judd (1930) reported a series of such cases
concluding that the procedure was successful in about 60%.
Pyloroplasty as a drainage procedure did not find favour in the U.S.A.
The American Gastroenterological Association conducted a study of over
4000 surgical procedures for peptic ulcer performed in the United States
(Jordan 1952). Vagotomy without drainage was followed by gastric retention
in 10-12%. Largely as a result of this side effect the total numbers of
vagotomy without drainage in the U.S.A. fell from 292 in 1946 to 130 in 1948
and by 1950 the numbers were "too small to consider analysis".
Weinberg and colleagues from California (Weinberg 1956) described a
single layer pyloroplasty which they claimed was superior to the double
layered Heineke-Mikulicz. In their report of 500 cases they claimed only 5%
of patients suffered untoward side-effects which they believed was due to
the elimination of retrograde movement of food seen with gastro-jejunal
anastomoses.
Vagotomy and gastrojejunostomy as advocated by Dragstedt increased
in popularity in the U.K. throughout the 1950's and 1960's. Weinberg (1956)
reported favourable results with pyloroplasty as an alternative drainage
procedure. Dragstedt adopted the Weinberg pyloroplasty (Dragstedt 1975)
and vagotomy and pyloroplasty became the most popular operation for
duodenal ulcer in the English speaking world in the 1960's and 1970's.
Prospective randomised trials comparing these drainage procedures, however,
showed no difference in results between them (Kennedy F. 1973 and
Kennedy T. 1973).
Given the enthusiasm with which truncal vagotomy had been adopted it
was surprising that several controlled studies found problems. In the
Leeds-York trial reported by Goligher (1968) vagotomy and gastro¬
enterostomy was inferior to vagotomy and antrectomy and also to subtotal
gastrectomy in terms of Visick grading, recurrent ulcer and the incidence
of diarrhoea. Furthermore vagotomy and drainage was not associated with
a lower incidence of operative mortality or of post gastrectomy symptoms.
Other trials, Cox (1968), Price (1970), Howard (1973) and Postlethwait (1973)
failed to show a clear benefit for vagotomy. While the mortality rate
tended to be higher following gastrectomy, the recurrent ulcer rate tended
to be lower. Truncal vagotomy and drainage probably remained the
preferred operation because of its lower mortality rate and because of
concern about the long term nutritional and metabolic sequelae of
gastrectomy.
The failure to demonstrate a clear advantage for vagotomy and drainage
over gastric resection was worsened by the demonstration of iron deficiency
and megaloblastic anaemia (Cox 1964), steatorrhoea (Cox and Bond 1964)
(Wastell 1966) and dumping (Kraft 1967) although none as severe as could
occur after gastrectomy. The most severe of the post vagotomy sequelae
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Pollock (1952) 16 7
Jordan (1952) 26 -
Kraft (1962) 38 -
Smith (1963) 28 -
Goligher (1964) 27 6.5
Cox & Bond (1964) 23 5
Burge (1964) 30 8




The problems of diarrhoea and dumping led to dissatisfaction with truncal
vagotomy and fuelled the search for a better procedure.
The controlled trials of the late 1970's and early 1980's showed a clear
advantage for H.S.V. over truncal vagotomy (Table 4.2) but doubts about the
recurrence rate after H.S.V. combined with its technical challenge have
ensured an occasional role in the 1990's for truncal vagotomy.
T Dumping Diarrhoea Vomiting Failed Op.Hb
HSV V&D I1SV V&D HSV V&D HSV V<5cD
Stoddard(1978) 64 62 3 18 4 7 2 10 3 7
Koffman (1979) 77 76 3 7 2 5 - - 14 11
Dunn (1980) 20 20 0 10 0 2 1 4
Christiansen (1981) 83 176 - - 10 0 2 16 34
Table 4.2
T.V. and drainage compared with H.S.V.
A summary of results of vagotomy and drainage in published series
is shown in Table 4.3.
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Visick
n Duration Recurrence Mortality I + 11
(years) (%) (%) (%)
Nobles (1966) 151 10- 19.2 1 _
Eisenberg (1969) 455 1-10 3.6 1.0 -
Goligher (1969) 119 5-8 5.9 0 89
Stempien (1971) 161 10-18 25.4 - 68.3
Berger (1972) 79 9- 10 0 81
Kennedy (1973)* 46 -5 8 0 -
Postlethwait (1973) 337 5- 6.2 0.6 83
Kronborg(1975) 435 6-8 10 - 74
Thompson (1975) 200 3.4-7 13 0.5
Brooke-Cowden (1976) 389 -15 16 1.6 -
O'Leary (1976) 348 7-17 5.8 1-2 -
Pemberton (1980) 182 1-17 12.3 4.4 -
Selking (1989)* 50 -6 8 0 71
Smith (1981)* 290 5-10 1.5 - 75
Fiser (1982) 645 1-10 4.5 0.4 96.4
Mulholland (1982) 183 0-10 11.6 0 62
Cetti (1983) 239 1-5 5 0.8 88.9
Koofman (1983)* 67 2.5-5.5 7.5 0 82
Koo (1983)* 51 1-6 12 0 86
Hoffmann (1984)* 73 5 13.6 - 79.7
* Randomised controlled trials
Table 4.3
Results of truncal vagotomy and drainage
in published series
CHAPTER 5
SELECTIVE AND HIGHLY SELECTIVE VAGOTOMY
Latarjet's was the earliest report on a technique of vagal section which
sought to selectively divide vagal fibres to the stomach whilst preserving
those to the rest of the G.I. tract (Latarjet 1922). Although drainage
procedures had overcome the problems of gastric stasis which vagotomy
produced, they had brought their own sequelae. Dumping could be attributed
to gastric incontinence and bile vomiting to reflux into the stomach through
the afferent loop or the incompetent pylorus. Diarrhoea was thought to
result from parasympathetic denervation of the abdominal viscera, which in
addition caused bloating, excessive borborygmi and abdominal discomfort.
Franksson of Stockholm (1947) devised a selective denervation without
a drainage procedure but, in the light of his subsequent experience came to
recommend one. Independently Jackson (1948) and Moore (1948) in the
U.S.A. described partial gastric vagotomy which consisted of preservation
of the coeliac division of the posterior vagus but division of the anterior
vagal trunk. It was Griffith and Harkins (1957) who published the first
account of selective vagotomy. They subsequently produced evidence,
based on insulin tests of vagally mediated acid output, that the procedure
resulted in satisfactory denervation of the parietal cell mass. Because the
motor innervation of the antrum was divided a drainage procedure was still
required.
Early results of selective vagotomy from Griffith (1960) and Burge
(1960) independently were promising both in terms of recurrent ulcer and
post-vagotomy sequelae. As has happened so often in the saga of operations
for duodenal ulcer, controlled trials and more especially long term
follow-up studies showed no advantage for the new procedure over truncal
vagotomy and drainage (Sawyers 1968, Mason et al 1968, Kennedy and Connell
1969). Longer follow-up by these groups (Sawyers 1977, Kennedy 1975)
confirmed that the problems of dumping, vomiting and diarrhoea were no
different following selective vagotomy and drainage. As it was more
technically demanding and time consuming the operation is no longer
performed.
A summary of the results from published series is shown in Table
5.1.
Visick
n Length F.U. Recurrence Mortality I + II
(years) (96) (%) (%)
Amdrup (1973) 100 5- 6 NK NK
Kennedy (1973) 49 -5 2 0 NK
de Miguel (1974) 131 5-9 9.2 0 83
Madsen (1980) 50 5.5-8 14 NK NK
Griffith (1980) 87 12-17 5.5 NK NK
Dejgaard (1980) 50 5.5-8 17.7 0 53
Siim (1981) 105 10-13 15 1 77
Hoffmann (1984) 81 5- 19.8 NK 44
Table 5.1
Results from published series of selective
vagotomy
Highly Selective Vagotomy
The search for a technique that would denervate the parietal cells but
avoid denervation of the intestine and its appendages had led Griffith in
1953, working in Harkins laboratory in Seattle, to perform in dogs a procedure
which he termed parietal vagotomy. Antral motility was retained whilst
complete denervation of the parietal cell mass was achieved as demonstrated
by negative insulin tests. Griffith sought the opinion of Drs. Dragstedt and
Hollander about the new technique, but neither the pioneer of truncal
vagotomy nor the developer of the insulin test approved. They rejected the
concept of selective or parietal vagotomy because they believed that any one
vagal fibre to the stomach, if left intact, could re-inervate the entire stomach
(The all-or-none law) (Griffith 1977).
Griffith describes 3 parietal vagotomies done in 1956 but because of the
disapproval of his seniors was not allowed to repeat the procedure. He states
that the three patients did "quite well without either dumping or recurrence"
(Griffith 1977).
Burge recognised the advantages of avoiding a drainage procedure and
published an account of selective vagotomy without drainage (Burge 1969).
He believed that bilateral selective vagotomy would preserve the innervation
to the prepyloric stomach. His failure to appreciate the anatomy of the
nerve of Latarjet resulted in its division with consequent gastric stasis.
Holle and Hart in Munich in 1967, apparently unaware of Griffith's work,
had shown in the experimental model that the vagal innervation of the antrum
actually inhibited gastric secretion. This led them on to develop a parietal
cell vagotomy preserving the antral innervation in order to preserve this antral
inhibition of acid secretion (Holle and Hart 1967).
Griffith meanwhile had continued with dog experiments designed to
produce evidence to show that the "all or none" law did not apply. He aimed
to further demonstrate that the vagal innervation of the stomach was
segmental and that the hepato-biliary vagal fibres did not contribute to gastric
innervation. These hypotheses were finally proved by 1969 (Griffith and
Amdrup 1969). On the basis of this knowledge Amdrup began to perform
parietal cell vagotomy in man. The antral innervation was preserved in
order to maintain antral motility. The initial experience with this operation
was reported by Johnston in 1970 (Johnston and Wilkinson 1970) and by
Amdrup the same year (Amdrup and Jensen 1970).
In previous chapters the superiority of H.S.V. in terms of dumping and
diarrhoea has already been discussed and results from published series are
shown in Table 5.2.
n Dumping Diarrhoea Vomiting
Kennedy (1975) 50 0 0 12
Jordan (1976) 45 4.4 0 0
Wastell (1977) 52 5.7 1.9 0
Sawyers (1977) 86 1.1 1.1 -
Stoddart (1978) 64 4.7 6.2 3.1
Faxen (1978) 25 12 0 -
Dorricott (1978) 116 4.3 4.3 5.2
Koffman (1979) 77 3.9 2.6 -
Dunn (1980) 20 - 0 10
Christiansen (1981) 83 0 - -
de Vries (1983) 82 2.4 5 7.3
Matheson (1983) 137 4 0 7
Donahue (1984) 40 4 0 -
Gorey(1984) 509 0 0 -
Teichman (1985) 68 2 2 -
Harling (1985) 41 4 2 -
Herrington (1986) 109 1.9 2.8 -
Hoffman (1987) 84 3.5 0 0
Soper(1989) 396 3 2 5
Table 5.2
Dumping, diarrhoea and vomiting in published
series of H.S.V.
(- indicates not described)
The one area in which H.S.V. remains under suspicion is that of recurrent
ulcer.
Recurrent ulcer has proved in the published literature to be the main
problem associated with the operation. The tables below show the recurrence
rate, operative mortality and Visick gradings in those published series with




F.U. Period Total Recurrence Mortality I + II
(Years) (%) (%) (96)
Goligher (1978) 5-8 259 5 (196) 0 NK
Nilsell (1979) 5-9 52 10 (1996) NK NK
Madsen (1980) 5-8 100 26 (2696) NK NK
Blackett (1981) 5-12 233 25 (1196) NIC NK
Storey (1981) 5-9 93 15 (1696) • 0 NK
Muhe (1982) 5-6 524 73 (1496)
Liavag (1982) 5-10 282 35 (1296)
de Miguel (1982) 5-9 143 14 (10%) 0.6 85
Lunde (1983) 5-11 428 51 (1296) NK NK
de Vries (1983) 5-7 71 7 (10%) 0 72
Gorey (1984) 5-12 350 28 (8%) 0 88
Graffner (1985) 5-10 405 57 (14%) 0.5 NK
Teichman (1985) 10- 68 18 (25%)
Herrington (1986) 6-13 109 10 (9%) 0.7 83
Paimela (1987) 8-11 67 11 (16%)
Holstein (1987) 10-13 100 18 (18%) NK NIC
Muller (1987) 5- 493 69 (14%) 0.2 92
Schache (1989) 5-15 242 20 (11%) 0 85
Soper (1989) 5-13 396 55 (14%) 0 89
Hoffman (1987) 14-18 106 32 (30%) 0 57
Johnston G.W.(1989) 10-20 305 46 (15%) 0.2 92
Table 5.2
Summary of results following H.S.V. in published series
with a minimum follow-up of 5 years
Series which have a maximum length of follow-up of more than 10 years
have also been considered.
Visick
F.U. Period Total Recurrence Mortality I + II
(Years) (%) (%) (%)
Donahue (1984) 4-12 40 8 (20%) 0 NK
Marceau (1986) 3-12 203 24 (12%) 0 88
Ensog (1986) 1-10 306 42 (13.8%) 0 67
Jordan (1986) 1-10 90 9 (10%)
Byrne (1987) 1-14 223 25 (11.296) 0.4 83.4
Martin (1989) 1-19 990 100 (10.1%)
Raab (1989) 1-16 984 271 (29.7%) 0.3 79.1
Table 5.3
Summary of results following H.S.V. in published series
with follow-up exceeding 10 years
For a given recurrence rate to be meaningful the length of follow-up of the
series is crucial. It has been well established that recurrent ulcer after
highly selective vagotomy continues to present throughout the length of
follow-up so that those series with long follow-up will have higher recurrence
rates (Taylor 1988). Indeed in one of the series with the longest follow-up
yet available (Hoffman 1988) only one-third of recurrences were manifest
at 5 years. For all these reasons only those series with a minimum follow-up
of 5 years or a maximal follow-up of 10 years or more have been included.
This review of published experience inevitably shows a considerable range
of recurrent ulcer rates. Apart from variations in the all important length
and completeness of follow-up, there must be variations in surgical technique
in a procedure in which the detail of that surgical technique is crucial. Jordan
(1987) has confirmed statistically significant differences between recurrence
rates of different surgeons on long-term follow-up. Nor can criteria of
selection for the operation be uniform - some of the series included pyloric or
prepyloric ulcers for which the procedure is now known to be inappropriate
(Muller 1987). Furthermore definitions of recurrent ulcer differ. For most
surgeons there are ethical objections to endoscoping asymptomatic patients.
The recurrent ulcer rates referred to are therefore symptomatic recurrences.
Most workers have accepted the definition that any peptic ulcer be it in
duodenum or stomach, large or small, acute or chronic, shall be designated
recurrent ulcer. Because of these differences in definition more emphasis
has been placed in this study on the behaviour of recurrent ulcer, its symptoms,
its complications and its response to treatment.
Other variations on the theme were described by Taylor in Edinburgh (Taylor
1979). His lesser curve sero-myotomy reduced the time and the tedium of
H.S.V. Hill (1978) developed a further variant combining anterior H.S.V.
and latterly sero-myotomy with posterior truncal reducing the operating
time still further.
With the continuing decline in the incidence of duodenal ulcer, the
increasing efficacy of medical treatment, and the introduction of endoscopic
therapy, it seems unlikely that further innovations in the surgical management
of the disease will be forthcoming. As surgical interest has inevitably
decreased and the time and resource devoted by surgeons to duodenal ulcer
has lessened so it seems increasingly likely that the above procedures will




Vagotomy combined with antrectomy represents an approach to duodenal
ulcer disease which more than any other is based on a clear understanding
of the physiology of gastric acid secretion. Arguably the procedure
abolishes both the cephalic and gastric phases of acid secretion without
the need for extensive gastric resection with its untoward sequelae. It is
undoubtedly the procedure which most successfully abolishes the ulcer
diathesis.
Klein (1929) published the first report of the combination describing
anterior truncal vagotomy combined with Billroth I gastrectomy in 8 patients
with duodenal ulcer "with hyperacidity". The problem of hyperacidity in
the aetiology of duodenal ulcer was appreciated by Winkelstein and Berg who
in 1938 advocated vagotomy and partial gastrectomy and were able to
demonstrate achlorhydria as a result of the procedure (Winkelstein and Berg
1938).
The experimental and clinical studies on vagotomy by Dragstedt have
been described in Chapter 4. His group (Woodward 1954) showed that in
dogs with a Pavlov pouch, gastric secretion was reduced after vagotomy
but subsequent antrectomy completely abolished secretion in the isolated
stomach pouch.
The experimental work of Storer (1950) in Dragstedt's laboratory
demonstrated in the dog the superiority of vagotomy and antrectomy in
preventing recurrent ulceration. In the Mann-Williamson preparation
vagotomy alone protected against ulceration in 55% of animals, antrectomy
alone in 66% and vagotomy plus antrectomy in 83%. Kay (1962) compared
the acid response to histamine in man following those three procedures.
Vagotomy reduced maximal acid output by 60%, antrectomy by 70% and a
combination of the two procedures by 95%. The first clinical reports of
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complete truncal vagotomy, as advocated by Dragstedt, combined with
gastric resection, came from Farmer and Smithwick (Farmer 1951) who
performed a 50% gastrectomy, arguing that by removing the antrum in
addition to performing truncal vagotomy they could in one operation reduce
the two major stimuli to parietal cell acid production. They made the
important observation that this procedure reduced acid output as much as
radical gastrectomy, alone or combined with vagotomy.
Edward and Herrington (1953) described a 40% gastrectomy a procedure
which they christened "antrectomy". They performed their first such
procedure in 1947 the same year in which Daintree Johnson in London
described a similar operation (Orr and Johnson 1947).
Dragstedt's group showed in a series of animal experiments an 86%
reduction in acid output in both Pavlov and Heidenhain pouches (Woodward
1950) and virtual complete protection against stomal ulcer in the Mann-
Williamson preparation (Storer 1950).
The procedure was taken up with enthusiasm in the United States
with numerous reports of series with recurrent ulcer rates of less than 1%
(Table 6.1).
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n 'Satisfactory' Recurrence Mortality Length
Visick I + II rate F.U.
Thoroughman (1964) 504 91% 0.4% 1.6% 2-14
Goligher (1968) 116 78% 1.7% 0% 5-8
Cox (1970) 2405 97% 0.7% 1.5% NK
Palumbo (1970) 510 90% 0.6% 2.7% 1-16
Wolf (1972) 547 90% 0.6% 1.1% 1-10
Postlethwait (1973) 331 89% 0.7% 0.9% ' 10
Smithwick (1974) 719 93% 1.5% 1.9% 1-26
Jordan (1974) 90 89% 1.1% 0% 1-8
Sawyers (1977) 50 94% 0% 0% NK
Dorricot (1978) 106 68% 0.9% 0.9% NK
Hubert (1980) 466 95% 0.7% 1.1% 13-25
Fiser (1982) 148 86% 1.4% 0.7% 1-10
Koo (1983) 51 96% 0% 2% 1-6
Donahue (1984) 46 80% 0% 0% 4-12
Herrington (1986) 3642 94% 0.5% 1.5% 1-30
Table 6.1
Results of published series of vagotomy with
antrectomy
The vast experience reported by Herrington represents the combined
experience of the three major hospitals in Nashville Tennessee, dating from
1947. The reconstruction was of the Billroth I type.
In many centres in North America this remains the operation of choice
for duodenal ulcer (Nyhus 1986) and in these centres it seems unlikely to




Since the first successful operation for perforated duodenal ulcer by
Dean in 1894 (Dean 1894), there has been controversy as to the best
operative management. Each new definitive operation had its advocates in
the immediate treatment of perforation.
The obvious first treatment was simple closure. Pyloric stenosis could
follow simple closure of large ulcers, and gastro-enterostomy, which was
being increasingly performed for non-perforated ulcer, was advocated as an
addition to simple closure but failed to find favour.
Recurrent ulcer dyspepsia in 50-70% of survivors (Illingworth, Scott and
Jamieson 1946) was the problem which stimulated the move toward an
immediate definitive procedure. This led to the introduction of partial
gastrectomy in some centres as immediate definitive treatment. This
resulted in a debate about safety. Was definitive surgery possible without
an increase in operative mortality ? Several small published series suggested
that this was so but again the procedure failed to gain widespread acceptance.
When truncal vagotomy became available this too was recommended as a
safer immediate definitive operation. This procedure and its successor
highly selective vagotomy was shown in several large series to carry no
greater an operative mortality than simple closure.
There remained, however, considerable controversy about the natural
history of perforated ulcer after simple closure and doubt persisted about
whether or not immediate definitive surgery was indicated at all. The many
published series of the natural history of ulcer disease following simple
closure showed considerable disagreement. One school suggested that
perforation was an isolated self-limiting complication of ulcer disease from
which further symptoms were uncommon. The other suggested that
perforation indicated an aggressive ulcer diathesis unlikely to resolve without
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further treatment. A compromise position between these extremes
resulted in the evolution of a policy of selection for immediate definitive
operation. Only those patients considered at risk of subsequent symptoms
were selected for immediate definitive operation, the remainder having
simple closure.
The problem of how to select patients remained. The most widely used
predictor was length of ulcer history; those with a short (less than 3 month)
dyspeptic history before perforation were, it was argued, likely to have
"acute" ulceration and thus unlikely to have future problems (Illingworth
1946). Neither this nor the surgeon's judgement about "acute" or "chronic"
at the time of operation proved a successful predictor.
On the other hand a blanket policy of definitive surgery for all at the
time of perforation resulted in unnecessary operations with their attendant
side effects.
The controversy seems to have been resolved by the advent of the H2
receptor antagonists which have restored simple closure as procedure of
first choice. The risks of recurrent ulcer dyspepsia can be reduced by
prescribing an H2 receptor antagonist at the time of simple closure. As in
the treatment of uncomplicated duodenal ulcer so in the treatment of
perforation, the H2RA or proton pump antagonists seem destined to replace
definitive ulcer procedures.
Historical Aspects
The first report of the clinical features and autopsy findings in patients
with perforated peptic ulcer came from Sir Benjamin Travers in 1817 (Travers
1817). Dr. John Abercrombie, an Edinburgh physician, described in 1828
the clinical and autopsy findings and refers to a specimen in the Royal
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College of Surgeons of Edinburgh (Abercrombie 1828). (This specimen
has been located and is shown in Plate 1. This is thought to have
originally belonged to the Wilson collection and came to Edinburgh in 1824
as part of the Bell collection) By 1843 Crisp was able to report 50 cases of
gastric and duodenal perforations in the Lancet (Crisp 1843).
The first attempt to treat the condition by surgical closure was made
unsuccessfully by Mikulicz in 1887 (Mikulicz 1888). Heussner in 1882
successfully closed a perforated gastric ulcer (Kriege 1892). Credit for
the first successful operation is ascribed to Dean who in 1894 successfully
treated a perforated duodenal ulcer by simple closure (Dean 1894). Gastro¬
enterostomy, which was being increasingly practised as the 19th century
drew to a close, was advocated by Braun in 1897 as an adjunct to simple
closure (Braun 1897). Initially this was to overcome the problem of
duodenal narrowing resulting from the closure of large ulcers. By the first
decade of the 20th century another advantage of the technique was claimed -
ulcer recurrence was allegedly lower. Moynihan who was to remain until
the 193O's an ardent advocate of gastro-enterostomy as the elective operation
of choice for duodenal ulcer, did not support its use in perforated ulcer
unless stenosis seemed likely as a result of closure. It gained acceptance in
only a few centres. Roscoe Graham's powerful advocacy of simple closure
based on his own series which carried a 2% operative mortality (Graham 1937)
continued to influence surgical practice well into the 1950's. He was clear
in advising surgeons that their responsibility to the patient with a perforated
ulcer extended only to life saving measures but not to trying to cure the
ulcer problem for good.
So simple closure remained the treatment of choice for about fifty years.
Harkins (1961) commented that while in 1946 simple closure remained the
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preferred treatment for perforated ulcer, by 1960 three methods - simple
closure, immediate gastrectomy and continuous aspiration were popular to
varying degrees in different clinics.
Immediate gastrectomy was reported by Keetly in 1902 (Keetly 1902) and
this treatment was advocated by von Haberer in 1919 (von Haberer 1919).
In a review of published literature DeBakey in 1940 calculated that for
the period 1930-1940 mortality rate following emergency gastrectomy was
25% in over sixteen thousand published cases (DeBakey 1940). Illingworth
showed that the mortality in Glasgow over the period 1924-1943 was 12.5%
(Illingworth, Scott, Jamieson 1946). Yudine in Moscow in 1939 reported
937 cases of perforated ulcer treated by immediate gastrectomy with a
mortality rate of 8.9% (Yudine 1939). Although this appeared to be an
improved on treatment by simple closure it was taken up by few British
or American surgeons. Lowden in 1952 published a series of sixty-five
perforations of whom 51 were treated by gastrectomy with no deaths when
fit patients under 70 years were selected for this definitive treatment
(Lowden 1952). Many authors continued to advocate the procedure
including Bisgard (1956), Emmet and Williams (1957), Jordan and DeBakey
(1961). Gastric resection failed to gain acceptance as an immediate
definitive procedure and has now largely been abandoned.
Non-operative treatment, first advocated in the 1930's enjoyed a vogue
in the 1940's and 1950's. Thereafter it fell into disuse except for very
high risk patients. With the development of more intensive and more
effective methods of support, the method has again evoked interest.
Lane (1931) was the first to record the use of non-operative treatment
and Wangensteen (1935) recorded 3 cases treated in this way. Seely reported
64.
a series in 1951 of 106 cases with 1 death (0.9% mortality). The incidence
of intraperitoneal abscess was 15% not greatly different from the levels
in operated series of the time.
Herman Taylor practised this technique from 1944 and published his 10
year experience in 1957. In this series of 208 perforations the mortality
rate was 1.9%. He considered that when the technique was confined to
young patients or "acute" ulcer perforations the mortality (1 to 7%) was as
good as that following operative treatment.
By 1956 Seely was able to record 784 cases treated non-operatively with
a mortality rate of 4.5%.
Heslop (1952) compared operative to conservative treatment in 2
unselected groups of patients but without randomisation. The mortality in
the operated group was 9% and was 8% for patients treated conservatively.
By 1960 Harkins reported that three methods, simple closure, immediate
vagotomy and drainage and partial gastrectomy were all widely practised at
that time by American surgeons (Harkins 1960).
But it was simple closure that remained the treatment of choice in the
U.K. Shepherd (1960) reviewing the three main treatment options then
available concluded that simple closure remained the treatment of choice
for most perforated duodenal ulcers. The controversies in treatment
centered around whether a definitive procedure should be added in any, or all,
or in selected patients only. There was also controversy amongst the
advocates of selection about how to select.
Illingworth (1946) showed that patients with a dyspeptic history of
less than 3 months before operation had a much lower incidence of subsequent
dyspepsia. He therefore suggested a policy of immediate definitive surgery
for those patients with a dyspeptic history of longer than three months at the
time of perforation. The concept of "acute" versus "chronic" ulcers led to the
advocacy of a policy of simple closure for "acute" and definitive treatment
for "chronic" ulcers.
There remained, however, considerable disagreement about the natural
history of perforated ulcer after simple closure and the need for subsequent
definitive surgery. Reports of the need for subsequent definitive surgery
ranged from 27-71% (Table 7.1).
n Subsequent Definitive
Surgery
Skovgaard (1977) 111 71%
Wagensteen (1972) 89 70%
Griffin (1976) 122 58%
Gillen (1986) 54 57%
Jarret (1972) 297 45%
Backgaard (1979) 80 43%
Nemanich (1970) 79 43%
Heuman (1983) 77 42%
Boey (1985) 393 39%
Sawyers (1975) 254 37%
King (1987) 86 27%
Table 7.1
Further surgery after simple closure
of perforated duodenal ulcer
The popularity of simple closure as the treatment of choice had been
enhanced by two series in the mid 1930's with very low mortality. Tilton
(1936) reported 52 consecutive cases treated by simple suture with 1 death
a 1.9% mortality. Roscoe Graham (1937) described a similar series of 51
consecutive cases with a single death giving an identical mortality of 1.9%
On the basis of this series Graham became a powerful advocate against a
definitive procedure writing in 1937 that: "We have no responsibility to
such patients but to save their lives. Any procedure of a more extensive
character which aims to do more than this under the conditions and
circumstances attending the perforation of a duodenal ulcer can, quite
justifiably be considered meddlesome surgery. We have no responsibility
during the emergency to carry out any procedure designed to cure the
patient of his original duodenal ulcer."
The controversy about simple closure versus definitive treatment has
its origins in the early years of the century. Only when long term
follow-up studies within controlled randomised trials become available can
the controversy be resolved. The lack of such trials (outwith the Far East
where the disease may well be different) has left insufficient evidence to
date to resolve the controversy.
The greatest advance in elective management of duodenal ulcer has
undoubtedly been the introduction of H2 receptor antagonists. How have they
affected the management of perforated duodenal ulcer ? There is
controversy in the published studies. Simpson (1987) showed that
Cimetidine prescribed immediately postoperatively reduced subsequent
dyspepsia and ulcer complications in the short term. By contrast Gillen
(1986) found that the introduction of H2 receptor antagonists did not reduce
the need for subsequent definitive surgery which remained at 57.4% in their
hands. This led these authors to conclude that duodenal ulcer should be
treated by definitive surgery whenever possible. This view was supported
by the controlled studies of Boey and Wong (1987) and Tanphiphat (1985) and
by the retrospective studies reported by Jordan (1982), Bennet (1985) and
Wara (1983).
In recent years the demographic profile of the population with perforated
duodenal ulcer has changed with an increase in the incidence in older age
groups in Britain (Watt 1986) and in Finland (Paimela 1991). At least one
recent series has suggested that, even with the improved resuscitation and
anaesthetic techniques now available, that immediate definitive procedures
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carry a significantly higher mortality in the elderly (Irvin 1989).
A major aim of our study into treatment of perforated duodenal ulcer was
to determine whether an immediate definitive procedure was associated
with a higher operative mortality, and to determine the effect of the
immediate prescription of H2 receptor antagonists on the need for
subsequent definitive surgery and the symptomatic outcome in patients with
perforated duodenal ulcer.
CHAPTER 8
THE DEVELOPMENT OF AUDIT IN DUODENAL ULCER SURGERY
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Billroth's remarkable contributions to gastro-intestinal surgery extended
far beyond the operating theatre. Before his time scant attention was
paid to the outcome after surgery. The assessment used by Florence
Nightingale in the Crimea War of "improved, disimproved, died" held sway
in many hospitals until the turn of the century and even beyond. It was
Billroth who imposed on himself and all his pupils the discipline of recording
each operation performed and the result. This methodical documenting of
operative detail and outcome was to become one of the hallmarks of the
Billroth school. His pupils including Esmarch, Mikulitz and Kocher passed
on this discipline to Holstead in the United States and Moynihan in the
United Kingdom.
The earliest account of the longer term results of surgery for duodenal
ulcer were published by Czerney in 1908 (Czerney 1908).
In the United Kingdom Moynihan documented in great detail all the
cases of duodenal ulcer which he operated on from his first case in January
1900. By 1910 he was able to publish the results of a series of 186
patients with 4 post operative deaths. Follow-up information extending up
to 9 years postoperatively was available in 171 of the 182 cases (Moynihan
1910).
As the number of operations for ulcer grew and the need to assess
their efficacy was recognised, clinics were set up specifically to review
the long term results of surgery after peptic ulcer disease. Amongst the
earliest of these was that established by Sir James Walton in London in
the 1920's (Walton 1935).
As the incidence of duodenal ulcer increased in the U.K. over the first
three decades of the 20th century, so too did its relative importance to the
workload of the general surgeon. The concept of a clinic or department
devoted to regular, comprehensive and accurate follow-up took root in
several centres in the United Kingdom.
The best known of these clinics were those in York established by
Hedley Visick in 1942, by Sir Charles Illingworth in Glasgow in 1951, by
Norman Tanner in St. James' Hospital, Balham, by Professor John Goligher
in Leeds and latterly by Terence Kennedy in Belfast. The clinic established
by W. P. Small at the Western General Hospital in Edinburgh in 1953 was
among the largest and most successful of these and it is the results from
this clinic which form the basis for the analysis of the results of surgery
for duodenal ulcer in this thesis.
Hedley Visick, a York surgeon, deserves much of the credit for
establishing a clinic devoted exclusively to the follow-up of patients
following surgery for peptic ulcer. Visick, in conjunction with a physician,
Dr. David Cameron, and a radiologist, Dr. C. N. Pulvertaft, organised a
follow-up department funded initially by Visick himself and latterly by the
York Peptic Ulcer Research Trust. Among the contributions of this clinic
was the development of the "Visick grading". This was the first attempt to
quantify the results of peptic ulcer operations.
In 1948 Visick outlined the techniques of follow-up in use at that time:
"We send a questionnaire to every patient a week before his regular six
monthly visit to the follow-up clinic. If he cannot come he returns it and
the board grade him according to his answers. Where a returned card
indicates that a patient does not clearly understand the questions the almoner
or the welfare officer calls to explain. If a returned card suggests that
the patient has pain or vomiting or has lost work, an appointment is made
for a personal examination and interview" (Visick 1948).
He goes on "only one patient was lost sight of in 1947". Pulvertaft
writing in 1952 comments that, in the first ten years of its existence,
follow-up at the clinic was 97.5% complete (Pulvertaft 1952).
The establishment of these follow-up clinics allowed a comprehensive
long term follow-up over many years after the duodenal ulcer operation.
By following-up over 90% and in many instances over 95% of patients it
became possible for the first time to assess the long term results and
sequelae of ulcer operations.
CHAPTER 9
THE CHANGING EPIDEMIOLOGY OF DUODENAL ULCER
While duodenal ulcer has been recognised as a clinical and pathological
entity since the early years of the 19th century, there have been, and
remain considerable difficulties in assessing the incidence and prevalence
of the disease. The changes which continue to take place in the temporal,
geographic, and gender incidence of the disease have been the subject of
considerable research. The reasons for these changes give rise to
continuing speculation.
Information about incidence has come from several sources; from
autopsy studies, from hospital admission rates, from mortality studies, and
more recently from studies of defined populations. Each one of these has
its own problems of interpretation. Because of these problems the
incidence of perforation of duodenal ulcer has been used as a readily
diagnosable index of the disease incidence. Yet this method too has
problems in interpretation. Finally rates of elective operations for the
condition have been studied.
Autopsy studies are performed on a selected population, biased toward
subjects who have died in hospital. Autopsies furthermore often fail to
distinguish between acute and chronic ulcers and may fail to diagnose the
scarring of the healed ulcer.
Hospital admission rates are subject to enormous variations in the way
duodenal ulcer is managed in different centres. Before the 1960's
uncomplicated ulcer was managed by hospital admission in many centres,
whereas since then admission to hospital has been reserved for complications
of the disease making hospital admission rates an unreliable marker for
disease incidence.
Mortality studies give information only about the small minority of
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ulcer patients who die from the condition. This minority are in many
respects unrepresentative of ulcer patients as a whole.
In many respects studies of the rate of consultation with a primary care
doctor for episodes in which duodenal ulcer is the final diagnosis, allow
more accurate estimation of the incidence of the condition. The problem
with this approach is that the method of diagnosing duodenal ulcer must be
a standard one, ideally by endoscopy. Furthermore symptom complexes
must be investigated using a standard protocol.
Studies of the incidence of duodenal ulcer in defined populations have
become possible in recent years because of full documentation of all medical
consultations in some general practices in the U.K., of Health Maintenance
Organisations in the U.S.A., and of accurate registration and documentation
in stable urban populations in Scandanavia. The increasing use of fibreoptic
endoscopy has arguably improved the accuracy of diagnosis of current and
more especially previous episodes of duodenal ulceration. Yet even in these
circumstances the real accuracy of incidence measurement may be distorted
by self-medication and by the asymptomatic ulcer.
The incidence of perforated duodenal ulcer as a yardstick of incidence
has several attractions. The diagnosis is usually unequivocal and
independent of observer variation. Treatment has uniformly been by
operation in the vast majority of cases providing reliable statistics. Several
authors, notably Sanders (1967) have suggested that perforations represent
some 11% of the ulcer population and that perforation incidence is the most
appropriate measure of incidence within a population. This is unlikely to
be the case, however, as perforation rates vary between different populations
and may be influenced by the age profile of the population and by other
variables such as consumption of NSAIDs.
Each of these types of study will be considered in turn.
a) Autopsy Studies
Amongst the earliest autopsy studies to address the problem included
those of Rokitansky (1839) who described 6 duodenal ulcers in his series
from Vienna. Grunfeld in 1882 in Denmark was probably the first to look
specifically for peptic ulcer in an autopsy series. In his personal series of
1,000 autopsies he found only 4 duodenal ulcers (Grunfeld 1882).
The earliest autopsy report from the U.K. was that of Perry and Shaw
(1893) who found 149 duodenal ulcers in 17,652 autopsies, an incidence of
0.84%. In 1900 Fenwick and Fenwick reported a series of 47,912 autopsies
from several centres which had been performed by several pathologists.
In 2,019 (4.2%) either an ulcer or a scar was present (Fenwick and Fenwick
1900).
The increase in the incidence of duodenal ulcer disease at autopsy
continued throughout the first half of the 20th century. In Stewart's series
(Stewart 1929) of 2,000 patients, 374 (9.5%) had acute or chronic duodenal
ulcer or scarring. This series is likely to be amongst the most accurate
because it was conducted by one pathologist with a declared interest in the
problem of duodenal ulcer.
These autopsy studies carried out between 1930-1960 have shown the
highest incidence of duodenal ulcer.
A subsequent study from Stewart's department in Leeds examined 12,640
autopsies between 1930-1949 and found that 11.6% of males and 4.8% of
females had duodenal ulcer (Watkinson 1960). Portis and Jaffe studied 9,171
autopsies at Cook County Hospital, New York, between 1929 and 1936. 218
patients (2.5%) were found to have duodenal ulcer (Portis and Jaffe 1938).
Falconer (1943) reported from Stockholm a series of 9,300 autopsies
performed between 1930-1941. A total of 14.5% had duodenal ulcer
disease.
The study by Levij in Rotterdam between 1940-1959 found that 15.6%
of 8,019 corpses examined had evidence of duodenal ulcer disease (Levij
1963).
Thus autopsy studies performed in the first 60 years of the century have
shown a progressive rise. Since 1960 the incidence of duodenal ulcer
reported at autopsy has declined.
Watkinson (1960) reporting the British National Survey of peptic ulcer
at autopsy, described duodenal ulcer lesions in 6.3% of which 3.9% were
active and 2.4% ulcer scars.
A necropsy study from Malmo in Sweden (Lindstrom 1977) showed that
of 2,218 subjects over 20 years and comprising 88% of all Malmo residents
who died during the study year of 1969, 122 (5.5%) had active or previous
duodenal ulcer.
b) Hospital Admission/Discharge Rates
Wilkie (1927) reported an increase in duodenal ulcers diagnosed in
Edinburgh Royal Infirmary from 24 in 1906 to 236 in 1926.
More accurate statistics about disease specific hospital admission rates
first became available in the 1950's. Before then the only discharge
statistics available were from the armed services. Tidy (1943) documents
British Army statistics for medical discharges resulting from inflammation
or ulceration of the stomach or duodenum. For the years 1914-1915
there were 709, whereas for 1939-1941 there were 23,574.
Ivy (1946) calculated that 10% of the male population of the Western
world would develop duodenal ulcer disease in their lifetime. This has
become a dictum frequently quoted since then and has become difficult to
disprove or alter despite the mass of epidemiological data which has become
available since then.
Langman and his colleagues (Brown 1976, Coggan 1981) studied Hospital
In-Patient Enquiry figures which record a one-tenth sample of all discharges
and deaths from acute hospitals in England and Wales. In their study
discharges for non perforated duodenal ulcer between 1958 and 1972
decreased from 34,083 to 29,988 a fall of 12.01%. In the succeeding five
year period 1973-1977 admissions fell to 21,500 a decline of 28% over 5 years
and 40% over 20 years.
A similar study (SCRIPS Review 1978) of discharges from all Scottish
hospitals, showed a decline in patients with a diagnosis of duodenal ulcer
between 1968-1975. For males the decrease over this 6 year period was
31%. This decline was confined to the under 65 age group.
A similar study from Finland showed a 15% decline in all hospital
discharges in Finland, between 1969-1984 (Tilvis 1987). This decline
occurred despite no change in the number of patients with perforation.
In the United States Kurata and colleagues (1982) reported discharge
rates for all non-federal hospitals. They found between 1970-1978 a fall
in hospital admissions from 153/100,000 to 82/100,000 a decline of 46%.
Elashoff and Grossman (1980) reported similar findings. Wylie reported
similar findings with the rate for hospital admission with a primary
diagnosis of peptic ulcer falling from 25.2/10,000 in 1965 to 16.5/10,000
in 1981 in 790 U.S. hospitals, a decline of 29.5% (Wylie 1981).
A study from the Trent region of England (Bardhan et al 1989) showed
no change in admission rates for perforated duodenal ulcer between 1972-1976
(99 per 10/6) and 1977-1984 (103 per 10/6). The rates for elective operations
for uncomplicated ulcer fell by 53% between these two periods.
c) Consultations in Primary Care
Declining hospital admission rates may merely indicate that uncomplicated
duodenal ulcer no longer requires admission to hospital rather than reflecting
a true decline in incidence of the condition.
Meade (1968) reported a 40% decline in the incidence of duodenal
ulcer amongst British physicians between 1940-1965. For male physicians
aged between 35 and 64 the incidence fell from 3.1/1,000 in 1947-1950
to 2.4/1,000 in 1957-1960 to 1.7/1,000 in 1961-1965. A study of physicians
in Massachusetts (Monson and McMahon 1969) showed a similar fall. In
this study the lifetime prevalence was 9% in a study group with a mean
age of 45 years.
The two studies by the Royal College of General Practitioners
(RCGP) and the Office of Population and Census Statistics (OPCS) showed
a fall in the numbers of patients consulting with a final diagnosis of
duodenal ulcer. In 1955-1956 the rate was 5.9 per 1,000 consultations,







Rates per 1,000 patients consulting
their General Practitioner 1955-1956
and 1970-1971 (RCGP/OPCS 1958,
1974)
In the United States, Vogt and Johnson (1980) reported on out-patient
attendances by members of a Health Maintenance Organisation with over
200,000 members. By studying a 5% sample they estimated that the
number of "out-patient episodes" for duodenal ulcer had declined from 13.7
per 1,000 patient years in 1967 to 4.1 episodes per 1,000 patient years in 1973.
Sonnenberg (1987) analysed National Disease and Therapeutic index
statistics, which record consultations with over 200,000 office based
physicians throughout the U.S.A. of whom a different 200 are randomly
sampled each month. The rates of consultation by patients whose final
diagnosis was duodenal ulcer fell from 43.0 in 1960 to 9.3 in 1981-1984 for
men. For women the fall for the same period was from 19.9 to 7.5 per 1,000
consultations.
d) Population Studies
The incidence and prevalence of duodenal ulcer in a defined population
has been difficult to assess until recent years because of the lack of a
reliable end point. A conclusive diagnosis of ulcer can now be made by
dependable barium or endoscopic examination applied to each member of
that population with possible symptoms of duodenal ulcer.
Two Scottish studies, one from the South-West, the other from the
North-East attempted to define the incidence of peptic ulcer in the
respective communities. Litton and Murdoch (1963) calculated that the
incidence of duodenal ulcer in South-West Scotland between 1957-1959
was 7.9 per 1,000 but this included perforations, diagnoses made at laparotomy,
and was weakened by confirming the diagnosis radiologically only in "the
majority of cases".
Weir and Backett (1968) reported on the incidence of dyspepsia in the
North-East of Scotland between 1960-1963 but their study of the incidence
of proven peptic ulcer was based on a sample of 1,328, did not discriminate
between gastric and duodenal ulcer and was confined to a rural community.
Bonnevie (1975) published what has been arguably the most accurate
study to date on the incidence of duodenal ulcer in a defined population.
The 500,000 residents of Copenhagen County were included and all barium
meal and operation reports on this population were studied. Between
1962-1968 the annual incidence of new duodenal ulcer cases averaged
1.3 per 1,000 inhabitants over the age of 15 years.
By extrapolating the data from the U.S. National Health Interview
Survey, Kurata and Haile (1984) calculated the one year period prevalence
in the U.S.A. between 1961-1981 was 1.7-1.9%. During this period the
prevalence for men fell from 2.31% in 1961 to 1.77% in 1981, while for
women it rose from 1.11% in 1961 to 1.72% in 1981. The net effect was
little change in the overall rate. From this data they reckoned that about
10% of U.S. citizens would develop peptic ulcer at some time in their life.
Schoon et al (1989) studied the population of Gothenberg in 1985. All
duodenal ulcers diagnosed by radiology, gastroscopy, or laparotomy were
included - a task facilitated by the computerised diagnostic registers in each
department involved. They found 563 duodenal ulcers in the study year 1985,
a rate of 1.56 per 1,000 population per annum.
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To date it has not proved possible to assess the incidence in a defined
British population.
e) Perforated Duodenal Ulcer Rates
Because of problems with collection, interpretation and comparison of
data about uncomplicated duodenal ulcer, perforated ulcer has been used
as a convenient yardstick of disease incidence (Susser 1962, Sanders 1967,
Pulvertaft 1968). Readily diagnosed and universally treated in hospital it
has allowed comparisons of geographical and temporal differences in
incidence.
The earliest case reports have been described in Chapter 7. Reviewing
the world literature at the turn of the century Brunner (1903) was able to
find only 361 cases of perforated peptic ulcer to that time. Moynihan's
entire experience by 1910 was of only 11 cases (Moynihan 1910). Schoemaker
(1915) described a further 244 cases reported in the published literature between
1903-1911.
Bager (1929) collected all cases of perforated peptic ulcer in fifty
Swedish hospitals between 1911-1925. Over this period he reported a
progressive annual increase in the number of male admissions from 60 per
year in 1911 to 130 per year in 1925. The difference in epidemiology
between the sexes which had been recognised before the turn of the century,
was again demonstrated in this study with no change in admissions in
females over the study period.
Jennings (1940) in a major review of the age incidence and sex
distribution over the previous 150 years clearly demonstrated the changing
epidemiology. He showed that, before 1900 some 50% of peptic ulcer
perforations affected females under the age of 25 years. After 1920, 90%
of such perforations affected males under 25 years.
The epidemiology of perforated peptic ulcer is an area in which studies
from Scotland have been pre-eminent.
The early studies of Caird (1913) in Edinburgh reporting the years 1898-
1912 and Dunbar (1929) who reported experience between 1913-1924 in
Glasgow are valuable in demonstrating the very low incidence of the
problem in the early years of the century. The major study of perforated
peptic ulcer in the West of Scotland by Illingworth and his colleagues
provides a unique record of the changing epidemiology of perforated peptic
ulcer from 1924 when it was a relatively uncommon condition to 1973
by which time the ulcer epidemic had begun to decline (Illingworth, Scott,
Jamieson 1944, Jamieson 1955, MacKay 1966, MacKay 1976). In these
four successive studies all perforated peptic ulcers in the West of Scotland
diagnosed at laparotomy or autopsy were included. The changing incidence
over this period is shown in Fig. 9.1.
PERFORATED PEPTIC ULCER












Perforated peptic ulcer in the West of Scotland
From 1953 the decline in annual incidence is apparent, but has remained
constant since 1963 with a relative increase in females.
The incidence of perforated peptic ulcer in South-West Scotland over
the period 1946-1980 was reported by Neilson (1966) and Dark and MacArthur
(1983). In the earlier part of the study period (1946-1965) the incidence
of duodenal ulcer perforations increased to a peak of 19/100,000 population.
In the later part (1966-1980) the incidence declined to 12/100,000 population.
The incidence in females remained static over the period of the study. Over
this time period the incidence of perforated gastric ulcer remained constant
at 2.5/10^ population.
English national statistics were published by Brown, Langman and Lambert
(1976) using Hospital In-Patient Enquiry,
perforated duodenal ulcer fell by 25% for
between 1958-1972 (Table 9.2).
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Yearly admission rates per 10
population perforated duodenal
ulcer in England and Wales
(from Brown, Langman and
Lambert 1976)
In an extension to that study, Coggan, Lambert and Langman (1981)
reported a continuing decline in cases of perforated duodenal ulcer in the
years 1973-1977. Analysis by age and sex, however, showed a persisting
decline in males of all ages, while the incidence in females over 45 years
rose. Thus between 1958-1962 and 1973-1977 the incidence of perforated
duodenal ulcer in females aged 65-75 increased by 46% while that for
females aged over 75 increased by 60%.
Yet several recent studies have suggested that since 1970 the annual
number of duodenal perforations has remained constant.
Dreghorn and Moffat (1984) found no change in annual number of
perforations when the period 1971-1982 was compared with 1970-1976 in
Western Scotland. Similarly Gillen (1986) found no change in annual
numbers over 1970-1982 in North-East England.
Gustavsson (1988) reported no change in the incidence of operations for
perforated duodenal ulcer amongst the citizens of Rochester, Minnesota
over the period 1956-1 985.
Christensen (1988) found in a Copenhagen population no change in the
incidence of ulcer perforation between 1974-1984.
Both Collier (1985) and Negre (1985) attributed the constant rate of
perforation to a relative increase in perforation in the elderly and
associated with the increasing use of non-steroidal anti-inflammatory
drugs. Walt (1986) confirmed these suggestions in an analysis of national
figures from England and Wales between 1958 and 1983.
Bardhan (1989) studied admission rates for perforated duodenal ulcer in
the Trent region, finding no change between the periods 1972-1976 and
1977-1984.
f) Elective Operation Rates
The first report of a decline in elective operations for duodenal ulcer
was from Seattle (Smith 1977). Between the periods 1966-1970 and 1971 —
1975 Smith reported a 35% decline in elective operations for duodenal ulcer.
A study of operations for duodenal ulcer for the entire United States showed
a 30% decline from 136,000 in 1966 to 97,000 in 1977 (Fineberg and Pearlman
1981). A similar decline was shown in a study from the Mayo clinic to have
occurred in the residents of the town of Rochester. The rate of elective
operations on previously unoperated patients fell from 49/100,000 per year in
1956-1960 to 6/100,000 in 1981-1985 (Gustavsson 1988).
A survey of the Hospital Discharge Survey of the U.S. National Center
for Health Statistics in 1981 (Fineberg and Pearlman 1981), showed a
progressive decline in the numbers of vagotomies and partial gastrectomies
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Fig. 9.2
Partial gastrectomy and vagotomy operations (000s)
in the U.S.A. 1966-1978 (Fineberg and Pearlman 1981)
This decline from 136,000 procedures in 1966 to 79,000 in 1978
represented a 41% decline over 12 years.
A recent study assessed changes in elective duodenal ulcer operations
in Helsinki between 1977-1987 (Paimela 1991). The rate per 10^ inhabitants
fell from 15.5 in 1977 to 12.3 in 1982 to 6.7 in 1987. Over the same
period the rate of operations for perforated duodenal ulcer remained
unchanged (1.2 per 10^ in 1977, 1.3 per 10^ in 1982 and 2.0 per 10^ in 1987).
Similar changes have been reported from several U.K. centres the
percentage decline varying from 28-70% depending on the years studied:
28% (Dreghorn and Moffat 1984); 30% (Quill 1983); 38% (Thomson 1981);
38% (Holmes 1987); 39% (Wylie 1981); 70% (Venables 1986).
The most recent report from the U.K. is that of Bardhan and colleagues
(1989) who reported patterns of change in operations for duodenal ulcer in
the Trent region of England between 1972-1984. Over this 13 year period
g
elective operations for duodenal ulcer per 10 population fell from 162.4
to 76.2. As with all other studies which have concomitantly studied
perforations, there was no fall in the rate of admissions for perforated
duodenal ulcer over this period - the rate per 10 population being
98.5 in 1972-1976 and 102.6 in 1977-1984. Yet these figures concealed
large rises in the rates for those patients aged over 65 from 264 in the
former period to 352 in the latter, a 33% increase.
PRESENT STUDY
Scottish national operation statistics are obtained from SMR1 forms
which are returned from hospitals to the Information and Statistics Division
of the Common Services Agency of the Scottish Health Service at Trinity
Park House. These are recorded on computer.
The number of operations for duodenal ulcer in Scotland for the years
1971-1987 have been calculated from the annual numbers of patients
with a coded diagnosis of duodenal ulcer (ICD9 Code 532) who were also
coded for the following operations: (OPCS 3 codes are in brackets) total
(422) or partial gastrectomy (423); gastro-enterostomy (426); vagotomy
with gastro-enterostomy (435); vagotomy with other gastric operations
(436); vagotomy not elsewhere classified (434). The results are shown in
Table 9.3 and Fig. 9.3.
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Year Male Female Total
1971 2410 677 3087
1972 2579 687 3266
1973 2186 675 2861
1974 2095 618 2713
1975 1924 554 2478
1976 1827 558 2385
1977 1291 399 1690
1978 1185 396 1581
1979 1103 418 1521
1980 1100 416 1516
1981 1264 501 1765
1982 901 358 1259
1983 997 437 1434
1984 918 386 1304
1985 746 309 1055
1986 681 278 959
1987 523 226 749
1988 504 204 708
1989 482 186 668
Table 9.3
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Fig. 9.3
Operations for duodenal ulcer in Scotland
1971-1989 (information Services Division -
Scottish Health Service)
This decline from 3087 procedures in 1971 to 668 in 1989 represents a
78.4% decline over the 18 year period.
In summary duodenal ulcer was difficult to diagnose in life before the
turn of the century but autopsy evidence suggests that up until then it was
a rare disease, most peptic ulcers occuring in the body of the stomach in
young women. Duodenal ulcer, which predominantly affected young men
increased from the turn of the century to grow into an epidemic in the 1930's,
40's and 50's. The decline in the incidence since the 1950's has continued,
through the 1980's and continues in the 1990's. The mean age has increased,
the male to female preponderance continues to decline. Both the numbers
and rates of duodenal ulcer perforation have remained stable since about
1970. This may be the result of medical therapy 'suppressing' the ulcer
without curing the diathesis, thus producing a larger number of patients
with 'suppressed' ulcer which may perforate. This suggestion has been
supported by the Cimetidine surveillance survey (Colin-Jones et al 1985).
CHAPTER 10
LONG TERM MORTALITY FOLLOWING
PEPTIC ULCER SURGERY
88.
As a result of improvements in peri-operative care, operative mortality
rates have fallen over the past 41 years and thus in Chapter 20 it has been
possible to report a series of 500 consecutive elective operations for
duodenal ulcer without operative mortality. This together with patient
satisfaction rates of the order of 85% for ulcer operations on long term
follow-up, suggests that modern surgical treatment has reached acceptable
standards for uncomplicated ulcer disease.
Yet several studies have suggested that surgery for duodenal ulcer is
associated both with an increase in overall long term mortality (shortened
life expectancy) and with increase in cause-specific mortality.
OVERALL MORTALITY
Krause (1958) studied 361 patients operated upon in Upsalla, Sweden
between 1905-1933 with a follow-up of 23 to 50 years after Billroth II
resection. He found a greater than expected mortality from suicide,
tuberculosis, and gastric carcinoma.
Ross (1983) analysed data from the Western General Hospital, Edinburgh.
In a study of 779 men followed for 15-25 years after operation it was
concluded that an operation for peptic ulcer shortened life expectancy by
9 years and that this excess mortality was due to tobacco related disease.
Yet other major studies have failed to confirm these observations.
Fischer (1985) followed 1,025 patients who had Billroth II gastrectomy
between 1948-1956 giving a follow-up between 22-30 years. There was no
overall increase in long term mortality but there was a significant increase
confined to males under 44 years.
Eriksson (1983) in Malmo, Sweden followed 1,575 patients who had gastro¬
enterostomy or gastric resection between 1930-1960. After follow-up for
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between 19 and 49 years there was no significant increase of observed over
expected deaths unless the operative mortality (within 30 days) was
included. When patients under 40 years at the time of operation were
analysed separately there was a significant increase in late mortality.
Caygill (1987) reviewed 4,514 patients who had gastric surgery in
London between 1940-1960. There was a significant increase in observed
over expected deaths only for patients who died more than 20 years after
the operation. This increased mortality was seen for "all neoplastic
disease" where the ratio of observed to expected deaths was 3.3:1 and
for "all non-neoplastic disease" where the ratio was 1.6:1.
CAUSE-SPECIFIC MORTALITY
a) Suicide
Increased mortality from several causes have been reported. Krause
(1958) was among the first to report an increase in suicide following peptic
ulcer surgery. In his study of 361 patients, 9 died as a result of suicide
compared to an expected of 2.5 an increased risk of 3.6. This increased
risk was confirmed by the reports of Westlund (1963), Viskum (1975), and
Eriksson (1983) who found the increased risk to be greater than 3 times.
Knop (1981) reporting a series from Copenhagen of 1,025 patients
found that deaths from suicide were 5 times the expected and accounted
for 13% of all deaths. Further investigation of this group showed that
of those committing suicide, 50% had had a prior psychiatric admission,
and 34% had been diagnosed as alcoholics (Fischer 1985). An increase in
symptoms of post-gastrectomy sequelae was not found in this group, leading
to the conclusion that pre-existing psychiatric illness or personality disorder
was an important aetiological factor and that post-operative complications
or sequelae were not. Ross (1982) also found a threefold increase in
expected deaths from suicide.
Viskum (1975) studied duodenal ulcer patients treated both medically
and surgically and found the increased risk of suicide was identical in
both groups suggesting that it is the duodenal ulcer diathesis which is
associated with a greater risk of suicide rather than the operation.
b) Gastric Cancer
Balfour (1922) was the first to describe the phenomenon of gastric
cancer following peptic ulcer surgery and many case reports followed.
Helsingen (1956) and Krause (1958) were the first to demonstrate an
increased risk compared to the expected and since then several series
have documented this phenomenon. A review of the series which have
compared the observed to the expected number of gastric cancer cases
following peptic ulcer surgery has been carried out and the results are
shown in Table 10.1.
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First Author Total Length Cancer Cancer 95% Confid
F.U. Observed Expected O/E Limits
Helsingen (1956) 222 10-34 11 5.2 2.12 1.06-3.79
Krause (1958) 361 23-50 25 11.3 2.21 1.43-3.27
Liavaag (1962) 616 15-35 9 9.6 0.94 0.43-1.78
Domellof (1977) 534 -12+ 14 8.2 1.71 0.93-2.86
Ross (1982) 779 15-32 8 10.4 0.77 0.33-1.52
Clark (1983) 225 22-27 1 0.25 4.0 NK
Shafer (1983) 338 -40 2 2.6 0.77 0.09-2.78
Eriksson (1983) 1403 19-49 24 20.7 1.16 0.81-1.38
Fisher (1984) 945 19-29 13 10.6 1.23 0.65-2.10
Pickford (1984) 307 30-40 9 2.6 3.1 NK
Tokudome (1984) 3827 10-33 34 100.6 0.34 0.23-0.47
Watt (1984) 735 15-25 16 4.8 3.3 NK
Caygill (1986) 4466 -20+ 32 12 2.67 1.94-3.24
Viste (1986) 3470 25-45 87 41.4 2.10 1.68-2.59
Lundegardh(1988) 6459 20-33 62 37.3 1.66 1.27-2.13
Arnthorsson (1988) 1795 15-48 30 13.8 2.17 1.46-3.10
Offerhaus (1988) 2633 25-59 8 2.5 3.13 NK
Toftgaard (1989) 2975 15-27 15 10.7 1.40 0.91-1.98
Table 10.1
Gastric cancer following previous peptic ulcer surgery in
published series
Helsingen and Iiillestad from Oslo studied patients who had had a
partial gastrectomy between 1919-1944. They found that in the group
operated on for gastric ulcer the observed frequency of gastric cancer was
three times as high as expected whereas in the group operated on for
duodenal ulcer the observed and expected were practically identical.
Krause (1958) studied 361 patients who underwent partial gastrectomy
between 1905-1933. He was able to trace 94% of these patients and found
a significantly higher mortality from carcinoma of the gastric remnant
compared to the expected for the Swedish population. Domellof from Umea
in Sweden studied 459 patients who had gastrectomy for ulcer disease
between 1952-1956 and followed up for 20 years. In 214 of these upper
G.I. endoscopy was performed and in this group 6 carcinomas were found.
Three patients with gastric carcinoma were found amongst 140 patients who
had died. On the basis of this study Domellof recommended regular upper
G.I. endoscopy and biopsy from the region of the stoma about 10-15 years
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after gastrectomy. Liavaag (1962) reported from Norway 616 patients
followed-up at least 15 years after partial gastrectomy. He reported no
difference between observed and expected incidents of gastric carcinoma.
Nicholls (1974) described a series from Tanner's unit in St. James's Hospital,
London. Thirty-six patients presenting with a carcinoma in the gastric
remnant represented an incidence of 1 carcinoma for every 76 patients
undergoing partial gastrectomy for benign disease. He considered, however,
that this increased risk was confined to patients who had their original
operation for gastric ulcer. Schrumpf (1977) reported a series of 421
patients from Oslo who had a partial gastrectomy 20-25 years previously.
Four patients with gastric cancer were observed although only 1 was
expected. Ross (1982) reporting from the Western General Hospital in
Edinburgh, studied 779 men who had had surgery for peptic ulcer disease
15 years or more earlier. No increased incidence of gastric cancer was
found with 8 cases observed as opposed to 10.4 predicted. Fischer (1983)
reported 1,000 patients from Copenhagen who had had Billroth II resection
for duodenal ulcer 22-30 years previously. Of 522 deaths, 13 were due to
gastric cancer which was not significantly different from the expected
number of 10.2. Schafer (1983) reported 338 patients followed up for up to
40 years after peptic ulcer surgery. He found 2 gastric cancers compared
to an expected 2.6 and concluded that there was no justification for
endoscopic screening of this group. Logan and Langman (1983) reviewing
the evidence available at that time concluded that endoscopic screening of
patients who had had previous peptic ulcer surgery would not be justifiable.
They calculated that as only 1 gastric cancer would be detected for every 125
patients screened and that only 3 deaths would be prevented by 1,000
endoscopies when inoperability, post-operative mortality and death from
other causes was taken into account. Clark (1983) reported 225 patients
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followed-up between 22 and 27 years after partial gastrectomy. They
found 1 gastric cancer which was four times the expected incidence. In
reviewing the literature to that time they concluded that routine endoscopic
screening was not justified.
The studies which had been reported before 1983 tended to involve small
numbers of patients, usually less than 1,000 and with expected numbers of
gastric cancers in single figures. After 1983, however, several large
scale studies have been reported and these in the main have found a
significant increase in gastric cancer in patients undergoing previous peptic
ulcer surgery but only after a delay of 15-25 years.
Pickford (1984) reported from the York Gastric Clinic 632 patients who
had a partial gastrectomy for peptic ulcer 15-40 years previously. They
found 9 gastric cancers compared to the expected 2.8 and found that if
gastrectomy was performed for gastric ulcer the risk of later development
of cancer was significantly higher than following operation for duodenal
ulcer. Caygill (1986) reported 4,466 patients followed-up for 0-20+ years
after gastrectomy for peptic ulcer in Tanner's Unit, St. James's Hospital,
London. There was no difference from the risk of death of gastric cancer
in the first 20 years of follow-up but a 4.5 increase thereafter. For patients
who had surgery for duodenal ulcer there was an initial decrease in risk
followed by a 3.7-fold increase after 20 or more years. The increased risk 20
years after duodenal ulcer surgery was greater in patients who had had
vagotomy than those who had had gastrectomy.
Viste (1986) reported 3,470 patients from Western Norway who had
surgery for peptic ulcer between 1900-1969. The risk of cancer at 10-15
years was not higher than expected but increased progressively with each
succeeding decade so that 40-45 years after the original surgery it was 7.3
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times higher than expected.
Offerhaus (1988) reporting from Amsterdam, followed 2,633 patients.
In 741 who had died mortality due to gastric cancer was 5.1%. Of 554
asymptomatic patients subjected to upper G.I. endoscopy 10 were found to
have gastric cancer and 7 of these had a radical curative resection. It was
concluded that the overall risk increased with increasing length of follow-up
and was higher in patients who had their original gastrectomy at an older
age.
Arnthorsson (1988) reported 1,795 patients from Iceland followed-up for
between 15 and 48 years after gastrectomy. There were 30 observed
carcinomas compared to 13.8 expected. In the first 15 years after operation
the relative risk was 2.17 (95% confidence limits 1.46-3.10). Lundegardh
(1988) followed up 6,459 patients in Uppsala for 25-33 years after partial
gastrectomy for peptic ulcer disease. There was no overall increased risk of
gastric cancer. After adjustment for potential confounding variables,
however, the average adjusted risk increased to 1.28 (95% confidence
limits 1.11-1.49) for each successive 5 year interval after operation. The
adjusted risk of stomach cancer was greater among women than men and
was greater among patients operated on for gastric ulcer than among those
operated on for duodenal ulcer. The relative risk decreased with increased
age at operation. Between successive decades of age at operation the
adjusted risk decreased on average by about half. Toftgaard (1989)
reported 4,131 patients from Western Denmark who had peptic ulcer surgery
between 1955-1960. Up to 15 years after operation the gastric cancer risk
was lower than expected. 20-24 years after operation the relative risk was
1.6 (95% confidence limits 0.5-3.6) and more than 24 years after the
operation the relative risk had increased to 1.9 (95% confidence limits 0.04-11).
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The relative risk was higher in patients who had had surgery for duodenal
ulcer as compared to gastric ulcer. Offerhaus (1988) reported 2,633
patients who had surgery for peptic ulcer in Amsterdam between 1931-1960.
The observed versus expected ratio of mortality from gastric cancer was
significantly increased among women from 15 years after the original
operation (relative risk 4.77) and among men after a post-operative latency
of more than 25 years (relative risk 3.13).
One major study from Japan, however, has found no increase in risk after
partial gastrectomy for peptic ulcer disease. Tokudome (1984) studied
3,701 patients 10 years after partial gastrectomy. Eleven gastric cancers
were observed compared with an expected 52.8. The length of follow-up
after original gastric surgery is considered inadequate to enable valid
observation about cancer in the gastric remnant.
Two studies have suggested an increased risk of gastric cancer in smokers
(Hirayana 1975, Noruma 1990). In Noruma's study an increased risk of
cancer (relative risk 2.7) was found in cigarette smokers (Noruma 1990).
c) Other Cancers
Ross (1982) reporting the Western General Hospital experience, studied
779 men followed for 15-32 years. There was an increase in observed over
expected deaths from bronchogenic carcinoma (47:35.7 p<0.05), carcinoma
of colon and rectum (16:8.9 p<0.01) and carcinoma of pancreas (11:3.9 p<0.01)
but no increase in carcinoma of oesophagus.
Eriksson (1983) from Lund found an increase compared to expected in
bronchogenic carcinoma (41:17.8 p<0.001). Watt (1984) from Belfast found
an increase of 3.53-fold (p<0.0001) in bronchogenic carcinoma and 2.3-fold
(p<0.05) for carcinoma of colon and rectum. There was no increase in other
cancers.
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Fischer (1986) found no increase in mortality from any malignant
disease.
Toftgaard (1990) followed 4,107 Danish patients and found a significant
increase in bronchogenic carcinoma (relative risk 1.66 p<0.001) and bladder
cancer (relative risk 1.44 p<0.01).
Caygill (1987) following 5,018 patients from St. James's Hospital, London
found no increase in mortality from any cancers for the first 15 post¬
operative years. From 20 years after operation there was a significant
excess of large bowel cancer (1.6-fold), bronchus (3.9-fold), pancreas
(4.0-fold), biliary tract (9.1-fold), oesophagus (2.3-fold), bladder (2.4-fold)
and breast (4.0-fold).
d) Other Diseases
Ross (1982) found a significant increase in deaths from cirrhosis (p<0.05)
but no increase in observed deaths from ischaemic heart disease, chronic
bronchitis and emphysema. When all "smoking related" diseases were
grouped there was an increase in observed over expected (p<0.025).
Eriksson (1983) found an increase in observed over expected death from
generalised arteriosclerosis (WHO 440-448) with 41 deaths compared to 21.3
expected (p<0.01). He also found an increase in death from bronchopneumonia
(61:25.8 p<0.001). He found no increase in ischaemic heart disease or
cerebro-vascular disease.
Watt (1984) found significant increases in deaths from bronchopneumonia
(17:4.4 p<0.0001), cerebro-vascular disease (29:18.5 p<0.05) but no increase
in cirrhosis or chronic bronchitis. Fischer (1986) found no increase in
mortality from cardio-vascular disease, respiratory disease or cirrhosis.
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Mortality in patients with duodenal ulcer not having surgery
The studies discussed above have led to the hypothesis that it is the
lifestyle which accompanies the duodenal ulcer diathesis that is responsible
for the excess mortality on long term follow-up - in particular cigarette
smoking and alcohol abuse (Ross 1982). In our series between the years
1948-1968 76.896 (1,063/1,384) of patients having surgery for duodenal ulcer
were cigarette smokers: 82.9% of males (914/1,103) and 5 3 96 (149/281) of
females compared to 61% of the U.K. population in 1951 and 5496 of males
and 4396 of females in 1968 (Tobacco Research Council 1972) (Table 10.2).
% Smokers
M F
Gastro-enterostomy (1948-1968) 75.0% 49.0%
TV + GE (1948-1968) 82.1% 54.5%
TV + P (1960-1968) 80.9% 78.3%
Polya gastrectomy (1948-1968) 83.9% 46.4%
All operations (1948-1968) 82.9% 53.0%
U.K. population (1951) 61% 40.0%*
U.K. population (1968) 54% 43%
Scottish population (1972) 54% 43%
* Data for females first became available in 1955
Table 10.2
Smoking habits of patients having operations for
duodenal ulcer Western General Hospital 1948-1968
compared with population
The figures for the Scottish Population first became available in 1972
(Scottish Health Statistics 1988) and were identical to the U.K. figures for
1968.
If this hypothesis were correct then those patients with duodenal ulcer not
coming to operation would be expected to show a similar excessive
mortality from tobacco and alcohol related disease, provided their
cigarette consumption was similar to those coming to operation.
This has been studied by Lee (1988) who found no increased mortality in
2,529 Japanese patients with peptic ulcer followed for between 9 and 23
years. This study must be interpreted with caution because another study
from Japan (Tokodume 1984) was one of the few to show no increase in any
cancers after surgical treatment of peptic ulcer.
In the only large scale European study in which cause of death after non¬
surgical treatment of duodenal ulcer has been studied Bardhan (1991) found
no significant increase in cancer deaths compared with expected after




THE GASTRIC FOLLOW-UP CLINIC
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The Gastro-Intestinal Unit at the Western General Hospital, Edinburgh
was established in 1948. Founded jointly by a physician (Dr. Wilfred Card)
and a surgeon (Mr. John Bruce) it pioneered the concept of combined care
in gastroenterology (Bruce and Card 1958). The problem which dominated
gastroenterology in the next three decades was peptic ulcer disease and its
complications. It was natural therefore that a special interest in duodenal
ulcer disease should develop.
Early research interest in acid output (Adam, Card, Riddell, Roberts, Strong
and Woolf 1954), resulted in trials to assess the effect of "tailoring" the
operation for duodenal ulcer. In 1953 the Gastric Follow-Up Clinic was
established to follow-up these and all other patients having primary and
revisional surgery for peptic ulcer disease. The clinic was established by
Mr. W. P. Small who described the techniques in the clinic in a series of
publications over the next 20 years (Small 1964, Leading article 1966,
Leading article 1967, Small 1971, Small, Philip, Cay, Neilson, Henderson
1978).
The clinic recruited patients from the theatre operations book. A
clerical officer completed a proforma with the patients' biographical details.
The details of investigation, operation and post-operative complications
were completed by a surgeon in the Follow-Up clinic. The proforma is
shown in Appendix A. Follow-up was planned to take place 6 months and
12 months after the operation and then annually. The clerical officer
arranged for those patients able to travel to the hospital to attend an evening
clinic, where follow-up data was added to the proforma. Those patients in
Lothian unable to attend the clinic were visited by the clinic visitor who
obtained the follow-up data and completed the form. For patients who
lived outwith the Lothians a postal questionnaire was sent with a reply paid
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envelope. Visick grading was performed on the basis of this data.
As the reputation of the Gastro-Intestinal Unit spread, a large practice
in peptic ulcer surgery built up. The numbers of patients and the volume of
data brought their own problems. By 1985 over 4000 patients had been
registered in the Gastric Follow-Up Clinic each with over 100 items of
standard data collected on proformas. Although provision had been made
for a coding system, the data was not coded so that all analysis had been
done manually. To facilitate analysis of these data a quality of life
questionnaire was devised which allowed calculation of a quality of life
score (Small, Philip, Cay, Neilson, Henderson 1978). Whilst this readily
identified those patients in whom an operation had failed, it did not allow
detailed analysis of symptoms or complications.
The second problem was of the decline in the incidence of peptic ulcer
disease which is discussed in detail in Chapter 9.
From 1985 the methods of patient recruitment and data storage analysis
were changed with the introduction of computer technology. An account
of these changes is given in Chapter 12.
CHAPTER 12
THE SURGICAL REVIEW OFFICE
The Surgical Review Office was a natural evolution from the Gastric
Follow-Up Clinic. The decline in incidence of duodenal ulcer disease,
described in detail in Chapter 9, resulted in a progressive decline in
operations. This decline was accelerated by the introduction of H2
receptor antagonists in 1975 and the proton pump antagonist Omeprazole
in 1987. The need to diversify into follow-up of other procedures was
recognised in the early 1980's and the documentation of patients with
gastric carcinoma began. The establishment of the Surgical Review Office
in 1986 saw the audit process extend into operations for gastr¬
oesophageal reflux, gastric carcinoma, diverticular disease and the
increasing problem of large bowel carcinoma.
The increasing number of patients being recruited required the
introduction of new techniques to recruit, document, analyse and follow-up
patients in these various groups, as well as to analyse the 4,000 or so
patients being followed-up after duodenal ulcer surgery. The following
description is confined to the technique devised for those patients with
duodenal ulcer.
EXISTING METHODS
The methods used by the Gastric Follow-Up Clinic have been described
in detail in Chapter 11. In summary these were as follows:
Recruitment and Documentation
Patients were recruited to the Gastric Follow-Up Clinic by a clerical
officer who consulted the operation book in theatre. This system relied
on the entries into the operation book by nursing staff being accurate and
complete. It also relied on the clerical officer being able to recognise
all primary, emergency and revisional operations for duodenal ulcer.
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Patient data was then stored manually on a proforma (Appendix A).
Although allowance had been made for coding this information, the coding
system had not been used. Furthermore much of the important follow-up
data from clinics was recorded in freetext and was unstructured. This
meant that the only method by which this data could be analysed was
manually. Given over 4,000 patients, each with over 100 items of
information a comprehensive analysis would have been a formidable and
time consuming task.
Follow-Up
Follow-up had been carried out at an evening clinic, timed so as to allow
patients to attend without losing work. As the patient population aged and
many moved from the area, this became a less effective method of obtaining
follow-up information. Furthermore the increasing financial pressures made
a hospital clinic an expensive option. Patients, symptomfree following an
operation many years previously, came increasingly to regard a hospital
visit as irrelevant and compliance in patient attendance had fallen.
INNOVATIONS
The innovations included changes in documentation, patient recruitment,
data collection, computerisation, patient follow-up, data analysis and
techniques used to accurately establish date and cause of death.
Documentation
A decision was first made on which of the existing data should be
recorded. Although much of this was structured most follow-up data was
in freetext. A computer file was designed which incorporated structured
and freetext data from the original proformas. This included biographical
data such as sex and date of birth; pre-operative data such as admission and
operation type (elective/emergency); indication; smoking habits; acid output
studies; operative details; post-operative complications; long term
complications and re-operations; post-operative acid output studies;
Visick grading; death certificate cause of death. In addition a standard
follow-up questionnaire which could be used for each follow-up visit was
designed (Appendix B). This allowed the same information to be recorded
irrespective of whether it had been obtained by clinic attendance, home
visit or postal questionnaire. The follow-up questionnaires scores could
be read by superimposing a transparent acetate over the answers
(Appendix C). All the biographical, pre-operative, operative, follow-up
data and questionnaire scores were keyed into the computer.
Computer hardware and software
The choice of computer system was governed by the need for a 20
megabyte hard disc for storage, the desire for IBM compatibility, ease of
servicing and low cost. In the event an NCR PC8 with 100% IBM
compatibility was donated by a patient (Mr. George Munro). This ran under
DOS using a 286 processor and had 20 Mbytes storage on hard disk. Of the
software then available, DBase III Plus (Ashton Tate Inc.) had the advantages
of power and speed to analyse large data sets, ease of operator use and the
prospect of regular up-dates. The original data set was therefore recorded
as a single file "Ulcer" containing 47 fields. The file structure is shown in
Appendix D. The Harvard Graphics software was used to generate
graphics.
Recruitment, Documentation, Follow-Up
The methods of patient recruitment, documentation and follow-up are





"Identifying data" by clerical officer
medical/surgical data by doctor
keyed by higher clerical officer
Follow-up as shown below
Letter to G.P.
Response













Summary of methods used by Surgical Review
Office
Patients are recruited to the register from the operation note, copies
of which are sent daily to the office. Standard biographical information
is entered on the proforma by the clerical officer taking information from
the case notes. The medical and surgical details are entered from the
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case notes by the surgeon or attached G.P. The information is then keyed
into the computer by the higher clerical officer. Before any patient is
approached for review a letter is written to the G.P. to establish vital status
to avoid any distress to relatives in the event of death of the patient
(Appendix E). If the General Practitioner indicates that the patient is alive
the standard postal questionnaire is sent with a business reply envelope. If
no reply is obtained a second questionnaire is sent and if this fails a home
visit is made by the clerical officer or the patient interviewed by telephone.
If the patient has changed G.P. then the new G.P. is established from the
Primary Care Division of the Lothian Health Board and a letter to establish
vital status sent to this G.P. If the G.P. indicates that the patient is dead
or this emerges from subsequent follow-up the certified cause of death is
obtained from a search of the records at Register House. If the patient is
not found on the records at Register House or is thought to have died in
another part of the United Kingdom a further search is made at the
Scottish National Health Service register at Ladywell House.
The questionnaire sent to patients is designed to elicit information both
about symptoms and quality of life, and is shown in Appendix B and is
discussed in detail in Chapter 13.
The questionnaire used to elicit symptoms from patients who had
closure of perforated duodenal ulcer or highly selective vagotomy is shown in
Appendix F. This took account of the considerable analytical power
available with the arrival of computer technology allowing, easily and
speedily, individual symptoms to be analysed and correlated with the need
to resort to a symptom score. This questionnaire is shown in Appendix F.
Analysis
By the end of 1990 it had been possible to transfer data into computer for
all patients undergoing operation between 1948 and 1968 inclusive. These
patients thus have a minimum of 22 years and maximum of 42 years of
follow-up. It is this group who have been subjected to analysis in the
following chapters.
CHAPTER 13
METHODS USED TO MEASURE QUALITY OF LIFE AND SYMPTOMS
AFTER OPERATIONS FOR DUODENAL ULCER-
METHODS USED TO MEASURE ACID OUTPUT.
STATISTICAL METHODS.
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Florence Nightingale was one of the first to try to measure the outcome
of surgical treatment. Her assessment of the results of treatment as
"improved, disimproved, died" although seemingly primitive was little
improved upon by surgeons for over 60 years. Perhaps it was not surprising,
because so much surgical interest was (and is) devoted to improving
diagnostic and operative techniques, that outcome assessment should have
attracted less attention. For this reason end points like for example
recurrent ulcer in ulcer surgery, resectability in cancer surgery, and operative
mortality came to dominate the surgical literature. From Visick's pioneering
work in the 1940's, techniques for measuring quality of life after surgical
operations have been developed and improved. Yet it was not until 1976
that "quality of life" appeared as a leading article in Index Medicus. Now
in the 1990's "outcome audit" has been given a new impetus by enshrinement
in the Health Act (1990) and a great variety of techniques or more precisely
instruments to measure quality of life are now available and have been
validated.
This chapter describes the techniques used to measure quality of life,
and assesses their strengths and weaknesses. In particular the methods
which have been applied to operations for duodenal ulcer will be described.
The instrument developed in the Western General Hospital, Edinburgh, is
described in detail.
The Development of Measurement of Quality of Life
The name of Visick is known to every surgeon because of the classification
which he developed and which carries his name. His was the first to attempt
to quantify the results of duodenal ulcer surgery (Visick 1948). His scoring
system used a numerical score of 1 to 4 for each of 13 clinical features
(Table 13.1), where 1 was the best and 4 the worst result. The highest















Parameters used to score the
Visick classification
The Visick grading was classified as follows:
Visick 1 - No symptoms
Visick 2 - Mild symptoms easily controlled
Visick 3s - Mild symptoms not controlled (satisfactory)
Visick 3u - Mild symptoms not controlled (unsatisfactory)
Visick 4 - Symptoms not improved or worse. Recurrent ulcer
It is surprising from the perspective of the 1990's that the concept of
quantifying clinical parameters was not more widely adopted for many years.
One of the earliest and probably the best known scoring system was that
devised by Apgar to evaluate the vitality of the newly born infant (Agpar
1953). Yet it was not until the 1970's that scoring systems became widely
accepted in medical practice.
Techniques, or instruments, to measure quality of life were developed
to assess the outcome of treatment or to monitor its continuing effects,
particularly in chronic, malignant or terminal disease.
Such instruments can be classified into general and disease specific.
General measures of quality of life will be considered first.
The first index to measure quality of life was the Karnofsky Performance
Status Index. Originally devised to measure the results of nitrogen mustard
chemotherapy in the treatment of patients with bronchogenic carcinoma,
it has become one of the most widely used and provided standards which
others were to follow (Karnofsky 1948). The Karnofsky Index comprises an
eleven point scale from 0 to 100% with 10% increments ranging from normal
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(100%) to dead (0%). Although this index is no longer used it had an
important influence on future developments.
Perhaps the simplest method of measuring quality of life is the visual
analogue scale. Quality of life can be measured using a 10cm. line between
two extremes of health such as "best imaginable state", and "worst imaginable
state". Despite the apparent advantage of simplicity many patients find
these difficult to understand. In an attempt to overcome this Aitken (1969)
suggested that guiding statements could be written along this line. Yet some
studies to investigate this showed that the addition of such statements
biased the results (Osborne 1975). The validity of the linear scale in
measuring quality of life was supported by Matell (1971) and Remington
(1979).
The Visick scale and linear analogue scale have both been compared with
the quality of life instrument used in the current study.
As the population in the 1960's came to contain an ever increasing
proportion of elderly patients, the need to assess the quality of life in the
elderly became increasingly important. The Barthel Index (Mahoney and
Barthel 1965) measured independence in the chronic sick and elderly.
In the 1970's two important methods for assessing quality of life were
published - the Sickness Impact Profile in the United States (Bergner et al
1976), and the Nottingham Health Profile (McDowell et al 1978). These
have been well validated and remain widely used today. The Sickness
Impact Profile contains 136 statements covering physical, psychological
and social aspects of life. The Nottingham Health Profile contains questions
classified under six categories: pain, sleep, energy, social isolation, emotional
reaction, and physical mobility.
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Cay and Small Quality of Life Score
Neither of these had been formally validated when, at much the same
time, the quality of life instrument subsequently used to assess the results
of duodenal ulcer surgery at the Western General Hospital, Edinburgh, was
devised (Cay et al 1975). This was based on statements made by 500
patients who were asked for their opinion about the outcome of the
operation. These statements were reduced to 53 questions which were
compiled into a questionnaire. This was then tested on 63 patients and
compared to Visick grading. As a result of this pilot study the number of
questions was reduced to 22 and the possible answers to each question
weighted to take account of a gradation of response by grading the
answers from 0 to 3. The 22 questions are shown in Appendix B. This was
then compared to Visick grade, to the 100 mm. line test (where the patient
grades the result from "worst possible" at 0 mm. to "best possible" at
100 mm.) and to post-operative alkali consumption. The results of this
validation were published in 1978 (Small et al 1978). In the 47 patients
tested there was a significant correlation between the Q.O.L. score and
Visick grade, but neither of these correlated with the 100 mm. line test or
alkali consumption (Table 13.2). The closest correlation between the Q.O.L.
score and Visick grade occurred when the Q.O.L. scores were classified
into 'good', 'moderate' and 'bad' as shown in Table 13.2.

















Comparison of Q.O.L. score, Visick grading and 100mm line test
(from Small et al 1978)
Of the 22 questions eight (Nos. 5,7,8,11)16,19,20,21) were regarded as
assessing physical symptoms while the remaining 14 assessed psychosocial
factors. The former were added separately to obtain a "physical symptom"
score with a possible total of 24; the latter can be totalled to give a
"psychosocial" score with a possible total of 42. By combining the two a
total or "quality of life" score is obtained with a possible total of 66. For
ease of interpretation and to allow for a readily understandable
interpretation of the result of the operation, the convention of subdividing
total scores into "good" (score 45-66), "moderate" (score 40-45), or "bad"
(score 0-39) was devised and correlated with Visick grades as described
above. The component parts, the psychosocial and physical symptom
scores, can also be classified in this way. The psychosocial scores of
greater than 34 are classified "good", 26-34 as "moderate" and 0-25 as "bad".
The physical symptom scores of greater than 20 are considered "good",
13-19 as "moderate" and 0-12 as "bad".
This allocation of questions into two groups by these authors was
necessarily arbitrary and has produced apparent anomalies. Thus questions
8 and 19 which quantify the patient's assessment of the operation have
been included in the "physical" score group whilst questions 1,2,10 and
22 which relate to bowel function, wind and dizzy spells have been included
in the "psychosocial" score. Arguably these could have been included in
either group. Because the original questionnaire was validated using that
classification it has been retained.
Since this questionnaire was validated the quality of life assessment has
been answered by over 1200 patients in most instances sequentially over
many years. This has allowed assessment of these changes with time
and ageing. It has also permitted the comparison of the results of various
operations performed for duodenal ulcer.
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In the present study Visick grading has not been applied to patients
after highly selective vagotomy. This was because in the Visick system
recurrent ulcer was automatically graded as Visick IV irrespective of
symptoms. As endoscopy was increasingly used in follow-up it became
apparent that some patients with recurrent ulcer, particularly small,
superficial or acute ones had minimal, and in some cases no symptoms.
Visick grading therefore seemed increasingly inappropriate particularly
with the advent of computer technology which allowed analysis of and
correlation between individual symptoms in large patient groups.
For four operations - Polya gastrectomy, gastro-enterostomy, truncal
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vagotomy and gastro-enterostomy and truncal vagotomy and pyloroplasty -
both Visick grading and Quality of Life scores have been performed.
The results of this assessment of quality of life have not previously
been analysed. They form one of the largest studies ever made to measure
the results of surgical treatment of duodenal ulcer.
Symptom Questionnaires
For two of the operations studied (highly selective vagotomy and closure
of perforated ulcer) it has been possible because of computer technology
to analyse and correlate symptoms in their own right in large patient groups.
To do this a questionnaire was devised in which patients were asked to
select from four options whether symptoms were experienced "every day,
most days, occasionally, never" (Appendix F).
In addition to symptoms the patients were asked about ability to eat a
normal meal, about enjoyment of food and appetite. They were asked
about consumption of H2 receptor antagonists and antacids. Patients were
also asked if the original problem was cured/improved/same or worse and
whether they regarded the operation as a success.
Techniques to measure acid output
Acid output has been measured at the Western General Hospital since
1956 by a series of nurses trained in the techniques of gastro-intestinal
investigation. Maximal acid output pre-operatively was measured until
1966 by the augmented histamine test (Kay 1953) as modified by Card and
Sircus (1958) using histamine (0.04mg/kg.). After 1966 pentagastrin
(Peptavlon, ICI) was used in a dose of 6ug/kg. (Makhlouf 1966).
All subjects were fasted and a naso-gastric tube placed into the most
dependent part of the antrum and the position confirmed by fluoroscopic
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screening. From 1972 the water recovery test (Finlay 1972) was used to
ensure that the tube lay in the antrum. Aspiration was continued for 1 hour
before stimulation and for 2 hours after.
Post-operative acid output was determined in this way. In addition, for
patients undergoing vagotomy, the vagally mediated acid output was measured
by the technique of insulin (0.2 I.U./kg.) induced hypoglycaemia initially by
bolus injection and latterly by the infusion technique (Carter 1972). In 1982
this technique was superseded by the sham feeding test (Kronborg and
Anderson 1980).
All aspirates were divided into 15 minute aliquots, the volume recorded
and total HCL concentration was calculated by titration. Acid output was
calculated for both the first and second post stimulation hours.
No calculation was made to take account of transpyloric loss of acid.
Basal and maximal acid outputs have been recorded.
Statistical techniques
The CIA statistical software package (Gardner and Altman 1989) was
used, where appropriate, to calculate the following:
1. Mean and standard error determinations for single observations
eg. quality of life scores.
2. Difference of mean between paired observations.
3. 95% confidence limits for single and paired observations and
95% confidence limits for differences of mean between paired
observations eg. pre- and post-operative maximal acid output.
Probability values for differences between the operations of complications
was calculated using a Chi square test. Cox proportional hazard analysis
was used to calculate the significance of individual risk factors e.g.
a) the pre-operative possible risk factors associated with recurrence
after highly selective vagotomy.
b) the association between 6 factors present in patients with perforated
duodenal ulcer and the need for subsequent definitive operation.
Life table analysis using the Kaplan-Meier product limit technique was used
to calculate actuarial cumulative recurrence rate eg. recurrence rate
after highly selective vagotomy.
CHAPTER 14
LONG TERM MORTALITY FOLLOWING DUODENAL ULCER
SURGERY - METHODOLOGY
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The long term survival and ultimate cause of death following
operations for duodenal ulcer has received increasing attention since
Krause (1958) demonstrated an excessive mortality in the years following
partial gastrectomy. Since then there have been several other studies
following up larger numbers of patients over a longer period of time
(McLean Ross 1982, Stemmermann 1984, Lundegardh 1991).
There are differences between the conclusions of each of these studies
almost certainly because of important differences in methodology.
Krause in 1958 obtained the cause of death from sources which included
local parish registers, relatives and the hospital at which the patient had
been treated rather than the exclusive use of death certificates. The
expected mortality was calculated by the person years at risk technique.
Krause describes the technique as follows: "Mortality in different age
groups at different periods from 1911 to 1950 was calculated on the
basis of data from official Swedish statistics. The resulting death rate was
applied to the number of years the patients in the series survived in the
different age groups and at the different periods". Thus Krause's study
has not taken account of gender nor does he describe the age bands used.
Furthermore the series was a small one studying only 361 patients operated
on between 1905 and 1933 and drawing conclusions from 210 deaths.
Nonetheless Krause's paper was an important landmark as it was the first
time the causes of death had been analysed in this group of patients. This
was the first study to conclude a higher than expected incidence of long
term mortality from gastric cancer after partial gastrectomy.
This study also showed the increased risk of death from pulmonary
tuberculosis after partial gastrectomy, a conclusion subsequently confirmed
by Balint (1958).
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The study by McLean Ross and co-workers (1982) on patients from the
Western General Hospital, Edinburgh, used a different method of calculation
of expected deaths. Survival curves using life table analysis were drawn
for each of three 10 year age groups and these were then compared with
survival curves calculated for the general population from life table
figures supplied by the Faculty of Actuaries.
Expected deaths from individual diseases were calculated using a
proportional analysis technique. Two methods were used. Firstly for
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those diseases for which the death rate per 10 population was available
from the Registrar General for Scotland (ischaemic heart disease, chronic
bronchitis and emphysema and carcinoma of the lung) the standard mortality
ratio was used. For the causes of death where the death rate was not
available this was calculated. Both methods of analysis "took account of
variations in causes of death with age and time".
This study was confined to men and concluded that there was an excess
mortality with expectation of life being reduced by 9.1 years. They further
concluded that excess mortality was due to smoking associated disease by
adding together all those which had been suggested to be tobacco related.
The study by Lundegardh (1991) used a person year at risk technique.
The observed survival rate in the patient group was compared with the
expected survival rate obtained from Swedish population tables by age
(at 5 year intervals), gender and calendar year. The cause of death was
that given by the death registry. Following a cohort of 6,459 patients
for 27-35 years after operation they demonstrated "a slight but significant
decrease in relative survival rate to 92% (95% C.L. 87-97%). No decrease
in relative survival rate was observed during the first 20 years after
operation".
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The major studies which have analysed mortality from individual
causes of death have all used person year at risk methodology (Dommelof
1977, Schafer 1983, Fischer 1983, Tokudome 1984, Caygill 1986, Watt
1984, Toftgaard 1989).
Method used in the current study
The person years at risk technique was used. This technique takes
into account the number of persons under observation and the duration of
observation of each person. This is particularly appropriate in assessing
mortality after a particular operation as the size of the cohort changes
during the period of observation. This is because rate of entrance to the
study varies depending on the date of operation and individuals will be lost
from the cohort because of death or loss to follow-up. The technique also
takes into account the differences in different age bands in disease specific
mortality. The changes in mortality from certain diseases from year to
year are also taken into account. These changes occur either because some
illnesses are becoming more prevalent (e.g. colon cancer) or mortality from
an illness is decreasing (e.g. pulmonary tuberculosis). The person years at
risk method in this study used the computer program described by Coleman
and colleagues (1986).
The cause of death in each instance was taken from the death certificate.
These were obtained from Register House, Edinburgh, and then coded to the
9th Revision of the International Classification of Disease (ICD9). The ICD
coding rules were observed. Thus any malignant process in part 1(b) or 1(c)
of the death certificate was coded as cause of death. Any malignant process
in part 2 was coded only if it was considered causally related to a diagnosis
in Part I.
An analysis of mortality from individual causes of death was made using
ICD9 codes as follows:
118.
Cause of Death ICD9 Code
Death from all causes
Death from all circulatory diseases












Carcinoma of female breast















Expected deaths were divided by 5 year age bands from 0-85 years and
for 5 year calendar periods 1946-1988 and were calculated separately and
then in total for each gender.
To assess the specific effect of the operation as opposed to the disease
diathesis or associated life style factors, the data was analysed to show
separately deaths in the first post-operative year and the remainder of the
study period. A further analysis was performed showing separately deaths
in the first 19 post-operative years and those 20 or more years post-operatively
to enable the effect of any long term risk factor to be demonstrated.
In the study group the date at which patients were recorded as lost to
observation was the last date at which they were known to be alive. Survival
rate after medical intervention in this method is computed by computing 5
year survival rates obtained by amalgamating yearly fatality rates in life
table form. The standard mortality ratio for each cause of death was
obtained from the Registrar General for Scotland statistics (Scottish Health
Statistics). Relative risk for each cause of death was obtained by dividing
the observed by the expected number of cases. The probability levels were
calculated on the assumption that the number of cases followed a Poisson
distribution.
PART m
LONG TERM RESULTS OF DUODENAL ULCER SURGERY -
WESTERN GENERAL HOSPITAL, EDINBURGH
CHAPTER 15
TRENDS IN THE SURGICAL TREATMENT OF DUODENAL ULCER AT THE
WESTERN GENERAL HOSPITAL, EDINBURGH
The records of the Gastric Follow-Up Clinic began on 1st August 1947.
The first complete year for which records are available is 1948 and this
year has therefore been taken as the starting point for the study. The
total numbers of operations done between 1948 and 1990 inclusive are














Operations for duodenal ulcer (excluding perforations)
Western General Hospital 1948-1990
As can be seen from this chart the total annual numbers peaked in 1965
when 150 operations were performed. Since that year there has been
a trend to a decrease in annual numbers with a more marked decrease
after 1983. The total of 12 operations in 1990 represents a mere 896 of the
1965 total.
120.
The trends in the individual operations performed are shown in Fig. 15.2.
OPERATIONS FOR D.U.
WGH 1948-90
— POLYA M T.V.& PYLOROPLASTY □ T.V & G-E BG-E ALONE
Fig. 15.2
Totals for specific operations for duodenal ulcer
Western General Hospital 1948-1990
Polya gastrectomy reached a peak in 1950 after which it was gradually
replaced by truncal vagotomy and gastro-enterostomy. This procedure in
turn reached its zenith in 1973 the same year as gastro-enterostomy alone.
Thereafter highly selective vagotomy became the most popular operation
reaching a peak in 1981 (Fig 15.3).
The unit was unusual in its advocacy of gastro-enterostomy alone into
the 1980's as part of the continuing policy of tayloring the procedure
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Fig. 15.3
Highly selective vagotomy Western General Hospital
1973-1990
CHAPTER 16
THE RESULTS OF BILLROTH H (POLYA) GASTRECTOMY FOR
DUODENAL ULCER
122.
The trend toward Billroth II (Polya) gastrectomy as the operation of
choice for duodenal ulcer in the U.K. in the years following the Second
World War has been outlined in Chapter 2. When the Gastro-Intestinal
Unit at the Western General Hospital, Edinburgh, was established in 1947
the senior surgeon was Mr. (later Sir) John Bruce. In common with other
former Army surgeons he returned to post-war civilian practice with the
clear belief that Billroth II gastrectomy should be the elective operation
for duodenal ulcer and this policy was followed at the Western General
Hospital from that time.
This chapter is concerned with the long term results of those Billroth II
partial gastrectomies performed in the 20 year period 1948-1968.
Although individual operation notes are not available the operation was
a standard one, the result perhaps of a discipline persisting from wartime
service days. The resection was a two-thirds to three-quarters gastrectomy
leaving a gastric remnant measuring some 5 inches from the fundus. The
gastrojejunostomy was antecolic and isoperistaltic with an afferent loop
some 10 inches long taken to lesser curve. The stoma was valved by using
a Friedrich stapling clamp to close the superior aspect of the divided
stomach to leave a stoma measuring no more than 2 inches.
For some 2 years between 1950 and 1952 the more extensive seven-
eighths gastrectomy which had been advocated by Visick was used but the
available records do not indicate in which patients this was performed.
The results of this 20 year experience with Billroth II gastrectomy are
considered in terms of operative mortality, revisional surgery, Visick grading,
quality of life, and long term mortality.
For purposes of this study operative mortality is defined as death
123.
occuring within 30 days of operation.
The sub group proceeding to revisional surgery comprise a relatively
small number of patients undergoing different revisional procedures for
a variety of indications without a uniform policy. This makes an analysis
difficult so that only the number, type and result of the revisional procedures
have been presented.
Two methods of quality of life assessment have been used - Visick
grading and the Cay and Small quality of life and pain score. The Visick
grading (Visick 1948) and the pain and quality of life score (Cay et al 1975)
described in detail in Chapter 12, were both devised to allow the
symptomatic result of the operation to be expressed in simple numerical
terms. The application of computer technology, which was not available
when those scoring systems were first described, has allowed the analysis
of individual symptoms from a large number of patients. The progression
of Visick and quality of life scores over a 20-40 year period paints a
picture of the effects of the operation throughout and in many cases beyond
the working lifetime of a large group of patients.
Between 1st January, 1948 and 31st July, 1968 a total of 847 patients
underwent Polya partial gastrectomy for duodenal ulcer at the Western
General Hospital. Of these 736 were male (90.1%). The mean age was
46.0 years with a range of 15-80 years. All procedures were elective but
16 were performed 'urgently' for bleeding. The distribution of the
operations performed between 1948 and 1990 is shown in Fig. 16.1.
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Fig. 16.1
Number of Polya gastrectomies performed annually at Western
General Hospital 1948-1990
Previous complications of the ulcer were noted as possible indicators
of the aggression of the ulcer diathesis. Previous haemorrhage was noted
in 167 (19.7%) and previous perforation in 108 (12.7%). 679 patients
(80.2%) were cigarette smokers.
RESULTS
Operating Surgeons
The majority of the procedures, 617 (72.9%), were performed by four












Number of Polya gastrectomies
performed by 4 consultant surgeons
Operative Mortality
The overall 30 day operative mortality was 1.9% (16/847). Three of
these patients had emergency gastrectomy for haemorrhage and died of
continuing haemorrhage. The operative mortality excluding these urgent
cases was 1.6% (13/847). The cause of death in the 13 patients who died
within 30 days of elective operation is shown in Table 16.2.
Complications on Follow-Up
Complications observed during the 22-40 years of follow-up are shown in
Table 16.3. The diagnosis of complications such as dumping and diarrhoea
and bile vomiting were made on review at the follow-up clinic, home visit
or from postal questionnaire. All recurrent or stomal ulcers were














Cause of death in 13 patients
dying within 30 days of elective
Polya gastrectomy
126.





Anaemia (iron and B12 def.)
Steatorrhoea







Complications related to gastrectomy
observed on long term follow-up.
(%ages expressed of 831 survivors)
Revisional Operations
A total of 69 revisional operations were performed in 63 patients (7.6%
of the 831 survivors). Only those operations for complications of the
original operation have been considered. Thus procedures such as further
resection for carcinoma of the gastric remnant have not been included.











Revisional procedures in 63
patients
Acid output studies
Maximal acid output (MAO) was measured in 537 patients pre-operatively
using maximal histamine stimulation. The mean pre-operative MAO was
39 (range 1-113) mMols. in the post-histamine hour. Post-operatively
MAO was measured in 120 patients, the mean MAO was 6 mMols. in the
















Visick grading was performed on at least one occasion on all patients who
survived for a minimum of six months and who were available for follow-up.
A first Visick assessment was recorded for 754 patients (90.7%) of the 831
patients who survived for more than 30 days post-operatively. Where
grading was performed on several occasions those assessments made closest
to the fifth anniversary and the fifteenth anniversary have been selected for
ease of analysis. The results of the first Visick assessments are shown in
Table 16.5.
Patients graded Visick 1 469 (62.2%)
Patients graded Visick 2 133 (17.6%)
Patients graded Visick 3 68 (9.0%)
Patients graded Visick 4 84 (11.1%)
(mean time to grading 6.4 years
range 6 months to 28.3 years)
Table 16.5
Results of first Visick grading in 754
patients
The range in timing is large because eleven patients assessed within 5
years subsequently died before formal assessment at 5 years have produced
a short interval to first grading. On the other hand eight patients lost to
follow-up were subsequently traced and assessed and they account for the
long delay to first grading.
The results of the second Visick grading performed in 333 patients are
shown in Table 16.6. The reasons for the large range in timing are as given
above. Where serial assessments have been made, the Visick score closest
to the 15th anniversary of the procedure has been selected for ease of
analysis and presentation of data.
Patients graded Visick 1 194 (58.2%)
Patients graded Visick 2 68 (20.4%)
Patients graded Visick 3 41 (12.3%)
Patients graded Visick 4 30 (9.0%)
(mean time to 2nd grading 17.2 years
range 3.8 - 34.8 years)
Table 16.6
Results of 2nd Visick grading in 333
patients
The differences in mean scores between first and second assessment are















■■ 1st grading IM1 2nd grading
Fig. 16.2
Results of 2 Visick gradings after Polya gastrectomy
Quality of Life Assessment
Quality of life was assessed using the technique of Cay and Small on one
occasion in 313 patients, on two occasions in 178, and on three occasions in
77.
The quality of life questionnaire was developed over several years and
became available in its final form in 1978. Thus the delay to first assessment
was at least 10 years. As described in Chapter 13 the Cay and Small quality
of life assessment gives three scores i.e. psychosocial score, physical symptoms
score and the two combined giving a 'quality of life' (Q.O.L.) score. The results
of the first quality of life assessment in 313 patients are shown in Table 16.7.
Mean psychosocial score 30.2+1.14 (28.7-32.1) [5-42]
Mean physical score 20.7+0.97 (18.4-22.9) [2-24]
Mean Q.O.L. score 50.9+1.11 (47.1-55.0) [7-66]
Table 16.7
Mean scores in 1st psychosocial and physical
symptom assessment
(n=313): 95% C.L. in () Range in []
The Q.O.L. scores have been classified into the range bands described in
Chapter 13, to give an assessment of the quality of life as "good", "moderate",
or "bad". These results are shown in Table 16.8.
Good (score 46-66) 223 (71.2%)
Moderate (score 40-45) 51 (16.3%)
Bad (score 0-39) 39 (12.5%)
(mean time to assessment 21.9 years
range 11.1-30.0)
Table 16.8
Results of 1st psychosocial and
physical symptom assessment
(n=313)
A second assessment was performed in 178 patients, a mean of 24.2 years,
after operation (range 16.0-34.7), and a third in 77 patients, a mean of
26.5 years, after operation (range 17.7-36.7 years). These results are




Good (score 46-66) 71.2%
Moderate (score 40-45) 16.2%
Bad (score 0-39) 12.4%
Table 16.9
Results of three quality of life
(Total scores i.e. psychosocial
symptom scores)
The differences in mean scores between the three assessments is not
statistically significant.
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Fig. 16.3
Results of three quality of life assessments after Polya
gastrectomy
The results are in keeping with the Visick assessment. The Visick















total score is calculated from the patient responses. It is of interest that
some 80% of patients score Visick I or II on first assessment while 87%
score "good" or "moderate" on first quality of life testing. The quality of
life score is shown graphically in Fig. 16.4 as an area curve. The percentage
















The physical symptom score has been expressed graphically in the
same way. The percentage of patients achieving each score between
2 and 24 is shown in Fig. 16.5.
10 15 20 25 30 35 40
SCORE
POLYA GASTRECTOMY
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Fig. 16.5
Polya physical symptom score curve
Correlation between Visick grading and Quality of Life scores
The correlation between Visick grading on first assessment and Q.O.L.
scores on first assessment is shown in Table 16.8. The mean Q.O.L. score in
the patients graded Visick 1 is significantly superior to the other Visick
gradings (p<0.05). The differences in Q.O.L. score between the patients
























Correlation between Q.O.L. score and Visick
grading after Polya gastrectomy. 95% C.L. in []
133.
Conclusions
In this study Polya gastrectomy has been shown to have a relatively
low mortality of 1.6% for elective cases. Bearing in mind that these
operations were performed between 1948 and 1968 this could be expected
to be lower today. It has been shown that operative mortality following
gastrectomy for gastric cancer has fallen significantly in the past 30
years (Macintyre 1991).
The incidence of dumping (4.3%) and bile vomiting (5.5%) are in keeping
with the results from other published series. The stomal/recurrent ulcer
rate (3.2%) is low compared to those from other contemporary series
(Table 2.2).
Using the convention that Visick I + II means a satisfactory result,
79.8% of patients had such a result after first grading and 78.6% after
second.
Similarly 87.5% had a good or moderate result using the quality of life
assessment. As with Visick grading this result did not worsen over 15 years.
The quality of life score appears to be more appropriate than the Visick
grading. Of 37 patients graded Visick 4, eighteen (48%) enjoyed a quality
of life score in the "good" range. On the other hand of the 177 graded
Visick 1 only six (3.4%) scored in the "bad" range for quality of life.
By these criteria Polya gastrectomy appears to be a useful operation for
duodenal ulcer. The all-important long-term nutritional and metabolic
sequelae which caused the operation to fall from favour have not been
examined in this study.
CHAPTER 17
THE RESULTS OF GASTRO-ENTEROSTOMY
FOR DUODENAL ULCER
134.
The policy pursued at the Western General Hospital of tailoring the
operations to acid output has been described in earlier chapters. This policy
resulted in gastro-enterostomy alone being carried out on patients with
maximal acid output of less than 30 mM. as late as 1985 some 50 years
after the operation had been abandoned by most surgeons in the English
speaking world. This has provided an unusual opportunity to review a
relatively large number of patients 22-42 years post-operatively.
Between 1st January 1948 and 31st December 1968 a total of 113 gastro¬
enterostomies were performed for duodenal ulcer at the Western General
Hospital. The annual distribution of these operations between 1948 and
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Fig. 17.1
Annual number of gastro-enterostomies performed at the Western
General Hospital 1948-1990.
135.
There were 60 males (53%) and 53 females with a mean age of 54 years
(range 18-88). All procedures were elective. Of the 113 patients 30 (26.5%)




The 30 day operative mortality was 0.9% (1/113). The one patient who died
was a 60-year-old man who died of post-operative pneumonia. The surviving
patients have now been available for follow-up between 22 and 42 years.
Complications on Follow-Up
Complications observed during the 22-40 years of follow-up are shown in
Table 17.1.
Dumping (early and late) 3 (2.7%)
Diarrhoea 5 (4.5%)
Bile vomiting 9 (8.0%)
Stomal ulcer 13 (11.6%)
Stomal obstruction 1
Recurrent duodenal ulcer 2 (1.8%)
Gastric ulcer 7 (6.2%)
Pulmonary T.B. 1
Table 17.1
Complications related to gastro-enterostomy
observed on long term follow-up (percentages
expressed of 112 survivors beyond 30 days)
Revisional operations
Revisional operations were performed on 19 occasions (16.8% of 30 day
survivors). Of these 9 were gastrectomies, 6 truncal vagotomies, 1 HSV,
2 revision of the gastro-enterostomy and one 'take-down' of the gastro¬
enterostomy.
Acid output studies
The maximal acid output (MAO) was measured in 79. The mean MAO
in these 79 patients was 23 mMol. in the first post-stimulation hour
136.
(range 4-51 mMol.) in keeping with the policy which aimed to reserve this
operation for patients with an MAO of less than 30 mMol.
The MAO was measured post-operatively in 28 patients. The mean MAO
post-operatively in these patients was 16 mMol. in the post-histamine/post-
pentagastrin hour. The pre- and post-operative results are shown in
Table 17.2.






























Pre- and post-operative MAO
measured in 28 patients before
and after gastro-enterostomy
In these patients the mean pre-operative MAO was 24 mMol. and post¬
operatively was 16 mMol., a mean reduction for this group of 33.3%. The
mean of the differences was 8.9 (S.E. + 1.44) and 95% confidence limit for
mean difference is 6.0 to 11.9.
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Visick Grading
Visick gradings were performed at approximately 5 year intervals. 109
of the 112 patients who left hospital were subsequently assessed and given a
Visick grade. The first Visick grading was allocated between 6 months and
14.4 years with a mean of 4.4 years interval since the procedure. Gradings
were allocated thereafter at approximately 5 year intervals. The results


















If the accepted convention of combining Visick 1 with 2 and 3 with 4 is
used, then at the first assessment 77.1% were in the former group and 22.
in the latter. By the second assessment there was no significant change with
72.4% classed as Visick 1 or 2 and 27.6% as Visick 3 or 4.






HI 1st grading 2nd grading
Fig. 17.2
Visick grading after gastro-enterostomy
138.
This demonstrates that combining the Visick scores has hidden a
significant fall in the percentage of patients graded Visick 1 from 61.0%
to 36.2% (p<0.001) those patients being downgraded to Visick 2 or 3 at the
second assessment.
Quality of Life Assessment
When the quality of life assessment was developed it was applied post¬
operatively to those surviving patients not lost to follow-up. It became
available for the first time in 1978 and the assessment therefore involves a
smaller number of patients than the Visick grading. The results of these
assessments are shown in Table 17.4 where psychosocial score and physical
score are added to give a quality of life (Q.O.L.) score.
This shows no deterioration in either component or the total Q.O.L. score
between the two assessments. The quality of life scores in these two
successive assessments is shown graphically in Fig. 17.3 expressed as
percentages of patients in the "good", "moderate" and "bad" result bands as





Mean psychosocial score 29.8+0.79 (28.2-31.4) 30.3+1.10 (28.1-32.6)
Mean physical score 18.8+0.71 (17.3-20.2) 19.4+0.7 (18.0-20.8)
Mean Q.O.L. score 48.6+0.91 (45.5-51.6) 49.7+1.8 (46.1-53.4)
Table 17.4
Mean scores + S.E.M. in 1st and 2nd psychosocial and
physical symptom assessments








Results of 2 quality of life assessments following
gastro-enterostomy
These results are shown in tabular form in Table 17.5 after classification
















Quality of life results calculated on the basis
of total score
The psychosocial score at the first assessment has been calculated as
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Fig. 17.4
Psychosocial score profile after gastro-enterostomy
This shows the percentage of patients who scored each possible score
between 16 (the worst score) and 40 (the best score).
This depicts the profile of the operation in terms of psychosocial
score - the more the area under the curve is moved to the right, the better
the result. The graph demonstrates that gastro-enterostomy is
associated with a broad scatter of low and medium scores indicating
a poor overall result from this operation in terms of psychosocial symptoms.
The physical symptom scores at first assessment have also been
calculated as an area graph in the same way.
141.
GASTROENTEROSTOMY




Area graph physical after gastro-cnterostomy
22 24
This demonstrates a much better result in terms of physical symptom scores
compared to psychosocial score following gastro-entcrostomy.
Correlation between Visick grading and Quality of Life Score
















Correlation between Visick grading and
Q.O.L. score after gastro-enterostomy.











The patients classified Visick 1 have a significantly better mean score
than all other Visick grades (p<0.05) but the differences between the mean
scores obtained between the other 3 Visick grades are not significant.
Conclusions
Despite the policy of gastro-enterostomy being reserved for patients
with an MAO of less than 30 mM, gastro-enterostomy has been shown in this
study to be an unsatisfactory operation for duodenal ulcer. The recurrent
ulcer rate (stomal, gastric and duodenal) of 19.6% is in keeping with those
in other published reports (Chapter 3).
Furthermore the rates of dumping (2.7%), diarrhoea (4.5%) and bile
vomiting (8.0%) are similar to those after gastrectomy.
The unsatisfactory long term outcome is reflected in the poor Visick
grading and quality of life scores.
There was no decline either in the Visick scores or the Quality of Life
score with the passage of time in the group overall.
CHAPTER 18
THE RESULTS OF TRUNCAL VAGOTOMY AND GASTRO-ENTEROSTOMY
FOR DUODENAL ULCER
143.
Truncal vagotomy and gastro-enterostomy was first performed in the
Western General Hospital in 1948, the year after Dragsted and his colleagues
had described the technique of trans-abdominal truncal vagotomy (Dragsted
1947). Between 1948-1968 a total of 317 such procedures were performed.
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Fig. 18.1
Annual number of truncal vagotomy and gastro-enterostomy
procedures for duodenal ulcer Western General Hospital
1948-1990
There were 196 males and 121 females so that males formed 61.8%
of the series. The mean age at operation was 47.1 years with a range of
18-81 years.
There were 227 cigarette smokers (71.6%). 66 patients (20.8%) had had
a previous haemorrhage from the ulcer and 25 (7.9%) a previous perforation.
RESULTS
Operative mortality
Five patients died post-operatively giving an operative mortality of
1.5896. The cause of death in these 5 patients was massive pulmonary
embolism in three, cerebral embolism in one patient who had mitral
valve disease with atrial fibrillation, and pneumonia leading to massive
pulmonary consolidation in the fifth.
Complications on Follow-Up
Complications observed during the 22-40 years of follow-up are shown
in Table 18.1.
Revisional operations
36 revisional operations were recorded in 33 patients representing
10.6% of the 312 patients who survived the 30 day post operative
period. The operations are shown in Table 18.2.





















Complications related to truncal vagotomy
and gastro-enterostomy observed on long
term follow-up (percentage expressed on
312 survivors beyond 30 days)
Polya gastrectomy
Billroth I gastrectomy



















Pre-operative MAO was measured in 225 patients. The mean MAO
was 31 mMol. in the first post stimulation hour with a range of 2-93 mMol.
MAO was measured post-operatively in 106 patients who had a mean MAO
of 8 mMol. with a range of 1-48 mMol. This represents a mean reduction
in MAO for this group of 77%.
Visick Gradings
At least one Visick grading was carried out on 286 patients (91.7% of
the 30 day survivors) and a second assessment on 141. The mean time to
first grading was 6.22 years with a range of 1.9 to 21.8 years and mean time
to second grading was 15.29 years with a range of 3.9 to 30.2 years. The









142 (49.7%) 59 (41.8%)
63 (22.0%) 34 (24.1%)
45 (15.7%) 31 (22.0%)
36 (12.6%) 17 (12.1%)
Table 18.3
Results of Visick grading after truncal
vagotomy and gastro-enterostomy -
Western General Hospital
These results are shown graphically in Fig. 18.2.
There were no significant differences between Visick gradings on
first and second assessment.
146.
VISICK GRADING
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Fig. 18 .2
Visick grading after truncal vagotomy and gastro-enterostomy
Western General Hospital
Quality of life assessment
Quality of life assessments were performed on at least one occasion
on 140 patients and twice on 73. The mean interval to first assessment was
18.5 years with a range of 6.0 to 30.2 years and the mean time to second
assessment was 21.8 with a range of 12.2 to 34.5 years.
1st Assessment 2nd Assessment
(n = 140) (n = 73)
Mean psychosocial score 29.G+0.59 (28.4-30.7) [13-41] 29.1+0.82 (27.4-30.7) [5-41
Mean physical score 19.4+0.38 (18.7-20.2) [4-24] 19.2+0.62 (18.0-20.4) [3-24
Q.O.L. score 49.0+0.97 (47.1-50.9) [17-65] 48.3+1.44 (45.4-51.1)
Table 18.4
Mean scores + S.E. in 1st and 2nd quality of life assessment after
truncal vagotomy and gastro-enterostomy.
95% C.L. in () Range in []
The Q.O.L. scores have been classified into the range bands described
in Chapter 13, to give an assessment of the quality of life as "good", "moderate",
or "bad". These results are shown in Table 18.5.
Good (score 46-66) 97 (69.3%)
Moderate (score 40-45) 15 (10.7%)
Bad (score 0-39) 28 (20.0%)
(Mean time to assessment 18.5 years
Range 6.0-30.2)
Table 18.5
Results of 1st Q.O.L. assessment
(n=140)
A second assessment was performed in 73 patients a mean of 21.8 years
after operation (range 12.2-34.5). These results are shown in Table 18.6.
Patients
1st Assessment 2nd Assessment
(n = 140) (n = 73)
Good (score 46-66) 97 (69.3%) 51 (69.7%)
Moderate (score 40-45) 15 (10.7%) 9 (12.3%)
Bad (score 0-39) 28 (20.0%) 13 (17.8%)
Table 18.6
Results of two quality of life assessments
There is no significant difference between results on first and second
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Fig. 18.3
Results of successive quality of life assessments after truncal
vagotomy and gastro-enterostomy - Western General Hospital
The psychosocial score at the first assessment has been calculated as an
area graph (Fig. 18.4). The percentage of patients who scored each possible
score between 13 and 14 has been recorded.
TV & GASTROENTEROSTOMY
PSYCHO-SOCIAL SCORE PROFILE
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Fig. 18.4
Psychosocial score after truncal vagotomy and gastro¬
enterostomy: area curve
The further to the right the area under the curve the better the result
profile.
The physical score has also been expressed graphically in the same way
in Fig. 18.5.
TV & GASTROENTEROSTOMY




Physical score after truncal vagotomy and gastro¬
enterostomy: area curve
Correlation between Visick gradings and Q.O.L. score
The correlation between Visick gradings and Q.O.L. score is shown in
Table 18.7. The number of patients in each Visick grade who attained
the "good", "moderate" and "bad" quality of life scores have been tabulated.



















Correlation between first grading and
Q.O.L. score after truncal vagotomy and
gastro-enterostomy. 95% C.L. in []
Those patients graded Visick 1 have significantly higher mean score than
any of the other three Visick groups (p<0.05). The differences between
the mean scores of the three remaining Visick groups is not statistically
significant.
Conclusions
Truncal vagotomy and gastro-enterostomy was the preferred operation
in the Western General Hospital in the 1960's, although, for reasons
described in detail earlier, gastro-enterostomy without vagotomy was also
popular at this time and indeed in one year (1965) surpassed truncal vagotomy
and gastro-enterostomy.
Whilst the incidence of dumping and bile vomiting does not differ from
gastrectomy or gastro-enterostomy, the incidence of diarrhoea (8.3%)
is higher than after either of these procedures. The incidence of recurrent
ulcer (stomal, duodenal and gastric) was 5.2%, significantly lower than after
gastro-enterostomy alone (19.6%) and, surprisingly, than truncal vagotomy
and pyloroplasty (14.0%)..
The Visick gradings showed no change between the first and second
assessment. By the time of the second assessment truncal vagotomy and
gastro-enterostomy scores were significantly worse than Polya
gastrectomy (Visick 1+2 = 65.9% compared to Visick 1+2 = 78.6% (p<0.01)).
The Cay and Small quality of life score showed no difference in "good"
results from the three other operations but significantly more "bad"
results than Polya gastrectomy.
CHAPTER 19
THE RESULTS OF TRUNCAL VAGOTOMY AND PYLOROPLASTY
FOR DUODENAL ULCER
Truncal vagotomy and pyloroplasty was first performed in the Western
General Hospital in 1951, four years after Dragsted and his colleagues had
described the technique of trans-abdominal truncal vagotomy (Dragsted
1947). Thereafter the operation was not performed again until 1960.
Between 1948-1968 a total of 107 such procedures were performed. The
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Fig. 19.1
Annual numbers of truncal vagotomy and pyloroplasty procedures
for duodenal ulcer, Western General Hospital
There were 84 males and 23 females so that males formed 78.5% of the
series. The mean age at operation was 40.0 years with a range of 15-75
years.
There were 86 cigarette smokers (80.4%). 35 patients (32.7%) had had a




There were no post-operative deaths.
Complications on Follow-Up
Complications observed during the 22-40 years of follow-up are shown in
Table 19.1.
Dumping (early and late) 7 (6.5%)
Diarrhoea 11 (10.3%
Bile vomiting 6 (5.6%)
Recurrent duodenal ulcer 12 (11.2%)
Gastric ulcer 3 (2.8%)
Steatorrhoea 9
Delayed gastric emptying 3
Table 19.1
Complications related to truncal vagotomy
and pyloroplasty observed on long term
follow-up (percentage expressed of 107
survivors beyond 30 days)
Revisional Operations
16 revisional operations were recorded in 16 patients representing 14.9%




Re-vagotomy with Polya gastrectomy 2
Roux-Y conversion 1
Dilation of pyloroplasty 1
Table 19.2
Revisional operations after truncal
vagotomy and pyloroplasty
Acid output studies
Pre-operative MAO was measured in 91 patients. The mean MAO was
35 mMol. in the first post stimulation hour with a range of 4-73 mMol. MAO
was measured post-operatively in 63 patients who had a mean MAO of 9 mMol.
with a range of 1-48 mMol. This represents a mean reduction in MAO for this
group of 74.3%.
Visick Gradings
At least one Visick grading was carried out on 100 patients (93.5%)
and a second assessment on 60. The mean time to second grading was
13.8 years with a range of 5.0 to 29.8 years. The results of these are


















Results of successive Visick gradings
following truncal vagotomy and pyloroplasty
These results are expressed graphically in Fig. 19.2. The differences
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Fig. 19.2
Results of successive Visick gradings after truncal vagotomy
and pyloroplasty
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Quality of Life Assessment
Quality of life assessments were performed on at least one occasion on
67 patients and twice on 36. The mean interval to first assessment was
15.1 years with a range of 10.2 to 27.1 years and the mean time to second
assessment was 18.1 with a range of 11.9 to 33.2 years. The results of
mean scores are shown in Table 19.4.
1st Assessment 2nd Assessment
(n = 67) (n = 36)
Mean psychosocial score 28.6+0.83 (27.0-30.3) [10-39] 29.0+1.00 (27.0-31.0) [12-39]
Mean physical score 18.7+0.59 (17.5-19.9) [6-24] 19.7+0.72 (18.2-21.1) [11-24]
Mean Q.O.L. score 47.3+1.42 (44.5-50.2) [16-65] 48.7+1.72 (45.2-52.1) [23-61]
Table 19.4
Mean scores + S.E. in first and second quality of life assessments after
truncal vagotomy and pyloroplasty. 95% C.L. in () Range in []
The Q.O.L. scores have been classified into the range bands described
in Chapter 13, to give an assessment of the quality of life as "good",
"moderate", or "bad". These results are shown in Table 19.5.
n = 67
Good (score 46-66) 40 (59.7%)
Moderate (score 40-45) 14 (20.9%)
Bad (score 0-39) 13 (19.4%)
(Mean time to assessment 15.1 years
Range 10.2-27.1)
Table 19.5
Results of 1st quality of life
assessment (n = 67)
A second assessment was performed in 36 patients a mean of 18.1
years after operation (range 11.9-33.2). These results are shown in
Table 19.6.
Patients
Result 1st Assessment 2nd Assessment
(n = 67) (n = 36)
Good (score 46-66) 40 (59.796) 25 (69.4%)
Moderate (score 40-45) 14 (20.996) 4 (11.196)
Bad (score 0-39) 13 (19.4%) 7 (19.5%)
Table 19.6
Results of two quality of life assessments
There were no significant differences between first and second assessment.
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Fig. 19.3
Results of successive quality of life assessments after
truncal vagotomy and pyloroplasty
The psychosocial score at the first assessment has been calculated as
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Fig. 19.4
Psychosocial area graph after truncal vagotomy and
pyloroplasty
This shows the percentage of patients who scored each possible score
between 16 and 40. The physical score has been expressed graphically in
the same way in Fig. 19.5.
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Fig. 19.5
Physical area curve after truncal vagotomy and pyloroplasty
158.
Correlation between Visick grading and Q.O.L. scores
Correlation between Visick grading and Q.O.L. scores is shown in
Table 19.7. The mean scores of each Visick group is not significantly



















Correlation between first Visick grading and
first Q.O.L. score after truncal vagotomy
and pyloroplasty. 95% C.L. in []
Conclusions
This study has shown that the recurrent ulcer rate after truncal
vagotomy and pyloroplasty (14.0%) lies between that for Polya gastrectomy
and gastro-enterostomy. The rates of bile vomiting (5.6%) and dumping
(6.5%) are similar to those for other operations. The incidence of
diarrhoea, however, is significantly higher (10.3%) than after either Polya
gastrectomy (3.2%) or gastro-enterostomy (4.5%).
The Visick gradings were significantly worse than those following Polya
gastrectomy with only 66% of patients graded Visick 1+2 compared to 79.8%
following Polya gastrectomy. Similarly patients have a worse quality of
life score after truncal vagotomy and pyloroplasty than after any of the
other operations. Only 59.7% of patients attained a "good" score after
truncal vagotomy and pyloroplasty compared to 71.2% (Polya), 69.3% (truncal
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vagotomy and gastroenterostomy) and 67.2% (gastro-enterostomy).
This finding, surprising given that truncal vagotomy and pyloroplasty
remains the standard operation for duodenal ulcer in many centres, suggests




Highly selective vagotomy (H.S.V.) may prove to be the last contribution
by surgeons to the elective treatment of duodenal ulcer. The development
of the operation was the culmination of increasing understanding about the
control of secretion of gastric acid and the role of that secretion in the
aetiology of duodenal ulcer disease. The evolution of truncal, selective
and highly selective vagotomy has been described in Chapters 4 and 5.
The pressure to develop increasing selectivity in vagotomy was brought
about both by the side effects of intestinal parasympathetic denervation,
particularly diarrhoea and bloating, and also by the consequences of gastric
incontinence. While H.S.V. fulfilled its promise in the reduction of side
effects this was apparently at the expense of an increased recurrent ulcer
rate as compared to truncal vagotomy or Polya gastrectomv.
The first published accounts of the procedure in clinical practice
appeared in 1969 (Johnston and Wilkinson 1969, Amdrup and Jensen 1969).
It was first introduced to the Western General Hospital in Edinburgh three
years later and rapidly became the procedure of choice in that hospital
and also in the surgical unit at Leith Hospital which was linked with the
Western General in 1979.
The annual number of operations performed between 1973 and 1990 is
shown below in Fig. 20.1.
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Fig. 20.1
Operations per year 1973-1990 Western General
Hospital and Leith Hospital
Since the peak of 70 procedures in 1981 there has been a progressive
decline to a mere 3 in 1990. By the end of 1988 a total of 500 operations
had been performed making this one of the largest series in the world
literature. It is an account of the results of these which forms the basis
for this chapter. The results in this group of patients are considered
under two main headings: Recurrent Ulcer and Symptoms.
1. RECURRENT ULCER
For a given recurrence rate to be meaningful the length of follow-up of
the series is crucial. It has been well established that recurrent ulcer
after highly selective vagotomy continues to present throughout the
length of follow-up so that those series with long follow-up will have higher
recurrence rates (Taylor 1988). Indeed in one of the series with the
OPERATIONS
longest follow-up yet available (Hoffman 1988) only one-third of recurrences
were manifest at 5 years.
For several reasons the concept enunciated by Visick that every
recurrent ulcer be deemed a failure (Visick IV) has been questioned (Martin
1989). In this study the Visick grading system has not been used. The
techniques of information storage and analysis now available on computer
allow detailed conclusions about the effect and behaviour of recurrent
ulcer which were not previously possible.
Possible risk factors associated with recurrent ulcer have also been
analysed. In particular the association of age, sex, acid secretion, smoking,
previous complications and the effect of the operating surgeon have been
examined. A report from one of the units which pioneered the procedure
(Primrose 1988) claimed that patients whose ulcers were "resistant" to
H2 receptor antagonist therapy, did badly following H.S.V., with a
recurrent ulcer rate of 30% at 5 years. Others, however, have failed to
find this (Goodman 1987). It is an important controversy to resolve as all
patients coming to elective operation now or in the future will have had
(or should have had) treatment with H2 receptor antagonists.
The recurrent ulcer rate in this study is based on symptomatic recurrence
as we did not, in common with other published series, subject asymptomatic
patients to endoscopy.
2. SYMPTOMS
It is tempting to use recurrent ulcer as the yardstick for success or
failure of the operation. An easily calculated numeric indicator has the
attractions of clarity and.simplicity. Indeed in the days before accurate
diagnosis by endoscopy and effective medical treatment by H2 receptor
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antagonists, recurrent disease was the most appropriate method of
assessment of operations for ulcer.
Today endoscopy can diagnose tiny transient and acute ulcers which may
resolve spontaneously and which may not represent the continuing ulcer
diathesis. Such ulcers may not be associated with other than minor or
transient symptoms. In this series 48 patients with recurrent ulcer
answered the question about whether they considered the operation a
success. Of these 33 considered the procedure a success and only 15
regarded the operation as a failure. It may therefore not be appropriate to
equate recurrent ulcers with failure. Also included in recurrence rate are
those more significant ulcers which can nevertheless be cured by a single
course of H2 blocker. Symptoms may therefore be regarded as a more
appropriate measure of success or failure. The use of symptoms in
assessment, however, is valid only if complications like bleeding or
perforation which are not always preceded by symptoms, are successfully
abolished by the procedure. In this series that condition appears to have been
satisfied to a large extent. Pre-operatively 133 patients had bled and 32
had previously perforated and 12 had had both bleed and perforation. After
the operation only 15 patients had a bleed and 2 a perforation.
The symptoms experienced by patients have therefore been analysed and
form the basis on which the efficacy of the procedure has been assessed.
The principal advantages claimed for H.S.V. over older operations was
a virtual abolition of operative mortality and a reduction in the side effects
such as dumping, bile vomiting and diarrhoea. In this study the incidence of
these side effects has been established by a series of specific questions on
structured questionnaire (Appendix F).
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Patients and Methods
The techniques used to recruit patients, methods of documentation and
techniques of follow-up have been described in detail in Chapters 11 and
12.
All patients who had highly selective vagotomy for duodenal ulcer in the
Western General Hospital and the associated surgical unit at Leith Hospital
have been studied between August 1973 and December 1988. A total of
500 patients underwent the operation without operative mortality. The
mean age was 39.7 years with a range of 12 to 71 years. The male to female
ratio was 365/135 (7396/27%). 382 patients (76.4%) were cigarette smokers
while 45 (9.0%) were ex-smokers and 73 (14.6%) non smokers.
Previous ulcer complications were recorded as possible indicators of the
severity of the ulcer diathesis. Out of the 500 patients, 326 (67.1%) had
had no previous complications. Of the 174 with previous complications
133 (26.6%) had had haemorrhage, 29 (5.8%) a perforation and 12 (2.4%)
both haemorrhage and perforation.
All patients had been kept under regular review by the Gastric Follow-Up
Clinic run by Mr. W. P. Small (Small 1971) and subsequently by the Surgical
Review Office (Macintyre 1988). All patients known to be alive were
contacted during 1989/90. The review was timed so as to give a maximum
follow-up of 16 years a minimum follow-up of 2 years with a mean of 5.7
years. Review was conducted by postal questionnaire shown in Appendix F).
In those cases where this was not returned a home visit was made to those




Two patients sustained oesophageal tears during the oesophageal dissection.
One was treated by Thai patch and the other by direct closure. Both
patients made uneventful recoveries and have remained symptomfree over
the subsequent 4 and 9 years respectively. Three patients required
splenectomy for splenic trauma. None subsequently demonstrated infective
complications and none has developed overwhelming post splenectomy
infections.
Post-Operative Mortality
No patient died during the post-operative in-patient stay or in the 30 days
following operation.
Post-Operative Morbidity
No patients had myocardial infarction or pulmonary embolism diagnosed
in the post-operative period. Post-operative complications recorded are
shown in Table 20.1.
Pulmonary infection 101
Wound infection/abscess/dehiscence/haematoma 47/1/1/3
Intra-abdominal haemorrhage/requiring splenectomy 11/1
Subphrenic collection 11
Intestinal obstruction/prolonged ileus 1/2
Acute gastric dilatation/gastric stasis 1/1
Lesser curve necrosis 2
Acute retention of urine 2
Atrial fibrillation 1
Superficial thrombo-phlebitis 1




Immediate post operative complications
Chest infection was defined as clinical or radiological signs of infection with
the production of purulent sputum. 91 (90%) of the 101 chest infections
occurred in smokers. Wound infection was defined as wound erythema with
the production of pus or fluid from which pathogenic organisms were grown.
Intra-abdominal haemorrhage included those patients in whom the diagnosis
was made clinically or on the basis of vital signs, excess drainage or fall in
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haemoglobin/haematocrit. Four patients required transfusion of whole
blood or red cell concentrate and one of these required laparotomy and
splenectomy. Of the 2 patients who developed lesser curve necrosis, one
was successfully treated conservatively, the other required a laparotomy to
drain a lesser sac abscess and, at a further laparotomy 17 days later, a
partial gastrectomy was performed. The patient who developed a perforated
duodenal ulcer on the eighth post-operative day was a 12-year-old boy
(the youngest patient in the series). This was treated by laparotomy with
simple closure.
Length of In-Patient Stay
The total number of in-patient days for the 500 patients was 5,491
giving an average hospital stay of 10.9 days. The median post-operative
stay was 7.71 days with a range of 2-70 days. 22 patients had a post¬
operative stay of more than 14 days and 6 of more than 21 days. The
complications which resulted in prolonged stay in these patients are shown in
Table 20.2.
Sex Age Post-Op. Stay Complications
1. M 40 year 23 days Intra-abdominal haemorrhage
Splenectomy. Wound infection.
2. F 46 year 70 days Lesser curve necrosis.
Laparotomy and drainage of
abscess in lesser sac.
Second laparotomy and partial
gastrectomy.
3. M 38 year 22 days Prolapsed piles - haemorrhoidectomy.
4. M 52 year 31 days Subphrenic abscess, laparotomy and
drainage.
5. M 48 year 39 days Pulmonary infection.
6. M 12 year 54 days Perforated D.U. Laparotomy.
Table 20.2
Reasons for in-patient stay exceeding 21 days
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Long Term Mortality
On review 22 patients had died. The causes of death taken from
death certificates are shown below in Table 20.3.
Carcinoma of bronchus 3 C.V.A.
Carcinoma of pancreas 3 Aortic aneurysm
Carcinoma of larynx 1 Pneumonia
Carcinoma of brain 1 Septicaemia
Carcinoma of colon 1 Hepatic failure
Carcinoma of oesophagus 1 Heroin overdose
Myocardial infarction 5 Violence
Table 20.3
Cause of death in 22 patients
The small numbers and relatively short follow-up does not permit any
conclusions about differences between observed and expected deaths.
46 patients were lost to follow-up leaving 432 (87.1%) available for
review. Of the 64 patients who had died or were lost to follow-up 7 were
shown to have had recurrent ulcer before being lost to the study and these
recurrent ulcers have been included in the calculation of recurrent ulcer
rate.
Recurrent Ulcer
By the end of 1990, when follow-up ranged from 2-16 years, 62 patients
were diagnosed as having recurrent ulcer. 59 of these have been fully
documented whilst the remaining 3 were diagnosed in other centres.
i) Time to Recurrence
Recurrent ulcer was diagnosed between 8 months and 15 years post¬
operatively. Life table analysis of ulcer recurrence is shown graphically
in Fig. 20.2.




WESTERN GENERAL & LEITH HOSPITALS
Fig. 20.2
Cumulative recurrence rate after highly selective
vagotomy: Western General and Leith Hospitals
This life table analysis represents a cumulative ulcer recurrence rate
of 17.5% by 10 years and 18.5% by 15 years, as can be seen from Table
20.4.










Life table analysis of ulcer recurrence
rate after H.S.V.
Upper gastro-intestinal bleeding from recurrent ulcer occurred in 14
patients. Only 2 had a subsequent perforation including the 12-year-old
boy described above.
ii) Risk Factors
Possible risk factors for recurrence are shown in Table 20.5 which
compares those with recurrence to those without.
Male


































H.S.V. - Possible risk factors compared in patients with
recurrent ulcer and those without
Differences between possible risk factors were tested using Cox proportional
hazards analysis. There was no significant difference in the proportion of
males or the mean age between the groups. The mean length of history
prior to operation was one year longer in those developing recurrence (p<0.01).
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The proportion of cigarette smokers was also higher in the recurrence group
at 84.7% compared to 74.8% in non smokers (p<0.01). The incidence of
previous haemorrhage or perforation did not differ between the two groups.
The recurrence rate was not increased in patients whose ulcers were
"resistant" to H2 receptor antagonists. Of the 157 patients whose ulcers
had failed to heal on these drugs 16 developed recurrence (10.2%) while
24 out of 214 patients (11.2%) who relapsed after an initial response
developed recurrent ulcer.
iii) Acid Secretion Studies
The emphasis on gastric acid output in the assessment and treatment of
duodenal ulcer has decreased since its heyday in the 1950's and 60's when
operations were selected on the basis of acid secretion (Bruce, Card, Marks,
Sircus 1959). In this series pre-operative acid output was performed in
about 90% of the patients because of continuing interest in various aspects
of acid secretion in ulcer disease in the Gastro-Intestinal Unit. Acid output
was not, however, used in the selection of a particular type of operation.
In this series pre-operative acid output in response to pentagastrin was
measured in 442 (89.1%) but post-operatively in only 195 (39.3%). A post¬
operative insulin test or sham feed test was performed in a further 66. Thus
259 patients had post-operative acid secretion studies.
Details of the techniques used to measure acid output are described in
Chapter 10.
Those patients with a high pre-operative maximal acid output were not
at greater risk of recurrence (Table 20.6).
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MAO* n Recurrence No Recurrence
<30 153 13 (8.5%) 140
31-40 151 18 (11.9%) 133
41-50 95 16 (16.8%) 65
51-60 34 4 (11.7%) 25
>60 9 1 (11.11%) 8
TOTAL 442 52 (11.7%) 390
Table 20.6
H.S.V. - Recurrence in relation to pre-op. MAO
(*MAO expressed as mMol in post pentagastrin hour)
In this table the maximal acid output has been divided into 5 bands after
Johnstone (1987). The first consists of those with an output of less than
30 mMol. in the post pentagastrin hour, the next 3 bands each with an
increment of 10 mMol. and final band contains those patients whose maximal
acid output was greater than 60 mMol. The recurrent ulcer rate in each of
these bands has then been calculated. The highest recurrent ulcer rate was
in fact in the 41-50 mMol. band. The differences between the bands were
not statistically significant.
Nor was it possible to distinguish those at risk from recurrence on the
basis of the mean pre-operative MAO of the two groups (Table 20.7).
Recurrence No Recurrence
Mean pre-op MAO (Pentag.)
Mean po^t-op MAO (Pentag.)
% reduction in MAO










H.S.V. - Mean acid output in patients with recurrence
compared to those without
The mean post-operative MAO in response to pentagastrin in the group
with recurrent ulcer was 25.3 mMol. compared to 18.6 mMol. in the group
with no recurrence, a statistically significant difference (p<0.01). The
mean percentage reduction in maximal acid output post-operatively was
also significantly less (pCO.OOl) in patients with recurrence (32.4%)
compared to those without (48.6%).
As can be seen from Table 20.8, in 44 patients with recurrent ulcer,
post-operative MAO in response to pentagastrin was measured post¬
operatively. Only 42 of these 44 patients had MAO in response to
pentagastrin measured both pre- and post-operatively, however. The
values for each of these measurements for individual patients are shown
in Table 20.8 below.
Patient Pre-op. MAO Post-op. MAO % Reduction
(mMol) (mMol)
26 28 19 32%
44 34 14 58%
45 45 29 35%
46 40 22 45%
47 44 41 6%
54 32 11 65%
74 33 40 Higher
81 33 22 33%
95 33 24 27%
116 21 20 4%
117 29 31 Higher
127 37 21 43%
131 38 40 Higher
133 54 35 35%
135 54 13 75%
136 48 36 25%
137 42 31 26%
191 19 8 57%
197 64 41 35%
207 19 20 Higher
208 37 34 8%
209 28 22 21%
211 41 24 41%
221 15 22 Higher
236 50 18 64%
243 32 30 6%
244 31 21 32%
248 44 39 11%
250 43 23 23%
251 32 20 25%
263 30 24 20%
291 15 11 26%
298 32 28 12%
310 49 23 53%
348 25 16 36%
360 47 31 34%
380 51 36 29%
382 37 0 72%
389 48 19 60%
399 40 34 15%
425 42 43 Higher
428 54 10 81%
Table 20.8
H.S.V.- 42 patients with recurrent ulcer who had
both pre-op. and post-op. MAO estimations
As can be seen in 6 of these patients (numbers 74, 117, 131, 207, 221
and 425) the post-operative response to pentagastrin was actually higher
than it had been pre-operatively. Only 9 patients show a reduction of
50% or more in maximal acid output as a result of the operation.
iv) Operating Surgeon
The operations were performed by a total of 41 surgeons - 6 consultants
and 35 surgeons in training. The consultants performed 240 operations
(48.0%) and surgeons in training 260 (52.0%). The number of operations
performed by each of the 6 consultants is shown in Table 20.9 below.


























Operations performed by 6 consultant surgeons with
individual recurrence rates
There were 24 recurrent ulcers following initial H.S.V. performed by
a consultant. As always when considering recurrence rates the length of
follow-up is crucial. There is a trend toward higher recurrence with
increasing length of follow-up. Nonetheless there do appear to be
striking differences between, for example consultant 3 (21.8%)
recurrence after mean F.U. of 6.55 years) and consultant 5 (4.5% recurence
after mean F.U. of 8.14 years) but these differences do not reach
statistical significance.
The number of operations, recurrence rates together with mean
follow-up and range of follow-up for those 6 surgeons in training who
had performed most operations is shown in Table 20.10 below.
Operations Recurrence Mean F.U.
Reg. 1 (CG) 41 6 (14.6%) 5.33
Reg. 2 (HT) 36 7 (19.4%) 3.25
Reg. 3 (AW) 28 6 (21.4%) 7.87
Reg. 4 (GB) 27 3 (11.1%) 8.04
Reg. 5 (SN) 14 0 (0%) 3.75
Reg. 6 (GW) 12 2 (16.6%) 1.71
Table 20.10
Operations, Recurrence and Mean Follow-Up for 6
surgeons in training who performed most operations
iv) Family History
Life table analysis showed a significant difference when the number of
first degree relatives with duodenal ulcer was compared (Table 20.11).
5 Years 10 Years
Number of first degree 0 9.7 (2.3) 13.5 (3.0)
relatives with D.U. 1 11.2(3.7) 17.2(5.0)
>1 25.9 (5.8) 33.2 (7.4)
Table 20.11
Estimated percent recurrence (S.E.) at 5 and 10
years according to family history
v) Behaviour of Recurrent Ulcer
The rate of recurrent ulcer by itself gives no indication of the severity
of the recurrent disease. There has been controversy in the literature as to
whether recurrent ulcer after highly selective vagotomy behaves aggressively
(Hoffman 1988) or whether the operation has modified the diathesis such
that recurrent ulcer represents less aggressive disease which is much easier
to treat (Johnston 1987). The natural history of recurrent ulcer has therefore
been assessed in terms of symptoms, treatment, response to treatment and
complications. Of the 59 recurrent ulcers, 19 (32.2%) could be considered
"innocuous" and 40 (67.8%) "malevolent" using the classification suggested by
Hoffman (1988). Of the 19 innocuous ulcers 10 required no treatment because
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symptoms were minimal or the patient did not feel that any treatment was
required. Five patients required occasional antacid or other drug treatment
but not H2 receptor antagonist, while 4 required either a single course of H2
receptor antagonist or no more than occasional therapy.
The "malevolent" ulcers comprised 15 who required repeated or frequent
courses of H2 receptor antagonist and 25 who required a further operation.
vii) Drug Treatment
402 patients answered questions about current medication for ulcer
disease. The medication taken for dyspeptic symptoms is shown in
Table 20.12.











Consumption of medication for dyspepsia every day or most
days
Overall 47 (11.7%) took H2 receptor antagonists or antacids every day
or most days and 10 of these took antacids on the same basis. Of the 48
patients with recurrence 25 (52.0%) took medication for dyspepsia but of
these only 15 required H2 receptor antagonists. On the other hand only 39
(11.0%) of 354 patients without recurrent ulcer took H2 receptor antagonist
or antacids every day or most days.
Revisional Operations
34 patients in this series underwent a further operation. Of these 27
were for recurrent ulcer and 7 for gastric stasis. The 27 operations for





Truncal vagotomy and antrectomy









Revisional operations for recurrent
ulcer
In addition 2 patients had simple closure of perforated duodenal ulcer
both within 2 months of the original procedure suggesting that the ulcer
was residual rather than recurrent.
Of the 7 operations for gastric stasis, 4 were gastro-enterostomies,
(2 with truncal vagotomy), 1 gastro-duodenostomy, 1 pyloroplasty and 1
Polya gastrectomy. The revisional operations were performed by 5
consultants and three senior registrars for both recurrent duodenal ulcer,
without and without pyloric stenosis, and for pyloric and prepyloric ulcers.
There was again no operative mortality. The most serious complications
were an anastomotic leak after a roux-en-y gastrectomy which was
successfully treated conservatively and efferent loop obstruction following
a Polya gastrectomy which also resolved successfully on conservative
therapy. Eight patients developed pulmonary infection and 3 wound infection.
One developed intra-abdominal haemorrhage following a Polya gastrectomy
but a laparotomy was not required.
Symptoms
Of the 432 patients available for review, 402 (93%) answered a detailed
symptom questionnaire. The symptoms of upper abdominal pain, flatulence
(or excessive belching) and heartburn were recorded as being experienced
every day, most days, occasionally or never. The percentage of patients who
experienced these symptoms every day or most days is shown in Table 20.14.
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All Patients Patients with Patients without
(n=402) Recurrence Recurrence
(n=48) (n=354)
Upper abdominal pain 39 (9.7%) 10 (20.8%) 29
Flatulence 89 (22.1%) 19 (39.5%) 70
Heartburn 46 (11.4%) 9 (18.7%) 37
Table 20.14
Symptoms on follow-up experienced every day or most days
Side Effects
The incidence of side effects after the operation was established by
specific questions about nausea, vomiting, a bloated ("bagged-up") feeling,
difficulty in swallowing or food sticking. The results expressed both as
numbers and percentages experiencing these symptoms every day or most
days are shown in Table 20.15.
All Patients Patients with Patients without
(n=402) Recurrence Recurrence
(n=48) (n=354)
Nausea 24 (6.0%) 6 (12.5%) 18 (5.1%)
Vomiting 8 (2.0%) 5 (10.4%) 3 (0.8%)
Bloating 93 (23.1%) 19 (40.0%) 74 (20.9%)
Dysphagia 2 (0.5%) 0 (0%) 2 (0.5%)
Table 20.15
Side effects on review
Patients were asked about their ability to eat and enjoy a normal meal
asking about appetite and enjoyment of food and food intolerance. The
results are shown in Table 20.16 below.
All Patients Patients with Patients without
(n=402) Recurrence Recurrence
(n=48) (n=354)
Appetite good 343 (85.3%) 35 (72.9%) 308 (87.0%)
Enjoy food 387 (96.2%) 43 (90.0%) 344 (97.1%)
Table 20.16
Appetite and enjoyment of food
The incidence of specific side effects of peptic ulcer surgery was
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established by asking about sweaty or dizzy spells after meals. Questions
about diarrhoea included the patients subjective response to this question
together with the more objective record of frequency of bowel function.
The results are shown in Table 20.17. 11 patients had more than 2 bowel
movements per day and only 3 had more than 3 per day.
All Patients Patients with Patients without
(n=402) Recurrence Recurrence
(n=48) (n=354)
Diarrhoea 16 (4.0%) 1 (2.1%) 15 (4.2%)
Dumping 22 (5.5%) 6 (12.5%) 16 (4.5%)
Table 20.17
Diarrhoea and dumping every day or most days
Finally patients were asked about their opinion of the operation.
Overall 356 of the 418 patients who answered the question (85.1%) felt
that the operation had been a success. Of the 48 patients with recurrent
ulcer only 15 (31.25%) replied that the operation had not been a success.
Conclusions
Highly selective vagotomy has been shown in this study to be safe. There
was no operative mortality. Second operations in the early post-operative
period were required in only 7 patients. The most serious operation specific
complication of lesser curve necrosis was seen in 2 patients (0.4%) and only
1 of these required reoperation.
The recurrent ulcer rate of 18.5% at 15 years appears at first to be
similar to that following gastro-enterostomy but there are important
differences. Firstly the rate of recurrent ulceration rises less sharply
after 12 years and others have found recurrence after 15 years uncommon
(Hoffman 1987, Johnston 1991).
Secondly the behaviour of recurrent ulcer following H.S.V. suggests
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that it should not necessarily be equated with failure. Only 52% of
patients diagnosed as recurrent ulcer required any form of medication on
a daily or regular basis. 32.2% of recurrent ulcers were regarded as
innocuous in that they required no therapy or a single course of H2
receptor antagonist. Furthermore 68.7% of patients with recurrent ulcer
regarded the operation as a success.
Cigarette smoking, family history of ulcer and operating surgeon are
associated with increased risk of recurrence whilst acid output, resistance
to H2 receptor antagonists and previous ulcer complications are not.
CHAPTER 21
THE MANAGEMENT AND RESULTS OF TREATMENT OF
PERFORATED DUODENAL ULCER
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From 1966 clinical details of all patients diagnosed as perforated duodenal
ulcer were collected by the Gastric Follow-Up Clinic. Clinical details
were recorded on a standard proforma. By 1986 some 185 patients had
been documented giving a minimum follow-up of 4 years when the analysis
was performed in 1989. This resulted in one of the largest series of
perforated duodenal ulcer reported in the English language literature in the
preceding 20 years. In Scotland incidence of duodenal ulcer is amongst
the highest in the world. It is surprising therefore that the three major
published Scottish series published to date (Weir 1960, MacKay 1966,
Dark and MacArthur 1983) have all considered perforated peptic ulcer,
when the aetiology and management of the perforated gastric and duodenal
ulcer is so different.
The aims of the study were to establish the outcome of simple closure
of perforated duodenal ulcer in terms of symptoms and the need for subsequent
definitive surgery. In particular the study sought to establish the effect
of the advent of H2RA on the symptomatic outcome after simple closure
after perforated duodenal ulcer.
Patients and Methods
All patients from the Western General Hospital, Edinburgh, between the
years 1966 and 1986 with a diagnosis of perforated duodenal ulcer were
studied. These patients were documented prospectively on a standard
proforma (Appendix A).
Of the 185 patients, 107 were treated by simple closure (Group 1) and
58 by simple closure plus H2 receptor antagonists for at least one month
post-operatively (Group 2). The remaining 20 patients had been treated
by immediate definitive surgery (truncal vagotomy and drainage in 15 and
Polya gastrectomy in 5). The patients were initially followed up by the
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Gastric Follow-Up Clinic and latterlv bv the Surgical Review Office
using techniques described in detail in Chapter 11. In 1989 a standard
symptom questionnaire was sent to all known survivors (Appendix B).
A comparison between the original groups in terms of age, sex, cigarette
smoking, consumption of non-steroidal anti-inflammatory drugs and
steroids, and previous diagnosis or family history of peptic ulcer is




52 (12-86) 59 (19-86) 73 (36-88)
2.0:1 2.0:1 1.9:1
78 (72.9%) 40 (69%) 13 (65%)
13 (12.1%) 17 (29.3%) 3 (15%)
5 (4.7%) 7 (12.0%) 1 (5%)
28 (25.7%) 8 (13.8%) 11 (55.0%)







Family history of P.U.
Table 21.1
The groups compared
The association between each of these factors and subsequent definitive
surgery was analysed using Cox proportional hazard regression. Differences
between the groups in terms of subsequent definitive surgery have been
analysed using log-rank tests. Fishers exact test was used to assess
differences in symptoms between the groups.
The distribution over the 21 years of the three procedures is shown in






IH SIMPLE CLOSURE M CLOSURE + H2RA □ DEFINITIVE SURGERY
Fig. 21.1
Annual distribution of perforated duodenal ulcer
Western General Hospital
Results
The operative mortality was 5.9% with no deaths following definitive
surgery. The outcome of patients in the three groups is shown in

































(Mean duration F.U. - 13.57
Range 4.32 - 22.71)
Fig. 21.2
Follow-up of 107 patients having
simple closure



















Available for Review in 1989
11
41
(Mean duration F.U. - 6.49
Range 2.22 - 11.2)
Fig. 21.3



















Available for Review in 1989
10
(Mean duration F.U. - 5.85
Range 2.06 - 13.36)
Fig. 21.4
Follow-up of 20 patients after
immediate definitive surgery
Further definitive surgery was performed in 37.2% of eligible patients;
in 43 of the 97 patients who survived simple closure (44.396) but in only 14
(24.1%) of the 58 patients who survived simple closure with immediate
prescription of H2 receptor antagonists. One of the 20 patients who had
definitive surgery required revisional operation - a resection of small
bowel and plication of afferent and efferent loops for retrograde jejuno¬
gastric intussusception described in detail elsewhere (Newell and
Macintyre 1973).
The rate of definitive surgery in Groups 1 and 2 over 10 years of





















Life table analysis showing rates of subsequent
definitive surgery in Groups 1 and 2
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Fig. 21.5
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The percentage rose from 18% at one year to 44.7% at 10 years in
the simple closure group. In Group 2 the rise was from 13% at one year
to 42.0% at 10 years. The differences between the groups were not
significant (p=0.15).
57 patients died before review in 1989 and 24 were lost to follow-up
leaving 104 available for review in 1989. The follow-up period ranged
from 2 to 22 years with a mean of 10.12 years.
Symptomatic Result at long term Review
The symptoms experienced every day or most days by these patients are
shown in Table 21.3.























There were no significant differences between the groups
The patients' appetite, ability to eat a normal meal, and to enjoy food
are shown in Table 21.4. There were again no significant differences between
these groups.
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Simple closure Simple closure Definitive
+H2RA surgery
(n=53) (n=41) (n=10)
Good appetite 45/52 (86.5%) 38/41 (92.7%) 8/9(88.9%)
Eat normal meal 43/53 (81.1%) 35/41 (85.4%) 8/9(88.9%)
Enjoy food 49/51 (96.1%) 39/41 (95.1%) 8/10(80%)
Table 21.4
Patients Opinion
Patients in Group 2 were more likely to continue to take H2 receptor
antagonists every day or most days, 12 out of the 40 patients (3096)
compared to only 4 out of 48 (8.3%) treated by simple closure alone
(p=0.05).
The one pre-operative factor which was significantly associated with
subsequent definitive surgery was NSAID consumption. Patients taking
NSAIDs at the time of perforation were significantly less likely (p<0.05)





1 10.0% (5.5) 15.5% (3.0)
2 10.0% (5.5) 27.5% (3.9)
5 15.0% (7.1) 37.3% (4.4)
10 15.0% (7.1) 47.4% (5.1)
15 15.0% (7.1) 47.4% (5.1)
Table 21.5
Life table analysis showing relation between
NSAIDs and subsequent definitive surgery
There was a highly significant relationship between year of operation
and outcome (p<0.01), with more recent cases less likely to come to
definitive surgery (Table 21.6).
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1 17.1% (4.9) 20.0% (5.4) G.896 (3.3)
2 31.5 96 (0.2 ) 27.7 96 ( 0.1) 14.096 ( 5.0)
5 44.8% (0.7) 33.8% (0.5 ) 21.896 ( 8.7)
10 5G.0% (7.1) 39.0 96 ( 7.1)
15 5G.0 96 (7.1)
Table 21.0
Life table analysis of patients having definitive surgery in 3
consecutive periods
For those having simple closure, a multivariate Cox regression involving
year of operation, use of NSAIDs and whether or not H2RA was used
immediately post-operatively showed no significance for the last factor
when adjusted for the other two. Year of operation remained significant
at p<0.05.
A dyspeptic history of more than 3 months prior to perforation was
not a significant predictor of the need for subsequent definitive surgery.
Conclusions
Whilst elective operations for duodenal ulcer have fallen markedly in the
last decade, the incidence of perforated duodenal ulcer remains static in
the U.K. (Bardham 1989). The controversy about whether it should be
treated by immediate definitive surgery has continued throughout this
century. The difficulty has arisen from inability to select, at the time of
the emergency operation, those patients who require definitive surgery.
Selection on the basis of preceding history (King 1987) or whether the
ulcer was judged acute or chronic by the surgeon (Khan 1970) has failed
to identify patients who require definitive surgery. Backgaard's study
suggested that as many as' 50% of patients were classified incorrectly
(Backgaard 1979). A blanket policy of definitive surgery for all will result
190.














17.1% (4.9 ) 20.0 96 ( 5.4) G.8% (3.3)
31.5% (G.2) 27.796 (G.l) 14.096 ( 5.0)
44.8% (G.7) 33.8% (G.5 ) 21.896 (8.7)
5G.G% (7.1) 39.G% (7.1)
5G.G96 (7.1)
Tabic 21 .G
Life table analysis of patients having definitive surgery in 3
consecutive periods
For those having simple closure, a multivariate Cox regression involving
year of operation, use of NSAIDs and whether or not H2RA was used
immediately post-operatively showed no significance for the last factor
when adjusted for the other two. Year of operation remained significant
at p<0.05.
A dyspeptic history of more than 3 months prior to perforation was
not a significant predictor of the need for subsequent definitive surgery.
Conclusions
Whilst elective operations for duodenal ulcer have fallen markedly in the
last decade, the incidence of perforated duodenal ulcer remains static in
the U.K. (Bardham 1989). The controversy about whether it should be
treated by immediate definitive surgery has continued throughout this
century. The difficulty has arisen from inability to select, at the time of
the emergency operation, those patients who require definitive surgery.
Selection on the basis of preceding history (King 1987) or whether the
ulcer was judged acute or chronic by the surgeon (Khan 1970) has failed
to identify patients who require definitive surgery. Backgaard's study
suggested that as many as 50% of patients were classified incorrectly
(Backgaard 1979). A blanket policy of definitive surgery for all will result
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in unnecessary operations with their attendant side effects (Drury 1978).
As H2 receptor antagonists, supplemented latterly by Omeprazole,
have now largely replaced definitive surgery in the treatment of elective
ulcer disease, it seemed logical to explore the hypothesis that these should
also replace definitive surgery in the treatment of perforated ulcer. These
drugs have rekindled interest in conservative treatment of perforation.
The present study has shown that simple closure with the immediate
prescription of 112 receptor antagonists was associated with a reduction in
subsequent definitive operations but this was not significant.
NSAID consumption prior to perforation was the only pre-operative
factor significantly associated with subsequent definitive surgery. The
lower rate of subsequent definitive surgery in these patients suggests that
ulcers in such patients may be acute rather than chronic.
A comparison of the symptomatic outcome of those patients in
Groups 1 and 2 with a separate group of 36 patients who had highly selective
vagotomy for duodenal ulcer in our hospital, following a previous perforation
elsewhere, and who had symptomatic review carried out 5-15 years
post operatively is shown in Table 21.7
Simple Simple closure









Epigastric pain 4/53 (8) 1/41 (2)
3/53 (6) 0/41 (0)
7/53 (13) 1/41 (2)
0/53 (0) 0/40 (0)






3/32 (9)112 blockers 4/48 (8) 12/40 (30)
Values in parentheses arc percentages
Table 21.7
Symptomatic outcome of groups 1 and 2 and elective highly
selective vagotomy (IISV) following previous perforation
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The symptomatic outcome of all patients in Groups 1 and 2 who had
no subsequent definitive surgery has been compared with that in the
group of 36 patients who had highly selective vagotomy following a
previous perforation. This is shown in Table 21.8.
Simple closure plus ITSV following
no definitive surgery previous perforation
(n = 57) (n = 3G)
Epigastric pain 1/57 (2) P = 0.08 5/3G (14)
Heartburn 2/57 (4) 2/34 (G)
Bloating 2/57 (4) P = 0.02 8/34 (24)
Vomiting 0/56 (0) 0/3G (0)
Diarrhoea 2/55 (4) 2/3G (G)
112 blockers 10/53 (19) 3/32 (9)
Values in parentheses are percentages
Table 21.8
Symptomatic outcome of patients having simple closure
and no subsequent definitive surgery, and patients
having highly selective vagotomy (IISV) following previous
perforation
Bloating, a recognised complication of H.S.V., is the only symptom
significantly different in both cases. These comparisons have not taken
place as part of a controlled study and those patients coming to II.S.V. will
include some with a more aggressive diathesis.
On the basis of this study a policy of simple closure for all patients who
present with perforated duodenal ulcer is recommended. The side effects
of definitive surgery arc avoided and the symptomatic results in the long
term are no worse. Immediate prescription of II2RA is recommended on
the basis of Simpson's study (Simpson 1987) which showed short term benefit
from this treatment, although the present study shows no significant long
term benefit from this practice. However, the significant decline in the
rate of subsequent definitive surgery is almost certainly the result of the
increasingly widespread use of II2RA in symptomatic patients.
CHAPTER 22
LONG TERM MORTALITY FOLLOWING DUODENAL ULCER SURGERY
AT THE WESTERN GENERAL HOSPITAL
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All patients undergoing an operation for duodenal ulcer at the Western
General Hospital between 1st July, 1947 and 31st July, 1968 were included.
Patients were followed until death, loss to follow-up or 31st December,
1988 when the study closed. Of the 2241 patients included 222 (9.9%) were
lost to follow-up and 726 were known to be alive leaving 1293 for further
analysis. Of the 1387 who died, 94 were aged 85 or more at the time of
death and in keeping with accepted convention were excluded. The cause
of death could be ascertained from the death certificate in 1251. Of the
patients who died only those patients in whom a death certificate was
traced were included in the study (Table 22.1).
Total Patients
2241




\ 42 C.O.D. from source other thandeath certificate




Summary of patients studied
Deaths from all causes in these 1251 patients is shown in Table 22.2.
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Study Group Years since No. in group Observed Expected Ratio O/E P (Poisson)
First exposed Deaths Deaths 1-sidcd
Total M+F 0-1 2241 101 32.08 3.09 0.000
Total M+F 2-19 2138 791 772.78 1.02 0.201
Total M+F 20-40 1170 401 333.75 1.20 0.000
Total M+F 0-40 2241 1293 1139.21 1.13 0.000
Tabic 22.2
Deaths from all causes (ICD 1-999)
The observed deaths in the first post-operative year exceeds expected
by a factor of 3.09 (p<0.001). The increase in observed over expected
deaths between years 1 and 19 is not statistically significant. Between
the 20th and 40th post-operative year, however, the observed deaths exceed
expected by a ratio of 1.2, a highly significant increase (p<0.001). Thus
overall the ratio of observed to expected deaths is 1.13, a significant
increase largely accounted for by the excessive mortality in the year
following operation.
The death rates for all neoplasms (ICD9 Codes 140-239) are shown in
Table 22.3.
Study Group Years since
First exposed







































Deaths from all neoplasms (ICD 140-239)
The deaths from all neoplasms exceeded the observed in the immediate
post-operative year in the ratio of 1.5:1 but the difference failed to reach
significance. From the 1st to the 19th post-operative year, however, the
observed mortality from all neoplasms significantly exceeded the expected
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and this increase was maintained between the 20th and 40th post-operative
years. Overall there is a significant increase in deaths from all neoplasms.
Deaths from stomach cancer (ICD9 Code 151) are shown in Table 22.4.
Study Group Years since No. in group Observed Expected Ratio O/E P (Poisso
First exposed Deaths Deaths 1-sidcd
Total M+F 0-1 2241 3 1.05 2.8G 0.089
Total M+F 2-19 2138 19 20.23 0.94 0.G38
Total M+F 20-40 1176 8 G.72 1.19 0.359
Total M+F 0-40 2241 30 28.00 1.07 0.377
Tabic 22.4
Deaths from stomach cancer (ICD 151)
There is a significant increase in deaths from stomach cancer in the
first post-operative year which, in common with other series, almost
certainly represents "missed" gastric cancers occurring either with or
without concomitant duodenal ulcer disease. Neither in the first 19 nor in
the subsequent 41 years, however, was there a significant increase in
deaths from stomach cancer with 30 observed compared to 28 expected.
It is, however, of note that since the study closed no fewer than 6 further
deaths from gastric cancer have occurred in the cohort.
Deaths from colon cancer (ICD9 Code 153) shown in Table 22.5, showed
a significant increase in the initial post-operative year.
Study Group Years since No. in group Observed Expected Ratio O/E P (Poisson)
First exposed Deaths Deaths 1-sidcd
Total M+F 0-1 2241 3 0.G5 4.G2 0.028
Total M+F 2-19 2138 20 14.42 1.39 0.095
Total M+F 20-40 1176 G G.06 0.99 0.564
Total M+F 0-40 2241 29 21.13 1.37 O.OGO
Table 22.5
Deaths from colon cancer (ICD 153)
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Again in common with other groups these deaths probably represent
undiagnosed carcinomas of the right side of the colon occurring with or
without concomitant duodenal ulcer disease. Between the 1st and the
19th post-operative year there was a significant increase in deaths from
colon cancer but no increase between the 20th and 40th post-operative
year. Overall the number of deaths from colon cancer remain significant.
At no time in the study did deaths from rectal cancer (ICD9 Code 154)
exceed the expected (Table 20.6).
Study Group Years since No. in group Observed
First exposed Deaths
Total M+F 0-1 2241 0
Total M+F 2-19 2138 7
Total M+F 20-40 1176 5
















Deaths from rectal cancer (ICD 154)
Deaths from oesophageal cancer (ICD9 Code 150) exceeded the expected
in the 1st and 19th post-operative year in a ratio of 1.4:1 and in the 20th
to 40th post-operative year by 1.6:1. Overall deaths from oesophageal
carcinoma significantly exceeded the expected in a ratio of 1.48:1
(Table 22.7).











Ratio O/E P (Poisson)
1-sidcd
0-1 2241 0 0.20 0.00
2-19 2138 8 5.57 1.44
20-40 1176 5 3.02 1.G5






Carcinoma of oesophagus (ICD 150)
Deaths from carcinoma of lung and pleura (ICD9 Codes 162 and 163) are
shown in Table 22.8.
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Study Group Years since
First exposed
No. in group Observed Expected Ratio O/E
Deaths Deaths
Total M+F 0-1 2241 3
Total M+F 2-19 2138 81
Total M+F 20-40 1176 50
















Carcinoma of lung and pleura (ICD 162,163)
While there is no increase in deaths in the initial post-operative year,
between years 1 and 19 and between years 20 to 40 there are significant
increases in observed over expected deaths from carcinoma of lung and
pleura.
No increase was found in carcinoma of the bladder, lymphoma or leukaemia.
These have been shown together in Table 22.9 together with carcinoma of the
pancreas.




Total M+F 0-1 2241
Total M+F 2-19 2138
Total M+F 20-40 1176
Total M+F 0-40 2241
Pancreas
Total M+F 0-1 2241
Total M+F 2-19 2138
Total M+F 20-40 1176
Total M+F 0-40 2241
Lymphoma
Total M+F r—H1o 2241
Total M+F 2-19 2138
Total M+F 20-40 1176
Total M+F 0-40 2241
Leukaemia
Total M+F 0-1 2241
Total M+F 2-19 2138
Total M+F 20-40 1176




























Deaths from carcinoma of bladder (ICD 188), pancreas (ICD 157),
all lymphomas (ICD 200-202) and all leukaemias (ICD 204-208)
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Between years 2 and .19 post-operatively an increase in expected deaths
from carcinoma of the pancreas was observed which just failed to reach
significance at the 596 level.
In female deaths carcinoma of breast, uterus and ovary (ICD9 Codes 174,
180-182, 183) were not greater than expected.
Years since No. in group Observed Expected Ratio O/E P (Poisso
First exposed Deaths Deaths 1-sidcd
Breast (ICD 174) 0-40 559 8 8.72 0 92 0 G42
Uterus (ICD 180-182) 0-40 559 5 3.I8 1.57 (E217
Ovary (ICD 183) 0-40 559 4 2.79 1.43 0.30G
Table 22.10
Deaths from cancers specific to females
In male deaths carcinoma of prostate (ICD9 Code 185) showed no increase
but there was an increase in carcinoma of testis (ICD9 Code 186) which was
just significant at the 5% level.
Years since No. in group Observed Expected Ratio O/E P (Poisson)
First exposed Deaths Deaths 1-sidcd
Prostate (ICD 185) 0-40 1682 17 12.47 1.36 0.129
Testis (ICD 186) 0-40 1682 2 0.35 5.79 0.048
Table 22.11
Deaths from cancers specific to males
Deaths from cirrhosis of the liver (ICD9 Code 571) are shown in Table
22.12.
Study Group Years since No. in group Observed Expected Ratio O/E P (Poisson)
First exposed Deaths Deaths 1-sidcd
Total M+F 0-1 2241 0 0.16 0.00 1.000
Total M+F 2-19 2138 9 4.17 2.16 0.027
Total M+F 20-40 1176 2 1.75 1.14 0.523
Total M+F 0-40 2241 11 6.09 1.81 0.046
Table 22.12
Deaths from cirrhosis of liver (ICD 571)
Between years 2 and 19 post-operatively there is a 2.16 increase in
observed over expected deaths from this cause, between years 20 and 40
after the operation there is no significant difference. However, overall
the ratio of observed over expected deaths remains significant at 1.8:1.
The considerable excess in deaths from all circulatory diseases (ICD9
Codes 390-420) and all respiratory diseases (ICD9 Codes 460-519) and
digestive diseases (ICD9 Codes 520-577) is shown in Table 22.13.
Study Group Years since No. in group Observed Expected Ratio O/E P (Poisson
First exposed Deaths Deaths 1-sidcd
Circulatory Disease
Total M+F 0-1 2241 23 12.43 1.85 0.005
Respiratory Disease
Total M+F 0-1 2241 11 3.09 3.56 0.000
Digestive Disease
Total M+F 0-1 2241 24 1.12 21.46 0.000
Table 22.13
Death from all circulatory diseases (ICD 390-429), respiratory
disease (ICD 460-519) and digestive disease (ICD 520-577) in
the first post-operative year
Each of these is highly significant. For circulatory disease 23 deaths
occurred compared to 12.4 expected, a ratio of 1.85:1; for respiratory
disease 11 deaths occurred compared to the expected of 3, a ratio of 3.56:1





Despite the fact that duodenal ulcer is a common condition and, until
the 1980's treatment by operation was also common, it has proved
difficult to compare all available operations by prospective randomised
controlled trial. Many trials have reported comparisons between two
operations and some, notably the Leeds/York trial (Goligher 1968) have
compared three. Ironically this, arguably one of the best such studies to
be published, found in favour of gastric resection at a time when gastric
resection for duodenal ulcer was becoming uncommon in the U.K.
Furthermore such controlled trials report largely short term results,
whereas long term results should determine the efficacy of operations for
duodenal ulcer.
In this chapter the results of five operations for duodenal ulcer are
compared. This was not a randomised study, and a degree of selection for
operations took place on the basis of acid output. Nonetheless 4 of the
operations were performed in the same hospital, by the same surgical teams,
over the same 20 year period, and patients have been followed using the
same techniques for at least 20 years after the operation. Such a
comparison has not, to our knowledge, been made before.
The principle comparisons have been made between Polya gastrectomy,
gastro-enterostomy, truncal vagotomy with pyloroplasty and truncal
vagotomy with gastro-enterostomy. Comparison of these with highly
selective vagotomy has only been made where considered justified as the
latter operation was performed in a later time period and follow-up is
therefore shorter. The patients, methods, and results have been described
for individual operations in earlier chapters.
Possible risk factors
Possible factors which might increase the risk of recurrent ulcer or a
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poor operative result were considered. A comparison of the groups in
terms of age, sex, previous perforation or haemorrhage, and cigarette
smoking is shown in Table 23.1.
Polya G-E TV + GE TV + P HSV
(n = 847) (n = 113) (n = 317) (n = 107) (n = 500)
Mean age 46 54 47 40 39.7
% Males 90.1 53.1 61.8 78.5 73.0
Prev. haemorrhage (%) 19.7 26.5 20.8 32.7 26.6
Prev. perforation (%) 12.7 5.3 7.9 3.7 5.8
Cig. smokers (%) 80.2 62.8 71.6 80.4 76.4
Table 23.1
Comparison of age, sex, previous complications and smoking
This reflects the policy of avoiding gastrectomy in females. The smaller
percentage of cigarette smokers in the gastro-enterostomy groups reflects the
smaller proportion of females who smoked.
Acid output studies
The mean pre-operative MAO for each group is shown in Table 23.2.
Polya G-E TV + GE TV + P
(n = 537) (n = 79) (n = 225) (n = 91)
Pre-operative mean gg 23 31 35
MAO
Table 23.2
Mean pre-operative MAO in the five groups
The lower mean in the two gastro-enterostomy groups reflects the policy
of selection according to acid output described above. The higher MAO in





The 30 day operative mortality for each procedure is shown in Table
23.3.
201.
Polya G-E TV + GE TV + P HSV
(n = 847) (n = 113) (n = 317) (n = 107) (n = 500)
Operative mortality (%) 1.6 0.9 1.6 0 0
Table 23.3
Operative mortality (30 day)
Complications and sequelae
A comparison of the commoner complications, sequelae and side effects
of the five operations is shown in Table 23.4.
Polya G-E TV + GE TV + P HSV *
(n = 831) (n = 112) (n = 312) (n = 107) (n = 500)
Dumping 4.3% 2.7% 6.1% 6.5% 5.5%
Diarrhoea 3.2% 4.5% 8.3% 10.3% 4.0%
Bile vomiting 5.5% 8.0% 6.7% 5.6% 0.9%
Recurrent ulcer 3.2% 19.6% 5.3% 14.0% 18.5%
Table 23.4
Complications, sequelae and side effects
(* follow-up 2-18 years)
The operative mortality for Polya gastrectomy of 1.6% is similar to that
recorded by Stammers and Williams (1963) as is the recurrent ulcer rate of
3.2%. As expected the incidence of diarrhoea after truncal vagotomy is
significantly higher than after other operations (p<0.01). The incidence of
dumping did not significantly differ between any of the operations. Bile
vomiting, however, was significantly less common after H.S.V. than Polya
gastrectomy (p<0.001), gastro-enterostomy (p<0.001), truncal vagotomy with
gastro-enterostomy (p<0.001) and truncal vagotomy and pyloroplasty (p<0.01).
The recurrent ulcer rate after H.S.V. (18.5%) and gastro-enterostomy
(19.6%) is significantly higher than after Polya gastrectomy (p<0.001) and
truncal vagotomy and gastro-enterostomy (p<0.01). As described in Chapter
19 recurrent ulcer after H.S.V. proved in the majority of cases to be amenable




The rate of revisional operations is shown in Table 23.5.
Polya G-E TV + GE TV + P HSV *
(n = 831) (n = 112) (n = 312) (n = 107) (n = 500)
Rate of revisional
operations 7'6% 16"8% 10'6% 14-9% 6"8%
Table 23.5
Rate of revisional operations (* follow-up 2-18 years)
Revisional surgery was significantly less common after Polya gastrectomy
than gastro-enterostomy (p<0.001) and truncal vagotomy with pyloroplasty
(p<0.01). The rate after H.S.V. was less than gastro-enterostomy (p<0.001)
and truncal vagotomy and pyloroplasty (p<0.01).
RESULTS
Visick grading
The results of each of the operations has been described in previous
chapters on the basis of a Visick grading and of a quality of life score. Results
of the first Visick grading for the four operations after which they were
performed are shown in Table 23.6.
Polya G-E TV + GE TV + P
Patients first Visick grading 754 109 286 100
% 1+2 at first grading 79.8% 77.1% 71.7% 66.0%
Mean interval to 1st grading 6.4 yrs 4.4 yrs 6.2 yrs 5.7 yrs
Patients second Visick grading 333 66 141 60
% 1+2 at 2nd grading 78.6% 72.8% 65.9% 53.3%
Mean interval to 2nd grading 17.2 yrs 10.5 yrs 15.3 yrs 13.8 yrs
Table 23.6
Results of first and second Visick gradings
These results show that truncal vagotomy and pyloroplasty gives
significantly worse results than Polya gastrectomy (p<0.01) at first and second
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grading. At second grading Polya gastrectomy gives significantly better
results than both truncal vagotomy and pyloroplasty (p<0.001) and truncal
vagotomy and gastro-enterostomy (p<0.01). Truncal vagotomy and gastro¬
enterostomy also scores significantly worse than Polya particularly by
the time of the second assessment.
The differences between first and second gradings suggest a tendency for
results of duodenal ulcer surgery to deteriorate with time although this is
not statistically significant.
Cay and Small Quality of Life Assessment
The technique of assessment using the Cay and Small Quality of Life
instrument has been described in earlier chapters. For purposes of comparison
the psychosocial scores and physical symptom scores have been assessed both
separately and together to give a quality of life score.
a) Psychosocial scores
The mean psychosocial scores for four operations are shown in Table 23.7.
There are no differences between the groups, indeed the similarity between
the groups in mean psychosocial scores is striking. This suggests firstly that
pre-operative psychiatric illness, personality disorder and social abilities
was similar between the groups and that no one operation had a more
detremental effect than the others on the group as a whole.
Polya G-E
(n = 313) (n = 58)
TV + GE TV - P
(n = 140) (n = 67)
Mean psychosocial score
+ S.E. (95% C.L.)
30.2+1.14 29.8+0.79 29.6+0.59 28.6;0.83
(28.7,32.1) (28.2,31.4) (28.4,30.7) (27.0,30.3)
Table 23.7
Mean psychosocial scores after 4 operations
The scoring system is designed, however, to be applied to individuals and
particularly to discriminate those with a bad result.
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The psychosocial scores have therefore been classified into three
groupings, described as 'good', 'moderate' and 'bad'.
Polya G-E TV - GE TV + p
(n = 313) (n = 113) (n = 317) (n = 71)
Good > 34 84 (26.8%) 15(13.3%) 36(11.4%) 14(19.7%)Moderate 26-34 155 (49.5%) 30 (26.5%) 69 (21.8%) 32 (45.1%)Bad 0-25 74 (23.6%) 68 (60.2%) 212(66.9%) 25 (35.2%)
Table 23.8
Psychosocial scores classified into good, moderate and bad
This demonstrates that significant differences emerge in the distribution
of patients between these groups. Significantly fewer have a 'bad' result
(score 0-25) in terms of psychosocial score after Polya gastrectomy
compared to truncal vagotomy and gastro-enterostomy (p<0.001) and
gastro-enterostomy alone (p<0.001).
These scores have also been plotted as an area curve showing the
percentage of patients achieving each score (Fig. 23.1). In this way the
area under each cover is identical and the further to the right the curve the
better the result. This confirms that gastro-enterostomy alone and with
vagotomy are associated with the poorest results in terms of psychosocial
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b) Physical symptom scores
The mean physical symptom scores for the four operations are shown in
Table 23.9. As with psychosocial symptom scores the differences between
the mean physical symptom scores are not statistically significant. Indeed
these mean scores are strikingly similar.
Polya G-E TV + GE TV + P
Mean physical symptom 20.7+0.97 18.8+0.71 19.4+0.38 18.7+0.59
score + S.E. (9596 C.L.) (18.4,22.9) (17.3,20.2) (18.7,20.2) (17.5,19.9)
Table 23.9
Mean physical symptom scores after 4 operations
This serves to emphasise once more that, when averaged, the scoring system
is not a good discriminant between operations when mean values are used
but is designed to identify those patients or groups of patients with poor
results and those with good results. Even when grouped into three groups
as already described no significant differences between the operations
emerge (Table 23.10).
Polya G-E TV + GE TV + P
(n = 313) (n = 58) (n = 140) (n = 67)
Good > 20 180 (57.5%) 29 (50.0%) 75 (53.6%) 30 (44.8%)
Moderate 13-19 77 (24.6%) 19 (32.8%) 45 (32.14%) 29 (43.3%)
Bad 0-12 25 (8.0%) 7 (12.1%) 12 (8.6%) 5 (7.5%)
Table 23.10
Physical symptom scores grouped into bad, moderate and good
None of these differences reach statistical significance.
The physical score profiles have also been plotted as an area curve
(Fig. 23.2) in the same way as the psychosocial scores. This confirms the
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c) Quality of Life scores
The psychosocial and physical scores have been added to give a "Quality
of Life" score for each operation and the results are shown in Table 23.11,
grouped into the three classifications by score as described in Chapter 13.
Polya G-E TV + GE TV + P
(n = 313) (n = 58) (n = 140) (n = 67)
% Good (46-66) 71.2 67.2 69.3 59.7
% Moderate (40-45) 16.2 13.8 10.7 20.9
% Bad (0-39) 12.4 19.0 20.0 19.4
Table 23.11
Quality of Life scores grouped into good, moderate and bad
This demonstrates that Polya gastrectomy has significantly fewer "bad"




It seems appropriate, almost exactly 100 years after the introduction of
surgery for duodenal ulcer, to take stock of the contribution that surgery has
made to the treatment of ulcer disease.
The strategy of treating uncomplicated duodenal ulcer by surgery had
several problems. The aetiology of the disease was not, and indeed is not,
fully understood. When surgery was first applied in the 1880's and 1890's the
role of acid was not appreciated. This role was emphasised by Schwarz in
1910 and his dictum of "no acid no ulcer" was to dominate future surgical
thinking on the disease. Gastro-enterostomy, introduced to bypass the
inflammatory mass surrounding the ulcer and to "rest" the duodenum, worked
almost by chance by diverting alkaline duodenal contents into the stomach.
Surgical operations were designed to reduce acid output whilst minimising
the effects of gastric incontinence and vagal denervation.
Each new operation has been vigorously advocated in its day. It was
ironic that highly selective vagotomy, widely regarded as the most physiological
operation and confirmed in this study to be associated with fewer side effects,
should have been introduced in an era when the incidence of duodenal ulcer
had already begun to fall. Even more ironic was that it should have been
followed within a few years by the first effective medical treatment. Indeed
Alexander-Williams has already written a "Requiem for Vagotomy" (Alexander-
Williams 1991) and major reviews of therapy are now appearing which do not
include surgical treatment - even for refractory ulcer (Soli 1990).
There appear then to be four principal reasons for the demise of
successive operations.
1. Complications and sequelae
These by and large became manifest for the first time several years
after the introduction of the procedure. This prompted one writer to remark
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that "every new operation for peptic ulcer is hailed as a breakthrough -
until it is found out". The "finding out" of gastro-enterostomy was stomal
ulceration; of partial gastrectomy the long term metabolic complications;
of truncal vagotomy with drainage diarrhoea and dumping; of highly selective
vagotomy apparently, recurrent ulceration.
2. Operations only reduce acid
It was serendipidy that gastro-enterostomy, introduced to bypass the
inflammatory mass around the ulcer, resulted in the healing of many ulcers.
This was initially thought to be by "resting" the duodenum until the role of
acid in the aetiology of duodenal ulcer was appreciated. The buffering
effect of delivering alkaline duodenal content, however, was much less than
the acid reduction produced by vagotomy. Yet the best vagotomy, whether
truncal or parietal cell, can reduce acid output by only 60%. Only
vagotomy and antrectomy can effectively reduce acid secretion but at the
cost of the side effects of both vagotomy and gastric resection.
Although Schwarz's dictum of "no acid no ulcer" holds true, many
patients with duodenal ulcer have normal acid output (Baron 1963)
emphasising that factors other than gastric acid are involved in the aetiology.
The importance of the mucosal barrier in the acid/pepsin - mucosal
barrier equation has been increasingly appreciated as techniques to study
barrier physiology and pathophysiology have been developed.
There is no evidence to suggest that any of the operations (which were
designed to reduce acid) had any effect on the cytoprotective mechanisms of
the gastro-duodenal mucosa.
The recognition of the role of Helicobacter Pylori in chronic gastritis
and duodenal ulcer as late as 1984 (Marshall and Warren 1984) has in a
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remarkably short time led the World Congress of Gastroenterology working
group to conclude that H. pylori is the single most important factor in
the aetiology of the multifactorial disease entity of peptic ulcer (Tytgat
et al 1990).
While the precise role of H. pylori in the pathogenesis of duodenal ulcer
remains to be clarified, and whilst an effective treatment regimen to
eradicate it permanently is awaited, there is no suggestion that surgery will
have any role to play in this treatment.
3. The declining incidence of uncomplicated duodenal ulcer
The decline in incidence of duodenal ulcer disease in the developed world
first became manifest in the 1960's (Chapter 9). This has resulted in a
decline in consultation rates in primary care of patients whose final diagnosis
is duodenal ulcer. This has in turn reduced the number of patients referred
from general practice. A further cause of decline in referrals for surgery
has been the development of effective medical treatment.
4. The development of effective medical therapy
The "gastric" diet and antacids were for decades the mainstay of medical
treatment for duodenal ulcer. The traditional regimen of hourly milk has
been shown to result in a persistently high acid secretion (Kirsner 1940).
Antacids, in the conventional doses used in the U.K. do no more than provide
symptomatic relief. The intensive therapy of 1000 mM per day can speed
ulcer healing but is associated with significant side effects and poor compliance.
Side effects limited and subsequently ended the use of anticholinergics
introduced to attempt a "medical vagotomy". Carbenoxolone was the first
drug in a randomised trial assessed by endoscopy shown to heal duodenal
ulcer more rapidly than placebo (Stadelmann 1972) but, yet again side effects
(in this case aldosterone-like effects) ended its use. Colloidal bismuth
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(tripotassium di-citrato bismuth) has also been shown to be an effective
ulcer healing agent (Salmon 1974). Introduced as a mucosal protective
agent it has latterly found an additional role as an agent active against
H. pylori. The H2 receptor antagonists heal between 80-90% of duodenal
ulcers by six weeks and side effects are uncommon. The proton pump
inhibitor Omeprazole can heal some 98% of duodenal ulcers by six weeks.
The problem with both of these agents is of ulcer relapse after initial
healing. Even with continuous maintenance treatment the one year relapse
rate for H2 receptor antagonists is about 25% (Palmer 1990) for Omeprazole
23-27% (Lauritsen 1991) and for citrated bismuth 31% (Dunk 1990). The
eradication of H. pylori using colloidal bismuth and two antibiotics is
possible in 80% of instances but antibiotic associated morbidity is common
and subsequent re-infection is likely.
Yet despite these problems medical therapy is perceived as curing
almost all ulcers and offering at least the hope of a reduction in recurrence
rate. Cost-effective medical therapy combining acid reduction with
eradication of H. pylori seems destined to improve treatment still further
making it most unlikely that the balance can be restored in favour of surgery
offering as it does only acid reduction.
There are still, however, several problems with current medical therapy
which might be summarised as follows:
a) Medical therapy heals the ulcer but does not cure the diathesis.
b) Ulcers recur even in the face of continuous medical treatment with
H2 blockers, Omeprazole or citrated bismuth.
c) Long term treatment with Omeprazole is not yet licensed and long
term therapy with the triple regimen (citrated bismuth plus two
antibiotics) is associated with antibiotic related morbidity and
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concerns about bismuth absorption causing toxicity.
d) Long term therapy with medical therapy is associated with poor
compliance in the U.K. (68%) (Penston 1989) and this seems likely
to be higher in developing countries.
e) Long term maintenance therapy is expensive. Cimetidine, the
cheapest of the H2 receptor antagonists costs (at 1991 prices for
800 mg. nightly) some £1800 for 5 year therapy and yet this regimen
is associated with recurrence rates as high as 50% (Parente 1989).
The costs are likely to make such therapy too expensive for developing
countries.
f) There is as yet insufficient information about long term morbidity and
mortality in patients receiving medical therapy for duodenal ulcer.
Cimetidine, for example, by its inhibition of the cytochrome P450
enzyme system can prolong the half life of drugs like Warfarin,
Propranolol and Diazepam. In some individuals Cimetidine produces
anti-androgenic effects and all H2 receptor antagonists stimulate
prolactin secretion and can impair vasopressin secretion. It remains
to be seen whether these produce any untoward effects when the drugs are
used for long term maintenance therapy. Doubts about possible
gastric carcinogenesis following long term exposure to acid reducing
agents remain to be resolved.
g) There is also insufficient information about the quality of life in
patients undergoing long term medical therapy for duodenal ulcer.
On the other hand the acid lowering operations have provided long term cure
for the diathesis in between 80% and 98% of patients. In this study the worst
results in terms of recurrent ulcer followed highly selective vagotomy with a
cumulative ulcer recurrence rate of 18.5% at 18 years but this should not be
regarded as failure. It has been shown that recurrence after 15 years is
uncommon (Mullen 1991). Furthermore this study has shown that recurrent
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ulcer after highly selective vagotomy is more amenable to medical therapy
and, because the recurrence group includes acute, superficial, and small
ulcers many require no treatment at all. The present study showed that
48% of patients with recurrent ulcer did not require any treatment at all
and that 69.7% of patients with recurrent ulcer regarded the operation as
successful. This has also been observed by others (Hoffman 1987). Thus
the Visick grading which has for 4 decades provided a gold standard against
which any operation can be assessed, no longer seems appropriate. This is
firstly because the Visick system scores recurrent ulcer as failure, and
secondly because computer technology now allows analysis and correlation of
symptoms and symptom complexes in large groups of patients. The present
study has shown that a quality of life scoring system measuring both physical
symptoms and psychosocial factors is a more sensitive and more appropriate
measure of outcome.
Using this technique the present study has shown that after 20 years
Polya gastrectomy is associated with fewer "bad" results than the three
other operations assessed so that any possible metabolic or nutritional
sequelae do not appear to be perceived by patients 20 years post-operatively.
Gastro-enterostomy even when confined to the low acid output group fails
because of a high stomal ulcer rate in the long term, a problem not amenable
to modern medical therapy. This failure is further manifest by higher
revisional surgery rate and lower Visick gradings and quality of life score
when compared to Polya gastrectomy.
Truncal vagotomy and drainage was associated more frequently with
diarrhoea. Truncal vagotomy with pyloroplasty was followed more often
by revisional surgery than Polya gastrectomy and was associated with
significantly poorer Visick gradings. By the time of second Visick grading
vagotomy with gastro-enterostomy also scores significantly lower than Polya
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gastrectomy.
Using the quality of life scoring system truncal vagotomy both with
pyloroplasty and with gastro-enterostomy give more bad results than
Polya gastrectomy.
These results call into question the use of truncal vagotomy and drainage
in modern surgical practice. It is worth noting that in Scandinavia Polya
gastrectomy remained the operation of choice until the 1970's when it was
superceded by highly selective vagotomy. In this study the two best operations
as assessed by long term symptomatic outcome were Polya gastrectomy
and highly selective vagotomy. Whilst Polya gastrectomy is unlikely ever
to be restored to first line therapy it can be confidently recommended to
the small minority of patients who, having relapsed after highly selective
vagotomy, fail to respond to medical therapy.
Of patients having H.S.V. some 85% regarded the operation as
successful and even 69.7% of these with recurrent ulcer regarded the
operation as successful. Whilst medical therapy must remain the first line
of treatment and should improve in future, the prospects of successful
treatment of the ulcer diathesis resistant to medical therapy are high
using H.S.V. as the initial procedure.
For perforated peptic ulcer the evidence from this study suggests that
simple closure accompanied by H2 receptor antagonists is the treatment of
choice, largely because it is not possible to predict pre-operatively those who
require definitive surgical treatment.
The decline in surgical treatment for uncomplicated and bleeding duodenal
ulcer seems likely to continue.
This study has demonstrated the value of auditing outcome of treatment
216.
by long term follow-up and of a quality of life scoring system to assess that
outcome.
The study has shown that there is an increased disease specific mortality
20 to 40 years post-operatively. Some of these are undoubtedly a reflection
of the higher proportion of cigarette smokers in the population coming to
duodenal ulcer compared to the population at large. The increase in deaths
from cirrhosis of the liver is a further indication of the sequelae of the
lifestyle common in patients with duodenal ulcer coming to surgery in this
period.
Although a significant increase in observed over expected cases of gastric
cancer was not demonstrated the large number of gastric cancers occurring
after the study closed suggests that, as others have shown, this risk continues
to rise with time. This has been attributed to a combination of high
intragastric pH, damaged mucosal defences, increased N-nitrosocompounds
resulting from altered bacterial flora and bile reflux.
The greatest increase demonstrated, however, was from circulatory,
respiratory and digestive disease in the first post-operative year. This is a
reflection of the surgical operations in the period 1948-1968 and should be
compared to the results from highly selective vagotomy between 1973-1990
where there was no 30 day mortality in 500 patients and neither of the two
deaths within one year could be attributed to the operations.
The era of elective operations for peptic ulcer has drawn to a close. In
the first five months of 1991 no elective operations for duodenal ulcer were
performed at the Western General Hospital.
What the late Sir Charles Illingworth called "the great human experiment"
appears to have ended. Studies of the long term effects, such as mortality
and quality of life following medical therapy must now begin.
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SHEET 1 GASTRIC FOLLOW-UP CLINIC
Patient's Name Hosp. No.
Address ; Card Type (1-2)
Follow-Up No. (3-6)
Sex: (9) Male = 1. Female = 2. Age (7-8)
Occupation:
Date of Operation (10-15)
Civil State: (16) Social Grade: (17)
1 Married 1 Higher admin. 6 Retired
2 Single 2 Int. admin. 7 Unemployed
3 Widowed 3 Skilled Worker 8 N/A
4 Separated or Divorced 4 Semi-skilled 9 Not known
5 Not known 5 Unskilled
Blood Group: (18)
A B AB O Not known


























Duration of symptoms in years (44-45)


































Pre-operative Insulin Test: (60-61)
(not known/not done = X)
Pre-operative Stimulation Test: (62-63)
(not known/not done = X)
Type of Stimulation Test: (64)
1 Histamine 4 Pentagastrin 5
2 Maximal Histamine 3 6
Oesophagoscopy/Gastroscopy: (65-73)
65 Not done/no records
66 Failure to pass gastroscope
67 Failure to pass fibroscope
68 Gastroscopy complicated by Trauma
69 Fibroscopy complicated by Trauma
70 Gastroscopy correct interpretation
71 Gastroscopy incorrect interpretation/
or ulcer not seen
72 Fibroscopy correct interpretation
73 Fibroscopy incorrect interpretation/
or ulcer not seen
Barium Meal: (74-80)
74 Not done / no record
75 Incorrect interpretation - reported normal








Primary Surgical Treatment: (7-20)
7 Polya Gastrectomy
8 Billroth I Gastrectomy
9 Gastroenterostomy
10 Pyloroplasty
11 Closure of Perforation
12 Total Gastrectomy





14 Vagotomy - Truncal
15 Vagotomy - Selective
16 Entero-anastomosis
17 Excision of ulcer
18 Suture of Ulcer (bleeding)
19 Blind resection (bleeding)
20 Cholecystectomy
Immediate complications of Primary Surgical Treatment: (21-49)
21 None 23 Peritonitis




28 Damage to C.B.D.
29 Damage to spleen
30 Damage to Oesophagus




34 Haem. post-op from 36 Pulmonary Infection/
anastomosis Collapse
35 Haem. post-op 37 Pulmonary embolism
intra-peritoneal
38 Deep Venous Thrombosis 42 Oliguria, uraemia
39 Coronary Thrombosis 43 Dysphagia
40 Cardiac Arrest 44 Diarrhoea





Revisionary and Additional Surgical
50 None
51 Conversion of Billroth I to Polya
52 Conversion of G.E. to Polya
53 Vagotomy - Truncal




nt during first Admission: (50-65)
58 Division of adhesions
59 Drainage of Abscess
60 Jejunostomy
61 Pyloroplasty





SHEET 4 Follow-up and Assessment Card Type
Name of Patient: F.U. No. ^
1 Address: (15) No. of Exam. ^ ^
2 Changed-U.K Date of Bxam.^ ^
3 Emigrated
1 Doctor: (16)
2 Changed (diff. practice)
Length of F.U. (years): (17-18)
Length of convalescence after operation/work loss since last report 8weeks) (19-21)
Post-operative Insulin Test: (22-23)
(not known/not done = X)
Post-operative Stimulation Test: (24-25)












5 Vag. Comp./Ant. Comp.
6 Vag. Comp./Ant. Incomp.
7 Vag. Incomp./Ant. Comp.
8 Vag. Incomp./Ant. Incomp.
9 N.A. eg. Pyloroplasty, G.E. etc.
Change of Job: (28-30)
Death during follow-up: (31)







7 Other abdo Ca
8 Pulmonary T.B.






















51 Ulcer recurrence - Jejunal
52 Ulcer recurrence - Gastric
53 Ulcer recurrence - Suture Line





New (not present pre-op) Where abnormal pre-op
58 Alcoholism 61 1 ISQ
59 Received Psychiatric treatment 2 Deteriorated
60 Attempted suicide 3 Improved





66 1 Polya to Billroth I
2 G.E. to Billroth I
3 Pyloroplasty to Billroth I
67 1 G.E. to Polya
2 Billroth I to Polya
3 Pyloroplasty to Polya
68 Polya to Higher Polya
Date:
69 1 G.E. to Pyloroplasty
2 Billroth I to Pyloroplasty
70 Interposition of jejunal loop
71 Entero-anastomosis
72 1 Vagotomy - Truncal
2 Vagotomy - Selective
3 Vagotomy - Completion
73 Repair of Hiatus Hernia
74 Repair of Incis. Hernia
75 Division of Adhesions
76 1 Cholecystectomy
2 Radiotherapy
Hospital: (if other than WGH)
Weight (Kgms)
Visick Grading: (80)
1 = 1 3 = 3s 5 = 4




Name: F.U. No :P
Address: Hospital: ....
Hospital No.:




Admission Type: Emergency / Elective






Cigarettes: Yes / No / Ex. / Not Known
Alcohol: Yes / No / Not Known / Heavy
Weight: (kilograms) Height: (centimetres)
Diagnosis: D.U. / G.U. / P.P.U. / Other
Secondary Diagnosis: None / Stenosis / Haemorrhage / Oesophagitis /
Oesophageal stricture / Other (specify)
Pre-Operative symptoms: Epigastric pain Yes / No Duration (months)
Heartburn Yes / No Duration (months)
Vomiting Yes / No Duration (months)
Dysphagia Yes / No Duration (months)
Weight loss Yes / No Duration (months)















■ (number of first degree relatives with proven D.U.)
Not Known No
Yes - Failed to respond Yes - Relapsed after course
Yes - Sustained remission




















Q 1 2 3 4 5 (Number of criteria for incomplete vagotomy)
CDMMENTS:
LOTHIAN HEALTH BOARD NORTHERN GENERAL. ROYAL VICTORIA AND WESTERN GENERAL UNIT
EWestern General Hospital SURGICAL REVIEW OFFICEALEXANDER DONALD BUILDING












You have been kind enough to help our studies into the long term effects of stomach
operations and I would again be very grateful if you could complete a short questionnaire.
I would also like to ask for your help in another way. We would like to find out more aboul
the operation you had all those years ago and to do this one of our nurses visits people at home
to weigh them and take a blood test. It would be of great help to us and to others who may
need the operation if you would be willing to help in this way. Could you please complete the
questionnaire and return it in the pre-paid envelope provided.
With many thanks in anticipation.
Yours sincerely.
VP
I. M. C. Macintyre
Consultant Surgeon
[Please circle the answer which applies to you]
1. I am bothered with diarrhoea:
every day often occasionally
2. I get sweaty and/or dizzy spells after meals:
after every meal often
3. I tend to be bad tempered:
always often
4. I have no social life:
true mostly true
5. I take antacids/stomach tablets:
every day often
6. I get on with other people:
true mostly true
7. I have had no pain at all since the operation:
true mostly true mostly false















9. I can enjoy going away for holidays and outings:
true mostly true mostly false false
10. My bowel movements are regular:
always usually rarely never
11. I have not needed antacids/stomach tablets since the operation:
true mostly true mostly false false
12. I can enjoy going out for a meal:
always usually rarely never
13. I enjoy alcoholic refreshment:
regularly often occasionally never
14. I do not seem to be able to put on any weight:
true mostly true mostly false false
15. I have given up going on holiday:
true mostly true mostly false false
16. I am hardly ever sick:
true mostly true mostly false false
17. I have gained some weight:
true false
18. I enjoy my food:
true false
19. I wish I had never had the operation:
true false
20. I am sick most days:
true false
21. I get attacks of pain:
every day often occasionally never
22. I get a lot of wind:
every day often occasionally never
23. Place of Birth:
24. Date of Birth:
25. If married woman enter maiden name:
26. N.H.S. number (if known): [this is on your brown N.H.S. card]
27. I am willing for a nurse to visit me to take a blood test: YES / NO
Signed:
Thank you for your help
LOTHIAN HEALTH BOARD NORTHERN GENERAL. ROYAE VICTORIA AND WESTERN GENERAL UNIT
SURGICAL REVIEW OFFICE
Western General Hospital Alexander donald building
Crewe Road, Edinburgh EH4 2XU Telephone 031-332 2525 Your Ref
Our Ref
Date




The Fol!ow-Up Clinic at the Western General Hospital was set up to monitor the
long term results of different types of operations. To do this successfully we count on th
cooperation of patients who have had the operations (sometimes many years before) to tel
us how they are getting on by answering a few simple questions.
We would greatly appreciate if you could spare a few moments to answer the
following questionnaire about your ulcer or hiatus hernia operation. I enclose a pre-paid




I. M. C. Macintyre
Consultant Surgeon





which applies best to you]
Every day / Most days / Occasionally / Never
Every day / Most days / Occasionally / Never
get nausea:
Every day / Most days / Occasionally / Never




Every day / Most days / Occasionally / Never
Every day / Most days / Occasionally / Never
am able to eat normal
sized meal:
Every day / Most days / Occasionally / Never
have difficulty in
swallowing or feel food
sticking:
Every day / Most days / Occasionally / Never
PN86
My appetite is:
In general I enjoy
my food;
.Since operation my weight
has:






■Since operation my original
.Problem has been:
My operation has been a
success:
.Please state how many
cigarettes you smoke per day:
Alcohol:
I take Tagamet (Cimetidine):
-Ltake Zantac (Ranitidine):






Increased / Decreased / Remained same




Every day / Most days / Occasionally / Never
Cured / Improved / Same / Worse
Yes / No
cigarettes a day
I don't drink alcohol / Would like to drink but
cannot / Drink alcohol as I want
Every day / Most days / Occasionally / Never
Every day / Most days / Occasionally / Never
Every day / Most days / Occasionally / Never
Place of birth:
Date of birth:
-If married woman enter maiden name:
N.H.S. number fif known):
[this is on your brown NHS card]




Name: Date of Review:
Address: F.U. No.:
Date of Birth:


























Every day / Most days / Occasionally / Never
Every day / Most days / Occasionally / Never / Unable To
Every day / Most days / Occasionally / Never
Every day / Most days / Occasionally / Never
Every day / Most days / Occasionally / Never / Unable To
Every day / Most days / Occasionally / Never
Yes / No




Increased / Decreased / Remained Same
Every day / Most days / Occasionally / Never
times / week
Every day / Most days / Occasionally / Never
Cured / Improved / Same / Worse
Operation been a success: Yes / No














T.T. / Unable / Drink
Every day / 'Most days
Every day / Most days
Every day / Most days
Yes / No (specify)
normally
/ Occasionally / Never
/ Occasinnarrnv / Never
/ Occasionally / Never





Overall (Visick) Grade: 1234
COMMENTS:





Hospital of Original Operation:
Date of initial Operation: Interval to Recurrent Symptoms:
Ciqarettes: Yes / No / Ex. / Not Known





























Ulcer failed to respond
Ulcer symptoms relapsed after course
Ulcer healed and ulcer symptoms relieved




Operation Type: Elective / Emergency
Surgeon's Name:
Surgeon's Grade:























The Surgical Review Office aims to review the long term outcome in patients
having gastro-intestinal operations in this hospital.
To do this we are dependant on the help of G.P. colleagues and I would be very
grateful for the following information on the above patient.
N.H.S. Number
Is the patient still alive ? ....
If YES any change of address
If DEAD date and certified cause of death




















































































































































































Field Field Name Type Width
57 Dateqpl Date 8
58 QOL2 Numeric 2
59 Pain2 Numeric 2
60 Res2 Character 1
61 Dateqp2 Date 8
62 QOL3 Numeric 2
63 Res3 Character 1
64 Pain3 Numeric 2
65 Dateqp3 Date 8
66 QOL4 Numeric 2
67 Pain4 Numeric 2
68 Res4 Character 1
69 Dateqp4 Date 8
70 Tests Character 1
71 Ulcerful Character 1
72 Dateful Date 8
73 Fulrecno Character 4
74 QP5 Character 1
75 Dateqp5 Date 8
76 Comments Memo 10
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HIGHLY SELECTIVE VAGOTOMY FOR DUODENAL ULCER
I. M. C. Macintyre, Department ofSurgery, Western General Hospital, Edinburgh
As the incidence of duodenal ulceration declines and medical treatment becomes ever more
potent, highly selective vagotomy, sometimes called proximal gastric vagotomy, may
represent the end of the era of surgical treatment.
The physiological basis for vagotomy as an acid reducing procedure was well established
by the early years of this century. Claude Bernard and Pavlov realised the potential of vagal
section in acid reduction, paving the way for Exner and Schwarzmann1 to report a series of
patients in whom anterior truncal vagotomy was successfully performed. The credit for the
detailed description of the anatomy of the vagal supply to the stomach goes to Latarjet.2 He
described a procedure which attempted to divide the secretory and motor nerve fibres to the
body of the stomach to the parietal cells whilst preserving the purely motor supply to the
antrum. Yet his report was ignored by, or unknown to, mainstream surgical opinion until
highly selective vagotomy was described in the late 1960s. Although gastric resection
remained the standard surgical approach for peptic ulceration, the short term sequelae
(dumping, bile vomiting) and the long term complications (osteomalacia, malnutrition,
anaemias) forced surgeons to seek a less radical alternative. The report by Dragstedt3 of
truncal vagotomy in 1943 established the basis of modern surgical practice. No sooner had
the need for a drainage procedure been appreciated, than the problems from the resulting
gastric incontinence became apparent. Indeed one surgical cynic was prompted to remark
that 'every operation for duodenal ulcer is a success—until it is found out.'4
Although Holle and Hart5 described fundal denervation in man in 1967 it was the
independent reports of Amdrup6 and Johnston7 in 1970 that heralded the introduction of
highly selective vagotomy to modern clinical practice.
The theoretical advantages of denervation of the parietal cell mass, with preservation of
antral emptying and thus avoidance of a drainage procedure, have been amply borne out in
practice. Many series attest to the reduction in morbidity from dumping, bile vomiting and
diarrhoea, and in mortality.8, 9" 10 Similarly early anecdotal reports of lesser curve necrosis
following the procedure have subsequently been shown to be associated with the use of
diathermy or accompanying fundoplication.11 The reported incidence of this complication
was 0-2 per cent in one large series12 and is even lower or absent in later series. In the Lothian
Health Board Area of South East Scotland the operative mortality over the past eight years
has been 0-05 per cent.13
If highly selective vagotomy has been 'found out' it is in the area of recurrent ulcer. Some
early series reported recurrence rates of the order of 20 per cent.14, 15 It seems likely that these
resulted from an inadequate vagotomy. By measuring intra-operative gastric pH, Johnson16
was able to define those anatomical areas in which surgeons commonly missed secretory vagal
fibres.
As a result the operation has evolved and improved. Denervation of the entire
intra-abdominal oesophagus and denervation of the fundus to divide the 'criminal nerve' of
Grassi17 are now practised as standard. Furthermore the length of antrum to remain
innervated has been reduced from 10 cm in the original reports to 6-7 cm in the modern
operation. Several series published since this was adopted have reported five year recurrence
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rates varying between 1-5 and five per cent.18-20 In general results are better in single surgeon
series than in multiple surgeon series.21
A study from Copenhagen reports long term follow-up 14-18 years after the
procedure.22 Although the recurrence rate is an alarming 30 per cent, the procedures were
performed between 1969-73 and may have been inadequate by modern standards.
Furthermore 40 per cent of the ulcers operated upon were pyloric or prepyloric which are
now known to do so badly following highly selective vagotomy that mainstream surgical
opinion no longer regards them as an indication for the procedure. Long term follow-up of
operations performed during 1975-80 will provide a more accurate test of the operation.
What is disturbing from the Copenhagen series is that only one third of the recurrences
were manifest at five years—some presented 16 years post-operatively—and it seems likely
that more will occur with time. This suggests, as the possible explanation, nerve
regeneration by sprouting from tbe antral and oesophageal mucosal plexuses but further
studies are required to validate this.
Before rejecting the operation on the grounds of a high long term recurrence rate we
should bear in mind that recurrent ulcer following peptic ulcer surgery no longer carries the
serious prognosis that once it did. Before H2-receptor blockers became available recurrent
ulceration following vagotomy and drainage, or Polya gastrectomy, was regarded as a
disaster which usually required further operation. All that has changed. Recurrent ulcer
following highly selective vagotomy usually heals rapidly with H2-receptor blockers.23, 24
Thus although the operation has failed in its objective of abolishing the ulcer diathesis it has
reduced the aggression of the disease. Nor should we lose sight of the fact that even in the
worst series 70 per cent of patients remain free of recurrence and most published series claim a
recurrence rate at 10 years of less than 10 per cent.
What should be the place of the procedure in the modern management of peptic ulcer
disease? Most agree that it has no place in the emergency treatment of the bleeding or
perforated ulcer. It is too time consuming and technically demanding. In pyloric stenosis the
operation is not indicated (Johnston's suggestion25 of pyloric bouginage has failed to
convince many surgeons). Failure of medical treatment remains the principle indication for
the procedure. The criteria of failure, however, remain subjective and vary widely between
clinicians.
In choosing between long term H2-receptor blockade and highly selective vagotomy the
clinician should remember also that H2-receptor blockade does not abolish the diathesis. The
more rigid standards by which surgery is assessed is exemplified by the different ways in
which studies of drug treatment and surgical treatment are reported. For drugs we read of
'healing rates at eight weeks'; for operation of 'recurrent rates at five years'. Those studies
which directly compared highly selective vagotomy and long term H2-receptor blockers
show an overwhelming advantage for the operation.26, 27
Do physicians, conditioned by drug induced healing rates at eight weeks, overlook the
failure of the drugs to control the disease in the long term? The ulcer recurrence rate after a
course of cimetidine, and the other FI2-receptor blockers are little different, at one year is
80-90 per cent.28 Even on low dose maintenance therapy the relapse rate is 30 per cent per
29
year.
The failure of short term courses of ulcer healing agents to prevent recurrence of the
disease in the long term has prompted Wormsley30 to observe that '. . . maintenance
treatment is necessary for the duration of the disease and since we do not know how long the
relapsing tendency lasts the treatment may be required throughout life'.
The prospect facing the clinician and the patient with the duodenal ulcer diathesis is not
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merely a short term course of an effective, safe and cheap preparation, but of maintenance
therapy for life with the attendant problems of compliance and cost and the concern about
carcinogenesis. Studies comparing the cost of the operation with maintenance Cimetidine
show drug costs equalling operation costs at five years and by 10 years the drug is £3,000
more expensive.31 Whilst the possible role of H2-receptor blockers in causing some forms of
gastric cancer must await long term follow-up, it is worrying that several animal models
develop stomach cancer when powerful ulcer healing drugs are given long term.32 It is
reassuring that no such reports concerning man have emerged about HSV almost 20 years
since its introduction into clinical practice.
Will highly selective vagotomy prove the final surgical offering in the treatment of
duodenal ulceration? Taylor's33 seromyotomy, a variation on the theme involving division of
the vagal branches by a single incision of the serosa has not found favour with many surgeons
and it is difficult to envisage any further refinements of denervation of the parietal cells.
Stripping of the human antral mucosa has not yet been reported but in dogs it produces
similar acid reduction to vagotomy and antrectomy whilst preserving normal gastric
emptying.34 Until such time as more powerful long acting ulcer suppressing drugs are
developed and shown to be free of the risk of cancer, highly selective vagotomy seems
destined to remain the best surgical contribution to the treatment of peptic ulceration and
probably the last one.
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Auditing Outcome After Gastro-Intestinal








The move to greater accountability affects everyone involved in health care. Clinicians
increasingly have to provide performance indicators demonstrating their workload and the
cost effectiveness of the management of their patients. Surgeons, particularly gastro¬
intestinal (GI) surgeons, were pioneers of auditing process. Theodore Billroth, Professor
of Surgery in Vienna towards the end of the last century, began a system of recording the
number and types of operations performed in his hospital and of the outcome in hospital.
In Edinburgh after the Second World War, James Learmonth established a system of
documenting a yearly record of operations and of post operative deaths in each surgical
unit which has developed subsequently into the Edinburgh Surgical Audit. This system1,
now computer based, audits process, allowing for the accurate and rapid analysis of
operative procedures. The natural corollary to this is the need for a system which will audit
outcome.
This paper describes such a system which audits the outcome following gastro-intestinal
surgery.
Historical Background
The Gastro-Intestinal Unit at the Western General Hospital was established in 1948. The
most common surgical procedures on the GI tract over the next two decades were for peptic
ulcer disease and its complications. As there was little in the way of effective medical
treatment most patients came to surgery.
TheGastric Follow-UpClinic was established in 1959 for the long term follow-upofpatients
following peptic ulcer surgery. The problems associated with long term follow-up of
patients and how these can be resolved have been outlined in earlier publications2'3.
As the reputation of the GI Unit spread a large clientele of peptic ulcer surgery was built
up. The sheer numbers of patients and the volume of data, however, brought further
problems.
Problems
By the early 1980s over 4,000 patients had been registered each with over 100 items of
standard data collected on proformas. Although provision had been made for a coding
system all analyses had to be done manually. In addition the follow-up information was
recorded in freetext and unstructured. To ease analysis of these data a 'quality of life'
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questionnaire was devised which allowed calculation of a quality of life score1. Whilst this
readily identified those patients in whom the operation had failed it did not allow detailed
analysis of symptoms or complications.
The second problem was of the decline in incidence of peptic ulcer disease which began
in the Western World in the 1960s. The introduction of H2 receptor antagonists in the
mid 1970s further exaggerated this fall5. By the mid 1980s operations for peptic ulcer had
fallen to less than one quarter of the 1960s peak and revisional operations for peptic ulcer
disease had virtually disappeared. Pari passu operations for gall stones and large bowel
disease now began to increase. The need to diversify into the follow-up ofother procedures
was apparent.
Solutions
The obvious solution to the problem ofdata volumewas a computer system. In preparation
for this it was first necessary to decide on which data to record, to structure the freetext
data and to devise a standard follow-up questionnaire to be used for each follow-up contact
whether by post, phone, clinic or home visit.
The choice of hardware was governed by the need for a 20 M byte hard disc for storage,
the desire for IBM compatibility and cost. An NCR-PC with 100% IBM compatibility was
selected.
Of the software then available, D Base III Plus had the advantages ofbeing tried and tested,
ofpower and speed to analyse large data sets, ease ofoperator use and the prospect of regular
software updates.
The original data set has been recorded as a single file 'ULCER' containing 47 fields and
4,300 patients.
The need to diversifywas achieved by setting up further data sets for differentGI operations
(Table I). Each of these has a common stem of identical biographical data and the same
uniform structure. The files can be linked to enable interrogation of the entire data set,
as required for enquiries under the Data Protection Act.
Table I: File Names and Contents
ULCER Operations for peptic ulcer from 1947
PUSURG Operations for peptic ulcer—prospective
PERFPU Operations for perforated peptic ulcer—retrospective
HSV Highly selective vagotomy—prospective
RECULCER Recurrent ulcer after peptic ulcer surgery
FUNDO Fundoplication—prospective
BOWELCA Colon and rectal cancer—prospecuve
GASTRICA Gastric carcinoma—prospective





'Biodata' by clerical officer
Medical/surgical data by doctor










The methods used by the Surgical Review Office are shown in Figure 1.
Patients are 'recruited' to the register from the operation note, copies of which are sent
daily to the office. Standard biographic information is entered on the appropriate proforma
by a clerical officer from the case notes. The medical and surgical details are entered from
the case notes by a surgeon and the information keyed by a higher clerical officer.
The follow-up is carried out annually. A letter is first sent to the general practitioner (GP)
to find out whether the patient is alive and remains on the practice list. If so a postal
questionnaire is sent. If no reply is received the patient is contacted by home visit or
telephone. If the patient has changed GP the new GP is located through the Primary Care
Division of the appropriate Health Board.
If the patient has died the certificated cause of death is found from Register House.
Discussion
Process has, and always will be, easier to measure especially for surgeons. Enumeration
of out-patients seen, operations performed and post-operative deaths is a basic indicator
of the performance of a unit6, '• *• '•l0. The statistics derived from this are valuable when
planning the deployment of medical manpower and resources, and have become a pre¬
requisite for the recognition of units for surgical training. The Royal College of Surgeons
of Edinburgh for example requires unit audit if a training post is to be recognised.
B
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However, such figures have their limitations. They indicate quantity of workload but not
quality of medical care. How can we best assess quality control? Firstly the patients must
be followed-up. Prolonged follow-up in the traditional way at the out-patient clinic is
becoming less practical as staffand resources are reduced. Nor is it appropriate for patients
to return year after year to repeatedly report no ill effects after a long forgotten operation.
A postal questionnaire is more convenient and less time consuming for patients and doctors
and is less expensive for the Health Service. It is important to establish that the patient
is alive before the questionnaire is sent. Yet follow-upmust also be long term. Initial reports
about the results following highly selective vagotomy claimed that the recurrent ulcer rate
was about 1% after 2-3 years follow-up". After 14-19 years follow-up the recurrence rate
on the same patients is 30%12.
The deficiencies of retrospective studies from case notes are well known. Case notes are
frequently missing, incomplete and unstructured, making information difficult to find.
Nor is it fair to expect the notes to contain information relevant to the disease under study.
'How can the man who recorded the note guess that years later some investigator will
require to know whether Pumpernikel's sign was present?'
The epitome then of good follow-up is that it should be prospecuve, structured and long-
term. It must be recorded in a form which collects all relevant information.
Review of outcome in this way seems likely to become an established part of surgical
practice. Audit must move on. Our political masters will not merely ask 'How many
operations did you do?'—both they and our patients will wish to know 'What are your
results like five, 10 or even 20 years on?'
Surgical Review is easy to establish—continuing improvements in computer technology
will make it progressively easier. It requires frommanagers a verymodest resourceallocation
and from clinicians a commitment to quality control of their work.
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Extending surgical audit: the
assessment of postoperative outcome
Everyone involved in health care is subjected increasingly to greater accountability. The present
Government's concept of 'value for money' seems destined to be applied more and more to the
Health Service; a policy that will inevitably involve auditing not only resources but results. If
surgeons are to 'sell' their skills on an internal National Health Service market, what criteria
will be used to judge which hospital or firm or consultant is best for a particular referral? In
many instances personality or geographical proximity will remain the major determinants. In
other cases general practitioners and their patients may be guided more by proven results.
Surgical audit seems destined to increase.
Auditing of process is already with us in the form of performance indicators of workload such
as numbers of new out-patients, admissions and operations, and these are now applied to most
surgeons in the UK. Yet the present emphasis on resources and their management has diverted
attention from the aspect of more concern to doctors and patients - the outcome of surgical
treatment. There is little merit in a clinician topping a league table for operations performed if
these are inappropriate or the results are bad.
The case for surgical audit is now well established. Audit has advantages across the spectrum
of those involved in patient care. It can tell surgeons how their results compare with those of
their peers - an important contributor to job satisfaction perhaps, or a stimulus to improved
technique. It can tell both surgeons and managers whether better performance indicators and
lower costs are achieved at the expense of, for example, increased re-admission and complication
rates. In short it can tell us all whether we are achieving our aims in surgical care.
Surgeons, especially gastrointestinal surgeons, were pioneers of auditing long-term outcome
in their patients. Billroth was not only the father of gastrointestinal surgery but was the originator
of surgical audit. In the UK, Tanner1 and Visick2 demonstrated both the feasibility and the
value of long-term follow-up after peptic ulcer operations. These and a few others like them
established exhaustive and detailed follow-up after gastric surgery and with them began reliable
follow-up where only clinical impression had gone before. For example, in 1928 the largest
prospective study then published, involving some 744 patients, reckoned the recurrent ulcer rate
after gastroenterostomy at 2-8 percent3. Even centres ofexcellence were not immune from dubious
results; the recurrence rate at the Mayo Clinic was claimed to be 3-5 percent after a minimum
follow-up of 5 years4. These results we now know reflect inadequacy of follow-up rather than
operative success. Has the audit of surgical outcome improved 60 years on?
Individual surgeons do not have the resources to follow up all cases in the long term. It is
difficult enough for most surgeons to follow up those groups of patients in whom they have a
particular interest. Pressure on hospital resources has squeezed out-patient clinics, making
increasingly inappropriate the continued review of patients who remain well years after
long-forgotten operations. How, then, can individual surgeons know whether their results
compare with those published in the literature? How can individual surgeons know, for example:
whether their recurrence rate after surgery for duodenal ulcer is 5 percent or 40 percent; whether
their 5-year survival rate after resection for colorectal cancer is 40 percent or 70 per cent; what
the symptomatic results of their transurethral resections are after more than 1 year (how many
of their patients are incontinent and how many require a further resection); whether their palliative
resections for gastric cancer improve the quality of life or whether the patient is better o(T without
surgery? It is unlikely that these questions can be answered by follow-up at the routine out-patient
clinic without a structured document for collecting the data. Most surgical clinics are too busy
to allow this additional time-consuming chore. It is equally unlikely that surgeons would take
time to analyse such documents manually. If an audit system is to succeed it must involve
minimal extra work for clinicians and secretarial or clerical staff; it must be cheap and easy to
use; and it must provide relevant results which are wanted by the clinician.
The origins and working of our Surgical Review Office formed a logical, natural progression
from a gastric follow-up clinic. The decline in incidence of peptic ulcer since the 1960s and the
even more dramatic decline in its surgery in the 1980s necessitated diversification into other
areas. Our system now audits operations for peptic ulcer (elective and emergency), gastric cancer,
gastro-oesophageal reflux and colorectal cancer. The detailed techniques of recruitment,
documentation and follow-up have been described elsewhere5.
Who should do the audit? Registrars and research fellows arc employed on a short-term
basis. As a result, short-term follow-up studies abound, as do 'snapshot' studies of the last 50
'-ectomies' or '-plasties'. But to obtain a sustained long-term audit of a consultant's results
requires that the consultant should make time to do it personally. Only the consultant has the
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continuity of employment to sustain the continuing organization of a long-term audit system.
Whilst enthusiasts have and will continue to audit their results for self-assessment, others
remain to be convinced. There are some who believe that if our political and managerial masters
wish to know the results of our clinical endeavours it is they and not we who should do the
auditing. This option, which would involve employing medically qualified 'assessors' working
for the manager, is an option that would be much less attractive to most clinicians and
unacceptable to many. - '•
Deciding which groups of patients to study in a consultant's or firm's practice and what
information to collect about them involves little time and no financial outlay. The powerful
commercial database packages now widely available for modern microcomputers make design
of the collecting documents easy - the days of elaborate codes and margins full of numbered
boxes are over. The proforma should record biographical, clinical and follow-up data. Follow-up
will be increasingly carried out by postal questionnaire worded in a form that all patients can
understand. The answers should be capable of direct entry on to a computer without any data
manipulation or analysis.
The choice of a computer system assumes little computer knowledge and less enthusiasm,
although this is progressively changing as consultants are appointed from a computer-literate
generation. The system should be on the list approved by the Health Authority, should be able
to run a 'friendly' commercial database, and should have at least 20 megabytes of hard disk
storage. Computer costs are falling and will continue to fall.
Having said this, the decision about who should pay for the exercise should be clarified from
the outset. Enthusiasts like Visick established follow-up systems out of their own pockets, but
today most are financed by 'soft' money. As has happened in Lothian, UK, consultant
commitment to audit can result in the Health Authority subsequently funding the system6. Few
managers are likely, even in the current climate, to view this as a priority. Consultant commitment
to the principle and a system bought with soft money will continue to be the most common method
of starting up.
If auditing of outcome is to become widely established, however, it must have the support
of the Royal Colleges. If they are to retain their role as guardians of quality control of a
self-regulating profession they should ensure that only those units that practice audit are
recognized as training posts. The Government, as paymaster of the National Health Service,
has a vested interest in establishing formal quality control. The recommendations of the National
Audit Office report Quality of care in the NHS1 seem likely to be implemented.
Surgical audit is here to stay and destined to increase. The enumeration of patients seen and
operations performed is a prerequisite in assessing performance of a surgical firm. Such statistics
enable the rational planning of medical manpower and funds. Basic audit within a firm must
be a criterion for recognition of surgical posts for training. Yet they only show one side of the
coin - the quantity of workload but not the quality of care. Meaningful audit must include the
assessment of outcome. This means prospective and long-term follow-up, which should be as
complete as possible.
A postal questionnaire is more convenient and less time consuming for patient and surgeon
and is cheaper for the National Health Service. Follow-up must also be long term. The early
results of highly selective vagotomy claimed a recurrence rate of about 1 percent after 2-3 years8.
After 14-19 years the recurrence rate on the same patients was 30percent9.
The audit of outcome therefore must be prospective, structured, long term and computer
based. It is easy to establish. Its continued success requires from surgeons a commitment to the
quality control of their work and from managers a modest resource allocation.
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Time since operation (years)
Figure 1 Recurrent ulcer rale after highly selective vagotomy. Sumbers
shown on the horizontal axis are the number ofpatients with recurrent
ulceration over those eligible for analysis at each point
ulcer after HSV was less aggressive both in terms of presenting
features and ease of treatment. In other words did 'failed" HSV
convert an aggressive ulcer diathesis into a milder innocuous
version, with minimal symptoms, more easily treated. We also
aimed to test the hypothesis that ulcers that had failed to
respond to H2-receptor antagonists did badly with HSV.
Finally we sought to determine the symptoms experienced and
the need for medical treatment 5-15 years after HSV.
Patients and methods
All patients undergoing surgery for peptic ulcer disease in our hospital
are documented and followed up by the Gastric Follow-Up Clinic20.
Those patients having HSV for duodenal ulcer between I January 1973
and 1 January 1983 were reviewed annually by postal questionnaire
or at an evening clinic or by home visit. A total of 307 operations were
performed without operative mortality. The median age was 39-6 years
with a range of 12-6-70-6 years. The male to female ratio was 229:78.
Seventy-six percent (234) were cigarette smokers.
Previous ulcer complications were recorded as possible indicators
of severity of the ulcer diathesis. One hundred and ninety one had
no previous complications, while 92 patients had previous complications:
74 had bled from the ulcer (eight with a concomitant or subsequent
perforation) and 18 had a perforation alone.
Pentagastrin tests were conducted using a dose of 6/rg/kg without
correction for gastric loss and duodenal reflux. Maximal acid output
(mmol/h) was calculated as the acid output during the four ISmin
periods after pentagastrin administration.
Only those patients with a minimum follow-up of 5 years were
considered. Ten patients had died and 14 were lost to follow-up within
5 years of the operation leaving 283 (92-2 per cent) with a minimum
follow-up of 5 years. In 1988 all surviving patients were reviewed by
the Surgical Review Office2' giving a 5-15 year follow-up. By this time
a total of 19 patients had died and 38 had been lost to follow-up leaving
250 (81-4 percent) available. Current symptoms and medical treatment
were analysed in this group.
The first 2 years of the study antedated the introduction of H,-
rcceptor antagonists and most of the 103 patients not treated by H.-
rcceplor antagonists came from this period. Of the patients 70 had
failed to heal on an H,-receptor antagonist regimen and 101 relapsed
on maintenance treatment or after cessation of treatment. No piatients
in the scries admitted to taking aspirin and one only was on steroid
therapy. Three were taking non-steroidal anti-inflammatory drugs.
Information from our standard questionnaire was transferred to an
NCR-PC microcomputer and analysed using D Base III Plus
(Ashton-Tate. Maidenhead, UK I. The recurrence rate was estimated
by life table methods and the significance of preoperative factors in
predicting subsequent recurrence was tested by Cox proportional
hazards regression.
Of the 2S3 patients available for review more than 5 yc
after operation. 49 (17-5 per cent) were diagnosed as hav
recurrent ulcer. The cumulative recurrence rate (Future I) v
13-2 percent at 5 years rising to 19-4 pier cent at 12 years. M
patients presented with epigastric pain with or without otl
symptoms (Table!). One patient was known to have
asymptomatic recurrence revealed by routine endoscopy. It v
not our policy, however, to endoscope all asymptomr
patients, so that the 'silent' recurrence rate is not known,
the 49 recurrent ulcers. 41 were duodenal, two gastric, th
prepyloric and three pyloric. Thirty-nine ulcers were diagno:
at endoscopy, six at barium meal and two at laparotomy. 1
remaining two were diagnosed in other centres without
method of diagnosis being recorded.
Risk factors
Possible risk factors are compared in Table 3 contrast
patients with and without recurrence. There was no signific:
difference between the two groups in age or length of histi
(defined as interval between diagnosis and operation). Anal;
of preoperative symptoms and their duration showed
significant difference between the groups. Patients present
with vomiting were at higher risk at the 5 per cent level
significance. There were relatively fewer recurrences in men £
relatively more in cigarette smokers but neither read
statistical significance.
A previous complication of ulcer was not associated w
an increased chance of recurrence. About one-third in e:
group had had a previous bleed and'or perforation. Nor w
those ulcers resistant to H,-receptor antagonists more lik
to recur after HSV. Of the 49 patients with recurrent ulcer,
<26 percent) had failed to heal on H,-receptor antagoni
while 66 of 234 (2S percent) without recurrence had failed
respond to H .-receptor antagonists. (Table4).
Table 2 Presentation of recurrent ulcer in 49 patients
Epigastric pain 36 (21 had other symptom
Haemorrhage 3 (I had other symptoms
Nausea 7 (all had other symptom
Vomiting IS (16 had other symptom
Heartburn 7 (5 had other symptoms
Weight loss 2 (both had other symptr

















Malct 33 (67) 180 (76-9) n.
Cigarette smokers'1' 42(S6I 174 (74 4) n.











55 (23 5) n.
14 (6-01 n.
7 (3<)| n.
" Median mange in parentheses I: t number of patients (pcrccnta
parentheses!: n.s.. no: significant
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Tjlilr I Resistance to II} blockers and recurrent ulcer
Recurrence No recurrence Total
(,, = 49) (n = 234) (« = 283)
failed to respond to 13(26-5)
Hj blocker
66 (28-2) 79
Relapsed after course of 18 (36-7)
Hj blocker
83 (35-5) 101
No Hj blocker 18 (36-7) 85 (36-3) 103
V are numbers of patients (percentages in parentheses)
Table 5 Percentage recurrence at 5 and 10 years according to family
history
Number of first degree relatives
with diagnosis of duodenal ulcer










Values are percentage (s.e.) recurrence
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* Range; "f mean(s.e.)
Patients with a strong family history of duodenal ulcer had
a significantly higher rate of ulcer recurrence (TableS).
Acid secretion studies
Maximal acid output in response to pentagastrin was recorded
before operation in 273 patients and after operation in 140. The
preoperative maximal acid output did not identify those at risk
of recurrence (Table 6). Using life table analysis, postoperative
maximal acid output was significantly higher (P<0-05) in
patients who subsequently developed recurrent ulcer. The
percentage reduction in maximal acid output was not, however,
significantly different in the two groups. In the recurrent ulcer
group, however, 10 of the 34 patients (29 percent) showed an
acid reduction of less than 20 percent and thus could be
considered to have had an inadequate vagotomy. This contrasts
with only 12 out of 106 (11-3 per cent) patients without
recurrence who had an incomplete vagotomy by these criteria.
Operating surgeons
Of the 19 surgeons involved in the scries, five were consultants
and 14 surgeons in training. The individual recurrence rate
varied from 5percent (1 of 19) to 26percent (10 of 39).
While the differences between the best and the worst of each
group were large they were not significant and the overall
consultant recurrence rate of 15-2 pier cent was not significantly
different from the overall recurrence rate of the surgeons in
training, 19 6 percent.
Behaviour of recurrent ulcer
Ulcer recurrence continued to present throughout the period
of follow-up (Figure I), the interval to recurrence varying from
1 month to 128 months after operation. The cumulative
recurrent ulcer rale increased from !3-2p>crcent at 5 years to
19-4 percent at 12 years.
The treatment of the recurrent ulcers is summarized in
Figure2. Of the recurrent ulcers in our scries, 19 could be
considered innocuous, and 30 malevolent according to the
classification suggested by Hoffman et al.'. Of the innocuous
ulcers, five required no therapy because of minimal symptom;
and three required occasional antacid or other drug treatmenl
but not Hj-reccptor antagonists. Eleven required either a single
course ofH2-rcccptor antagonist or occasional treatment only.
The 30 malevolent ulcers included 10 which required
repeated or frequent courses of treatment with H2-receptoi
antagonist and 20 which required a further operation. The
operations performed are shown in Table7. There was nc
operative mortality following these revisional operations. O
the 30 malevolent recurrent ulcers, three presented with
haemorrhage and one with perforation.
Current symptoms
The symptoms experienced by 250 patients 5-15 years aftei
operation are shown in TableS, comparing those with known
recurrent ulcer with the others. The results are expressed as a
percentage of those who had symptoms every day or most days
Overall 8-9 percent had epigastric pain, 11 -8 per cent had
heartburn, 5-4 percent dumping and 41 pier cent diarrhoea. The
commonest symptom was postcibal bloating in 21-4percent.
Drug treatment
Of the 240 patients who answered the question 26 (10-8 percent
took H,-receptor antagonists every day or most days (Table9)




















Figure 2 Behaviour of recurrent ulcer in 49 patients
Table 7 Operations in patients with recurrent ulcer
Polva gastrectomy
Billroth 1 gastrectomy
Truncal vagotomy and antrectomy
Truncal vagotomy and pyloroplasty
Truncal vagotomy and gastroenterostomy
Truncal vagotomy with pyloric dilatation
Gastroenterostomy
Simple closure of perforated duodenal ulcer
Table 8 Percentage ofpatients 5-15 years after operation with iaria
symptoms every day or most days (n = 250)
All patients Recurrence No recurrent
Epigastric pain 89 n 6-3
Hcariburn ll-S 23 1 9-7
Bloating 21-4 37 5 18-3
Vomiting 1-3 5 3 0 5
Dumping 5-4 15 3-5
Diarrhoea 4-1 2-4 4-4
Hj blocker 10 7 30 8 6-9
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Table 9 Need for If receptor antagonists 5-IS years after operation
(eight patients did not answ er this question)
Recurrence No recurrence All
(n = 39) (n = 203) (n = 242)
II2-reccptor antagonists 12 (30-8) 14 (6-9) 26(10-7)
every day or most days
Hj-reccptor antagonists 27 (69-2) 189 (931) 216 (89-3)
occasionally or never
Values arc numbers of patients (percentages in parentheses)
Almost one-third of patients in the recurrent ulcer group took
H2-reccptor antagonists on this basis and almost one-third of
these took antacids in addition.
Patients assessment
Of the 239 patients who responded to the question about the
success of the operation 203 (84-9 percent) considered the
operation to have been a success while 218 (91-2percent)
considered that their symptoms were cured or improved.
Discussion
The continuing rise in ulcer recurrence rate with time
emphasizes the need for long-term follow-up in the assessment
of highly selective vagotomy. The reasons for this recurrence
seem to fall into two groups. First there are those in whom a
seemingly satisfactory reduction in acid output has been
achieved. Only one of the possible risk factors that we studied
has proved to be implicated - a strong family history of ulcer
disease. This raises the possibility that the aggression of the
ulcer diathesis is genetically determined but not mediated
through acid output. In the second group with recurrence, acid
secretion studies suggest an incomplete vagotomy. We have
confirmed the large individual variation between surgeons and
shown that this does not correlate with seniority or experience.
Although recurrence varied greatly between individual surgeons
these differences were not statistically significant. The
preoperative maximal add output is not a predictor of success
or failure in either group.
Our series was performed in the era of a more complete
oesophageal denervation and extension of the distal denervation
of the parietal cell mass. We believe that the superiority of our
results compared with Hoffman's may well be explained by
these improvements in technique although our follow-up period
is shorter.
In studies of more radical forms of surgery22 we have shown
that patients who 'earn" their operation by enduring symptoms
for many years fare no better than those with a short
preoperative history. Our present study confirms that this
applies also to HSV. A previous haemorrhage from or
perforation of the ulcer did not predispose to recurrence after
HSV. Both of these complications remain important con¬
tributors to the indications for elective duodenal ulcer surgery.
It is important to know that they do not in themselves indicate
an aggressive ulcer diathesis and thus do not decrease the
chances of a successful HSV.
Only seven of our 49 patients with recurrent ulcer were
non-smokers and two of those were considered by subsequent
acid studies to have had an unsatisfactory vagotomy. Although
not statistically significant this trend may mean that cigarette
smoking having contributed to the failure of medical treatment
can also influence surgical failure.
In this series, like those of Weaver and Temple23 and
Goodman et al,24, prior resistance to H2-rcceptor antagonists
was not associated with increased failure of HSV, in contrast
to other scries2 25. This difference may be explained by differing
definitions of failure and differences in patient compliance
between the series. It is important to resolve this controversy
since all patients now coming to elective surgery will have had
H,-rcceptor antagonists. Furthermore it is those very patic
in whom these agents have failed who are selected out
surgery. This study shows clearly that a high maximal a
output, a previous ulcer complication and resistance to I
receptor antagonists are not associated with a poorer rcsul
It should be emphasized that the aim of the surgi
procedure is to prevent complications and abolish svmptoi
Since only four patients in our series had a bleed or perioral
after HSV compared with 92 before the operation,
procedure is clearly successful in preventing these complicatior
It is also successful in abolishing symptoms or reducing th
to acceptable levels in about 90percent of patients. 1
commonest symptom is postcibal bloating caused by the 1
of adaptive relaxation as a result of denervation of the funi
and body. We have shown that this symptom persists in
long term in some 20 per cent of patients. Our practice is
warn patients before operation of the possibility of I
symptom although it is regarded as a problem by very f
The incidence of diarrhoea every day or most days \
4-1 percent, similar to that reported in other series. Simils
only 5-4 per cent complained of symptoms of dumping and
all of these the symptoms were readily controlled by medi
means. Furthermore as Salaman et al.26 and Muller et a
have demonstrated these symptoms may be present in 5perc
of subjects who have not had a vagotomy.
Approximately 10 percent of patients overall had dyspe|
symptoms every day or most days and were required to t:
daily or regular antacids or H2-receptor antagonists to com
them.
This level of symptom control 5-15 years after operat
indicates that the operation is successful in controlling
disease in the long term. To assess results simply in term!
recurrent ulcer can be misleading. We \vouId support the v
of Busman and Munting28 and Byme et al_29 that measurem
of symptom control is a more appropriate measure of sua
or failure than recurrence rate alone. We have shown t
40 per cent of recurrent ulcers are readily treated or require
treatment at all. Furthermore the side effects which resulta
the demise of gastrectomy and truncal vagotomy are
frequent and occur in a milder, less distressing form after H
The mortality rate in the Lothian Health Board area for H
5s 0-05 percent in over 800 procedures confirming it as the sa
operation for peptic ulcer disease30.
We judge HSV a success in providing a disease-free intei
of 15 years in about 80 percent of patients and curing
improving symptoms in some 90 per cent.
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APPENDIX 3e
IMPACT OF H2 RECEPTOR ANTAGONISTS ON THE OUTCOME OF
TREATMENT OF PERFORATED DUODENAL ULCER
Impact of H2-receptor antagonists on the
outcome of treatment pf perforated duodenal
ulcer
I. M. C. Macintyre and A. Millar
Surgical Review Office, Western General Hospital, Edinburgh EH42XU, UK
One hundred and eighty-five patients were perforated duodenal ulcer were treated at one
hospital over the 21-year period which straddled the introduction of H2-receptor antagonists. Of
these 107 had simple closure, 58 simple closure with immediate H2-receptor antagonists and 20
immediate definitive surgery. The overall operative mortality rate was 5.4%. The rate of
subsequent definitive surgery declined significantly in the years after the introduction of
H2-receptor antagonists. Only a minority of those who came to subsequent definitive surgery
had done so within the first year, the percentage rising from 16% at 1 year to 43.7% at 10 years.
Of the patients treated by simple closure alone, 44.3% had subsequent definitive surgery
compared with 24.1% having H2-receptor antagonists in addition, but this difference was not
statistically significant using life table analysis. Review of the 104 patients available in 1989
showed no significant differences in symptoms between the treatment groups. The only
preoperative predictor of subsequent definitive operation was non-steroidal anti-inflammatory
drug consumption which showed a negative correlation. A 3-month history of dyspepsia before
perforation did not predict the need for subsequent surgery. The symptomatic results in a
different group of patients who had undergone highly selective vagotomy subsequent to a
previous perforation were no different from patients treated by simple closure alone or with
immediate prescription of H2-receptor antagonists. Bloating, however, was significantly more
common after highly selective vagotomy. We believe that perforated duodenal ulcer should be
treated by simple closure. While other studies have shown a short-term benefit from the
immediate prescription of H2-receptor antagonists, this study has shown no long-term benefit
from this practice. It seems likely, however, that the significant reduction in definitive surgery
after perforation is the result of the introduction of H2-receptor antagonists into the community.
Keywords: duodenal ulcer, perforation, operation, H2-receptor antagonists
Since the first successful procedure for perforated
duodenal ulcer in 18941, there has been controversy
about the best operation. Each new definitive opera¬
tion has had its advocates in the immediate manage¬
ment of perforation. Although several series2-5 had
claimed good results with immediate gastrectomy,
Graham's powerful advocacy6 of simple closure (based
on his series with a 2% operative mortality rate)
continued to influence surgical thinking well into the
1950s. By 1960 Harkins7 reported that three methods -
simple closure, immediate vagotomy and drainage and
immediate gastrectomy - were all widely practised at
that time by American surgeons. The next 20 years saw
the controversy change to simple closure versus
definitive surgery, but the lack of prospective control¬
led trials meant that there was little scientific evidence
on which to base a decision. Many surgeons adopted
the policy first suggested by Illingworth et al8 in 1946
that only those patients with a prior dyspeptic history of
3 months or more should have a definitive procedure.
In the 1960s and 1970s several series9-11 showed that
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definitive surgery was possible without any increase i
operative mortality. There remained, however, consic
erable disagreement about the natural history c
perforated ulcer after simple closure and the need fc
subsequent definitive surgery. Reports of the need fc
subsequent definitive surgery ranged from 27-719
(Table I)9'12-21.
Table 1 Further surgery after simple closure of perforated duoden
ulcer
Study n Subsequent definitii
surgery (%)
Skovgaard (1977)12 111 71
Wagensteen etal. (1972)13 89 70
Griffin and Organ (1976)14 122 58
Gillen et al. (1986)1S 54 57
Jarrett and Donaldson (1972)16 297 45
Backgaardetal. (1979)17 80 43
Nemanich and Nicoloff (1970)18 79 43
Heumane/a/. (1983)19 77 42
Boey and Wong (1987)20 393 39.5
Sawyers etal. (1975)9 254 37
King and Ross (1987)21 86 27
348 J. R. Coll. Surg. Edinb., Vol. 35, December 19:
Effect ofH2-receptors on treatment ofduodena! ulcer: /. M. C. Macintyre andA. Millar
The greatest advance in the elective management of
duodenal ulcer has undoubtedly been the introduction
of H2-receptor antagonists. In this study we have
examined the effect of the introduction of H2-receptor
antagonists on the need for a definitive operation.
Several studies in the 1980s, well into the era of the
H2-receptor antagonists, have come to differing conclu- '.
sions. Simpson and co-workers22 in 1987 demonstrated
that cimetidine prescribed immediately after surgery
reduced subsequent dyspepsia and ulcer complications
in the short-term. By contrast Gillen et al.15 found that
the introduction of H2-receptor antagonists did not
reduce the need for subsequent definitive surgery
which remained at a rate of 57.4% in their hands. They
concluded that perforated duodenal ulcer should be
treated by definitive surgery wherever possible, a view
supported recently by two controlled studies20,23 and
three retrospective studies24-26.
We, therefore, aimed in this study to determine the
effect of the immediate prescription of H2-receptor
antagonists on (a) the need for subsequent definitive
surgery and (b) the symptomatic outcome in patients
with perforated duodenal ulcer.
Patients and methods
All patients from the Western General Hospital,
Edinburgh between the years 1966 and 1986 with a
diagnosis of perforated duodenal ulcer were studied to
allow comparison between the patients presenting
before and after the introduction of H2-receptor
antagonists. All patients were documented prospective¬
ly on a standard proforma by the Gastric Follow-up
Clinic27.
Of the 185 patients, 107 were treated by simple
closure (group 1) and 58 by simple closure plus
H2-receptor antagonists for at least 1 month after
operation (group 2). The remaining 20 patients had
been treated by immediate definitive surgery (truncal
vagotomy and drainage in 15 and Polya gastrectomy in
five). The patients were initially followed up by the
Gastric Follow-up Clinic and latterly by the Surgical
Review Office using techniques described in detail
elsewhere28'29. In 1989 a standard symptom question¬
naire was sent to all known survivors.
A comparison between the original groups in terms
of age, sex, cigarette smoking, consumption of
non-steroidal anti-inflammatory drugs and steroids,
and previous diagnosis or family history of peptic ulcer
is shown in Table 2. The association between each of
these factors and subsequent definitive surgery was
analysed using Cox proportional hazard regression.
Differences between the groups in terms of subsequent
definitive surgery have been analysed using log-rank
tests. Fisher's exact test was used to assess differences
in symptoms between the groups.
The distribution over the 21 years of the three
procedures is shown in Figure 1. All of the patients who
had H2-receptor antagonists were treated after 1975.
Results
Postoperative complications
The operative mortality rate was 5.4% with no deaths
following definitive surgery.
Table 2 Comparison of the groups
Simple Closure plus Definitive
closure H2-receptor surgery
antagonists
(n = 107) IT II LZl 00 (n = 20)
Median age (range) 52 (12-86) 59 (19-86) 73 (36-88)
years
Male;female ratio 71:36(2.0:1) 39:19(2.0:1) 13:7(1.9:1)
Cigarette smoking 78 (72.9) 40 (69) 13 (65)
NSAID consumption 13(12.1) 17 (29) 3(15)
Steroid consumption 5(4.7) 7(12) 1(5)
Total NSAID plus 18(16.8) 24 (41) 4(20)
steroids
Previous diagnosis of 28 (26.2) 8(14) 11(55)
peptic ulcer
Previous history of 22 (20.6) 4(7) 0(0)
peptic ulcer
NSAID, non-steroidal anti-inflammatory drug. Values in parentheses
are percentages
Outcome
The outcome of patients in the three groups is shown in
Figure 2. Further definitive surgery was performed in
36.8% of eligible patients: in 43 of the 97 patients who
survived simple closure (44.3%) but in only 14 of the
58 patients (24.1%) who survived simple closure with
immediate prescription of H2-receptor antagonists.
One of the 20 patients who had definitive surgery
required revisional operation - a resection of small
bowel and plication of afferent and efferent loops for
retrograde jejunogastric intussusception described in
detail elsewhere30.
The rate of definitive surgery in groups 1 and 2 over
10 years of follow-up is shown in Table 3. The
percentage rose from 18.0% at 1 year to 44.7% at
10 years in the simple closure group. In group 2 the rise
was from 13.3% at 1 year to 42.0% at 10 years. The
differences between the groups were not significant
(P = 0.15).
Fifty-seven patients died before review in 1989 and
24 were lost to follow-up leaving 104 available for
review in 1989. The follow-up period ranged from 2 to
22 years with a mean of 10.12 years.
Time (years) from 1966 - 1986
Figure 1 Distribution over 21 years of the three groups of operation
for perforated duodenal ulcer: simple closure; closure plus
H2-receptor antagonists; □, definitive surgery
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Available for review in 1989
(10)
Mean (range) duration of follow-up
= 13.57 (0.32 - 22.71 ) years
Mean (range) duration of follow-up
= 6.09 (2.22 - 1 1 .2) years
Figure 2 Mortality, definitive surgery and follow-up
Mean (range) duration of follow-up
= 5.85 (2.06 - 13.36) years
Symptomatic result at long-term review
The symptoms experienced every day or most days by
these patients are shown in Table 4. The patients'
appetite, ability to eat a normal meal and to enjoy food
are shown in Table 5, together with their opinion on
whether the operation was a success. There were no
significant differences between these groups.
Patients in group 2 were more likely to continue to
take H2-receptor antagonists every day or most days,
12 out of 40 patients (30%) compared with only four
out of 48 (8%) treated by simple closure alone
(P = 0.05).
The one preoperative factor which was significantly
associated with subsequent definitive surgery was
consumption of non-steroidal anti-inflammatory drugs.
Patients taking these drugs at the time of perforation
were significantly less likely (P < 0.05) to proceed to
subsequent definitive surgery (Table 6).
There was a highly significant relationship between
year of operation and outcome (P < 0.01), with more
recent cases less likely to come to definitive surgery
(Table 7). For those having simple closure, a multivari¬
ate Cox regression involving year of operation, use of
non-steroidal anti-inflammatory drugs and whether or
not H2-receptor antagonists were used immediately
after surgery showed no significance for the last factor
when adjusted for the other two. Year of operation
remained significant at P < 0.05.
A dyspeptic history of more than 3 months before
perforation operation was not a significant predictor of
the need for subsequent definitive surgery.
Discussion
Whilst elective operations for duodenal ulcer have
fallen markedly in the past decade, the incidence of
perforated duodenal ulcer remains static in the UK31.
The controversy about whether it should be treated by
Table 3 Life table analysis showing relation between groups 1 and 2
and subsequent definitive surgery
Years after Percentage(s.e.m.) coming to definitive surgery
perforation
Simple closure Simple closure plus
H2-receptor antagonists





Table 4 Symptomatic outcome (symptoms present every day or
most days)
Simple closure Simple closure plus
H2-receptor antagonists
IT II Lt\ U> (n = 41)
Epigastric pain 4/53 (8) 1/41 (2)
Heartburn 3/53 (6) 0/41 (0)
Nausea 1/53 (2) 1/38 (3)
Vomiting 0/53 (0) 1/41 (2)
Bloating 7/53 (13) 0/40 (0)
Diarrhoea 3/51 (6) 1/41 (2)
Values in parentheses are percentages
Table 5 Patients' opinions on success of operations
Simple closure Simple closure Definitive
plus H2-receptor surgery
antagonists
(n = 53) (n = 41) (n = 10)
Good appetite 45/52(87) 38/41 (93) 8/9(89)
Eat normal food 43/53(81) 35/41(85) 8/9(89)
Enjoy food 49/51 (96) 39/41(95) 8/10(80)
Values in parentheses are percentages
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immediate definitive surgery has continued throughout
this century. The difficulty has arisen from our inability
to select, at the time of the emergency operation, those
patients who require definitive surgery. Selection on
the basis of preceding history21 or whether the ulcer
was judged acute or chronic by the surgeon32 has failed
to identify patients who require definitive surgery. ,
Backgaard and co-workers' study suggested that as
many as 50% of patients were classified incorrectly17.
A blanket policy of definitive surgery for all will result
in unnecessary operations with their attendant side
effects33.
As H2-receptor antagonists, supplemented latterly
by omeprazole, have now largely replaced definitive
surgery in the treatment of elective ulcer disease34, it
seemed logical to explore the hypothesis that these
should also replace definitive surgery in the treatment
of perforated ulcer. These drugs have rekindled
interest in conservative treatment of perforation. The
present study has shown that simple closure with the
immediate prescription of H2-receptor antagonists was
associated with a reduction in subsequent definitive
operations but this was not significant.
Consumption of non-steroidal anti-inflammatory
drugs before perforation was the only preoperative
factor significantly associated with subsequent defini¬
tive surgery. The lower rate of subsequent definitive
surgery in these patients suggests that ulcers in such
patients may be acute rather than chronic.
We have compared the symptomatic outcome of
those patients in groups 1 and 2 with a separate group
of 36 patients who had highly selective vagotomy for
duodenal ulcer in our hospital, following a previous
perforation elsewhere, and who had symptomatic
Table 6 Life table analysis showing relation between non-steroidal
anti-inflammatory drugs (NSAID) and subsequent definitive surgery
Years after Percentage(s.e ,m.) coming to definitive surgery
simple closure NSAID No NSAID






P < 0.05 for patients proceeding to definitive surgery
Table 7 Life table analysis of patients having definitive surgery in
three consecutive periods
Years after Percentage(s.e. m.) coming to definitive surgery
perforation 1966-1975 1976-1980 1981-1986
oTtoII (i.-51) IT II LA LA
1 17.1(4.9) 20.0(5.4) 6.8(3.3)
2 31.5(6.2) 27.7(6.1) 14.0(5.0)
5 44.8(6.7) 33.8(6.5) 21.8(8.7)
10 56.6(7.1) 39.6(7.1) —
15 56.6(7.1) —
P < 0.01 for year of surgery
Table 8 Symptomatic outcome of groups 1 and 2 and elective highly
selective vagotomy (HSV) following previous perforation
Simple Simple closure HSV following
closure plus H2-receptor previous perforation
antagonists
(n = 53) (n = 41) (n = 36)
Epigastric pain 4/53 (8) 1/41 (2) 5/36(14)
Heartburn 3/53 (6) 0/41 (0) 2/34 (6)
Bloating 7/53 (13) 1/41 (2) 8/34 (24)
Vomiting 0/53 (0) 0/40 (0) 0/36 (0)
Diarrhoea 3/51 (6) 1/41 (2) 2/36 (6)
Hj-blockers 4/48 (8) 12/40 (30) 3/32 (9)
Values in parentheses are percentages
Table 9 Symptomatic outcome of patients having simple closure and
no subsequent definitive surgery, and patients having highly selective
vagotomy (HSV) following previous perforation
Simple closure plus HSV following
no definitive surgery previous perforation
a II LA (n = 36)
Epigastric pain 1/57 (2) P = 0.08 5/36 (14)
Heartburn 2/57 (4) 2/34 (6)
Bloating 2/57 (4) P = 0.02 8/34 (24)
Vomiting 0/56 (0) 0/36 (0)
Diarrhoea 2/55 (4) 2/36 (6)
H2-blockers 10/53 (19) 3/32 (9)
Values in parentheses are percentages
review carried out 5-15 years after operation. The
comparison is shown in Table 8. We have also
compared the symptomatic outcome of all patients in
groups 1 and 2 who had no subsequent definitive
surgery with the group of 36 patients who had highly
selective vagotomy following a previous perforation.
This is shown in Table 9. Bloating, a recognized
complication of highly selective vagotomy, is the only
symptom significantly different in both cases. These
comparisons have not taken place as part of a
controlled study and those patients coming to highly
selective vagotomy will include some with a more
aggressive diathesis.
We recommend a policy of simple closure for all
patients who present with perforated duodenal ulcer.
The side effects of definitive surgery are avoided and
the symptomatic results in the long-term are no worse.
We would recommend immediate prescription of
H2-receptor antagonists on the basis of the study by
Simpson and co-workers22 which showed short-term
benefit from this treatment, although our study shows
no significant long-term benefit from this practice.
However, the significant decline in the rate of
subsequent definitive surgery is almost certainly the
result of the increasingly widespread use of H2-receptor
antagonists in symptomatic patients.
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bstract. The safety and efficacy of highly selective vagot-
my were assessed in a prospective series of 500 patients
ho underwent the operation during a 15-year period. There
as no peroperative or immediate postoperative mortality,
one of the 22 late deaths was attributable to the operation,
i six cases complications prolonged the hospital stay be-
rnd 21 days, requiring a second laparotomy in four. The
ite of ulcer recurrence was 18.5 % by 15 years. Bloating was
le commonest long-term complication (8.8%), but half of
lese patients regarded the operation as successful. Less
immon were dumping (5.4%), diarrhoea (3.8%) and gas-
ic stasis (1.4%). Revisional surgery was performed on 37
itients—for recurrent ulcer in 28, for gastric stasis in seven
id for perforation in two. Although almost 20% of the
viewed patients continue to required regular or frequent
edication, the study shows that highly selective vagotomy
in be therapeutically effective for duodenal ulcer, particu-
rly in preventing haemorrhage and perforation in patients
ho have previously suffered these complications. Above all
is a safe operation with low long-term morbidity.
ey words: highly selective vagotomy, prospective study,
jodenal ulcer.
lthough the need for surgical treatment of uncompli-
ited duodenal ulcer has been reduced, initially by
2 receptor antagonists and latterly by proton pump
itagonists, highly selective vagotomy (HSV) re¬
ams an important—in many centres the most im-
jrtant—surgical contribution to the management of
lis condition. The immediate and long-term seque-
e of H2 receptor antagonist treatment have been
ihaustively researched in what is arguably the most
orough post-marketing surveillance study to which
ly new drug has been subjected (4-6). The aim of
e present study was to document the complications
id side effects of HSV. For this purpose 500 cases
ere analysed to assess the safety of the operation in
>th the short and the long term.
MATERIAL AND METHODS
e series comprised 500 consecutive patients who under-
nt HSV over a 15-year period, from August 1973, in the
strointestinal Unit or the Surgical Unit of the Western
neral Hospital or the associated Surgical Unit at Leith
tspital. The case distribution per year is shown in Fig. I.
All cases were documented prospectively, and all complica¬
tions diagnosed during the postoperative in-patient stay
were recorded. The patients were thereafter followed up
either at an evening clinic, or by postal questionnaire or a
home visit supplemented, when necessary, with telephone
calls, using procedures described in detail elsewhere (10, 11,
18).
Before patients were approached for follow-up, their gen¬
eral practitioners were contacted for information regarding
vital status. If patients had died, the cause of death was
obtained from the death certificate.
All but one of the 500 operations were elective. The male/
female ratio was 365/135 (73%/27 %) and the median age
was 39 (range 12-71) years. Table I shows that at the time of
operation 76.4% of the patients were cigarette smokers.
Previous complications of the ulcer were perforation in 29
cases (5.8%), haemorrhage in 121 (24.2%) and both haemor¬
rhage and perforation in 12 (2.4%).
The operations were performed by eight consultants (235
operations), nine senior registrars and 29 registrars (39 and
226 operations). Concomitantly performed surgical proce¬
dures are listed in Table II. Unit policy dictated that all
patients aged >40 years and all those considered to be at
high risk routinely received low-dose subcutaneous heparin.
Prophylactic antibiotics were not used. Recurrence rates
were calculated with Cox hazards regression analysis.
RESULTS
Peroperative complications. An oesophageal tear oc¬
curred during dissection of the oseophagus in two
patients. It was repaired with suture in one case and
Thai patch in the other. Both patients made an un¬
eventful recovery and have remained symptom-free
for 4 and 9 years, respectively. Splenic trauma neces¬
sitated splenectomy in three patients, none of whom
subsequently had infective complications. No patient
died during the postoperative hospital stay or in the
30 days after surgery.
Postoperative morbidity. No myocardial infarction
or pulmonary embolism occurred in the postoper¬
ative period. The postoperative complications are re¬
corded in Table III. Pulmonary infection was defined
as clinical or radiologic manifestations and produc¬
tion of purulent sputum, and 90% of these infections
occurred in smokers. Wound infection denoted ery¬
thema of the wound with production of pus or fluid
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OPERATIONS
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Fig. 1. Number of highly selective vagotomies performed
yearly from 1973 and prospectively evaluated.
from which pathogenic organisms were cultured. In¬
tra-abdominal haemorrhage included patients in
whom the diagnosis was made clinically or on the
basis of vital signs, excessive drainage or fall in hae-
moglobin/haematocrit. Transfusion ofwhole blood or
red-cell concentrate was necessary in four cases, one
requiring laparotomy and splenectomy. One of the
two cases of necrosis after the lesser gastric curvature
was successfully treated conservatively, but partial
gastrectomy had to be performed (after 17 days) in
the other. Perforation of duodenal ulcer occurred on
postoperative day 8 in a 12-year-old boy (the youngest
patient in the series) and was treated with simple
closure at laparotomy.
Length of in-patient stay. The total hospital stay for
the 500 patients was 5 491 days, i.e. an average of 10.9
days, with 7.8 (range 2-70) days postoperatively. The
postoperative stay exceeded 14 days in 22 cases, and
in six it was more than 21 days. The complications in
these six cases are summarized in Table IV.
Long-term mortality. Fifty patients had been lost to
follow-up by August 1990. Twenty-two of the remain¬
ing 450 had died. The causes of death are listed in
Table V. The numbers are too small to permit analy¬
sis of or conclusions on the influence of the operation
on postoperative survival or cause of death. The re¬
maining 428 patients responded to a standardised
questionnaire.
Table I. Preoperative smoking habits
Males Females Total
Smokers 271 111 382 (76.4%)
Ex-smokers 34 11 45 (9.0%)
Non-smokers 60 13 73 (14.6%)
Total 365 135 500
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Repair of oesophageal injury 2
"Take down" gastroenterostomy 2
Appendectomy 1
Small-bowel resection for carcinoma 1
Gastrotomy 1
Vasectomy 1
Recurrent ulcer and its complications. At follow-u
ranging from 1 to 16 years, 64 patients had had recui
rence of ulcer. With life table analysis this represent
a cumulative ulcer recurrence rate of 17.5% by 1
years and 18.5% by 15 years (Table VI), figures i
keeping with our previously published (11) recurrenc
rate.
Upper gastrointestinal bleeding from recurrent ui
cer in the duodenum or stomach occurred in 14 pr
tients. Only two had subsequent perforation, incluc
ing the previously mentioned 12-year-old patient.
Late postoperative complications. Gastric stasis dt
veloped in seven patients, all within 12 months of th
original operation. In each case the disordered moti
ity was demonstrated by barium meal. Treatmer
consisted of truncal vagotomy and gastroenterostom
(2 cases), gastrojejunostomy alone (2), pyloroplast
alone (2) and Polya gastrectomy (1). The incidence c
stasis and other late postoperative complications i
shown in Table VII, where the differences in liste








Anaemia (requiring transfusion) 1
Subphrenic collection 11
Intestinal obstruction/protracted ileus 1/2
Acute gastric dilatation/gastric stasis 1/1
Necrosis of lesser gastric curvature 2




Acute urinary retention 2
able IV. Complications in patients with postoperative
tay >21 days
lase Sex/ Days of
o. age stay Complications
M/40 23 Intra-abdominal haemorrhage,
splenectomy, wound infection
F/46 70 Necrosis of lesser curvature,
laparotomy and drainage of
abscess in lesser sac
Second laparotomy—partial
gastrectomy
M/38 22 Prolapsed piles—
haemorrhoidectomy
M/52 31 Subphrenic collection—
laparotomy, drainage
M/48 39 Pulmonary infection
M/12 54 Perforated duodenal ulcer—
laparotomy
)tal cases resulted from failure of patients to reply to
le specific question. Only four of the 16 patients who
amplained of diarrhoea stated that it was a daily
ccurrence, with stools averaging 25 per week. No
atient had had explosive diarrhoea or faecal inconti-
ence. Dumping symptoms were reported by 22 pa-
ents (7.3%) but occurred daily in only 17. Bloating
as the commonest postoperative symptom occur-
ng in 36 (8.8%) but 16 of the patients with daily
loating nonetheless regarded the HSV as successful.
Medication. Of the 413 patients who answered the
uestion on medication, 47 were taking antacids daily
r on most days, and 16 of these also took H2 receptor
ntagonists at similar intervals. A total of 50 patients
2.1 % of the responders) took H2-blockers daily or
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Table VI. Life table analysis of ulcer recurrence rate
Year of









most days. Altogether 79 (19.1%) required medica¬
tion for dyspepsia regularly or frequently.
Revisional surgery. The revisional operations for
perforation or stasis after the original HSV have al¬
ready been described. They are listed in Table VIII
along with 28 revisional procedures for recurrent ul¬
cer. These latter were performed by five consultants
and three surgeons in training (23 and 5 operations,
respectively). There was no operative mortality. The
most serious complications were anastomotic leak af¬
ter a Roux-en-Y gastrectomy and efferent loop ob¬
struction following a Polya gastrectomy. Both compli¬
cations were successfully managed conservatively.
Pulmonary infection developed in eight patients and
wound infection in three. Intra-abdominal haemor¬
rhage occurred after Polya gastrectomy in one case,
but did not require laparotomy.
The surgical treatment was judged to have been
successful by 375 (85.8%) of the 437 patients who
answered the relevant question, while 62 (14.2%)
considered it unsuccessful.
able V. Causes ofdeath during follow-up
No. of


















The decline in elective surgery for duodenal ulcer
during the period of the present study (Fig. 1) reflects
the trend throughout the western world (1-3, 8, 12,
19). Omeprazole seems certain to bring about further
reduction of referrals for surgery from primary care
Table VII. Late postoperative complications experi¬
enced daily or on most days
No. with complication/
Complications total replying to question
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Table VIII. Revisional surgery
No. of
Revision required by Revisional operation cases
Perforation Simple closure 2





Recurrent ulcer" Polya gastrectomy 9
Roux-en-Y anastomosis 1
Billroth I gastrectomy 4
Truncal vagotomy + 3
antectomy
Truncal vagotomy + 3
gastroenterostomy
Truncal vagotomy + 3
pyloroplasty
Truncal vagotomy only 1
Gastroenterostomy only 4
" Recurrent duodenal ulcer with or without pyloric stenosis
and pyloric or prepyloric ulcer.
and medical units. H2 receptor antagonists are de¬
monstrably safe. The evidence for possible carcino¬
genicity is slim (9, 14). The weight of opinion against
carcinogenicity of Omeprazole (15) was demonstrat¬
ed by release of the drug onto the market.
Against this impressive pharmacological competi¬
tion, is there still a role for highly selective vagotomy
in the treatment of duodenal ulcer? For long-term
prevention of ulcer recurrence HSV is more effective
than H2 receptor antagonists. In a previous analysis
of series with more than 5 years of follow-up we found
cumulative rates of ulcer recurrence around the mid-
teens of percentage in most studies (11). In one long-
term follow-up after H2 receptor antagonist treat¬
ment, the symptomatic recurrence rate at 6 years was
16% (16), and in a study from general practice 76 % of
patients given continuous therapy over 5 years and
100% of those treated intermittently developed clini¬
cally important symptoms (20).
Among patients receiving Ranitidine for 2 years as
maintenance treatment after haemorrhage from du¬
odenal ulcer, 44% were reported to have recurrence
of ulcer or erosions (13). Our study, like many others,
showed HSV to be effective in preventing haemor¬
rhage and perforation in patients who originally pre¬
sented with these complications.
We believe that ulcer recurring after HSV repre¬
sents a less aggressive form of the disease, resulting in
fewer perforations and bleeds and more amenable to
medical therapy. For this reason the Visick system,
which assigns to grade 4 any recurrent ulcer, is no
longer felt to be appropriate in assessing the outcome
of surgery for duodenal ulcer.
Like other investigators (7, 21), we previous!
showed (10) that the failure rate after HSV is nc
higher in ulcers "resistant" to H2 blockers than i
ulcers that initially responded and subsequently n
lapsed. At least one study, however, did not share th:
conclusion (17).
If the effectiveness of HSV in controlling ulcer di:
ease is equal to or exceeds that of H2 receptor antagc
nists. relegation of HSV as a treatment method mu:
result from concern that it is less safe. The preser
study showed that HSV can be performed withot
immediate or long-term mortality. Serious postope:
ative complications arose in only three of the 50
patients (Cases 1, 2 and 4 in Table IV), and in none c
the three was the complication life-threatening or pre
ductive of long-term sequelae.
Has HSV been discredited by the postoperativ
sequelae that brought about the demise of previor
ulcer operations? In this series 5.4% of the patienl
complained of dumping and 3.8% of diarrhoea. Th
explosive, urgent diarrhoea described after trunc;
vagotomy was never experienced.
This study has shown HSV to be a safe operatio
for duodenal ulcer disease. It appeared to cure th
ulcer diathesis during the period of the review i
more than 80% of patients. HSV was found to b
particularly effective in preventing the complicatior
of duodenal ulcer in patients who had previousl
experienced such complications, and in our hanc
proved effective in patients with ulcers resistant t
H2 receptor antagonists. The sequelae which dogge
earlier ulcer operations were much less commor
while the incidence of complications specific t
HSV—antral stasis and lesser curve necrosis—wr
1.4% and 0.4%, respectively.
It is ironic that HSV, having been shown to be sal
and effective, is now disappearing from the surgic;
armamentarium and may prove to be the last surgic;
contribution to management of duodenal ulcer di;
ease.
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